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A B S T R A C T
The human microbiota is defined as the collective microbes living
on and in the human body. Microbes can confer many benefits to
the host including pathogen protection, complex carbohydrate break-
down and essential compound biosynthesis. Imbalances in the micro-
biome have been linked to disease, in particular obesity. The aim of
this thesis is to explore the genetic and environmental effects on the
human gut microbiome in twins, and characterise the microbiome
species related to obesity. The primary dataset included gut micro-
biome 16s profiles of 982 twins from the TwinsUK cohort with exten-
sive phenotype data.
I first explored the heritability of the gut microbiome and obesity
using twin modelling. The results revealed several heritable families,
including the most heritable family, Christensenellaceae, which was
also associated with lean BMI and measures of adiposity, including
visceral fat. In addition, I found further associations between Chris-
tensenella and immune-related phenotypes such as white blood cell
count, as well as host immune genetic variants.
The next major analysis focused on identifying gut bacterial species
that significantly differed between obese and lean individuals. I refer
to these analyses as a Microbiome-Wide Association Study (MiWAS).
The majority of the significant MiWAS results in obesity were ob-
tained for members of the Ruminococcaceae and Lachnospiraceae.
A candidate gene analysis was performed which aimed to identify
obesity-associated human variants linked to these microbes. The strongest
association was obtained between Lachnospiraceae and a variant within
the human RPTOR gene, which controls the insulin-signalling path-
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way in response to nutrient availability by either binding or disso-
ciating from MTOR. This finding and further associations of Lach-
nospiraceae with insulin, diet and cholesterol measures implicate a
role for Lachnospiraceae in insulin resistance as well as obesity.
The final project explored the association between the gut micro-
biome and metabolites in serum, plasma and faeces. First I identi-
fied associations between serum and plasma metabolites. The peak
serum & plasma metabolite signals were obtained with the metabo-
lites palmitate and cholesterol, which both play an important role
in human metabolic health. The top associations were with the fam-
ily Christensenellaceae indicating the importance of this microbial
family not only in obesity, but also in extended metabolic pheno-
types. Next, I obtained strong signals both between adiposity and
faecal metabolites as well as with 16S microbial profiles. This indi-
cates a useful role for faecal metabolomics as well as serum/plasma
metabolomics in future phenotypic analyses.
In conclusion, my thesis explored the genetic and environmental
basis of the human microbiome in twins, identifying host genetic in-
fluences on the gut microbiome. The project also aimed to charac-
terise the human gut microbiome in obesity. The results confirm and
extend previous findings of obesity-related microbiome profiles, and
identify interesting host genes that may provide a starting point to
understand the interaction of host genetics with the gut microbiome
in human metabolism and obesity.
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Part I
B A C K G R O U N D
1
I N T R O D U C T I O N
The complexity of the human microbiome and its effect on human
health has been the focus of research in recent years. Composed of
mainly bacteria and archaea, these microbes make up approximately
100 trillion cells and live in a complex symbiosis with the host, pro-
viding pathogen protection and carbohydrate processing in return for
a safe environment and nutrients. It is believed a healthy human pos-
sesses up to 15,000 species across all body sites, including the oral
cavity, gut (via faecal samples), skin and vagina, but other, perhaps
more invasive, areas are being increasingly studied such as the colon,
lung and conjuctiva. In this Chapter I will provide an overview of
variation in the human microbiome and how dysbiosis, defined as a
microbial imbalance either on or in the human body, in host microbial
communities has been linked with disease.
1.1 spatial variation
The human body possesses a number of sites and niches that mi-
crobes can colonise, and the diversity and structure of these colonies
can vary greatly from site to site. The first study to categorise the dif-
ferences in microbial communities between body sites was Costello
and colleagues in 2009 [Costello et al., 2009]. Microbial communities
assayed from hundreds of samples, collected from various body sites
including the gut, external auditory canal, nasal cavity, oral cavity
and a selection of skin sites, clustered according to the body site sam-
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pled during PCoA analysis which explained the majority of the varia-
tion in microbial community composition. Skin had the highest level
of intrapersonal variation while the oral cavity had the lowest vari-
ability. Both the gut and the skin were approximately equal in terms
of having high interpersonal variability, likely due to the persistent
exposure to environmental variables. In terms of taxa, the forehead,
nose and ear possessed similar abundant taxa, in particular Propioni-
bacteriaceae, but these sites were very different to areas elsewhere
on the skin such as the palm of the hand or the sole of the foot. A
subsequent study also found the same trend in body site diversity,
showing the oral cavity and gut to have the highest diversity [Hutten-
hower et al., 2012].
It has been established that an individual only shares approximately
17% of their microbes on their palms, and only 13% of bacteria are
shared between unrelated hands [Fierer et al., 2008], showing that
both interpersonal and intrapersonal variation in the human gut mi-
crobiome is vast.
1.2 temporal variation
The structure of human microbiome is constantly shifting from day to
day, reacting to the various environmental pressures imposed upon
it. The earliest study to address temporal shifts in the microbiota
was performed by Caporaso and colleagues in 2011 [Caporaso et al.,
2011]. Principle coordinates analysis (PCoA) revealed that samples
clustered according to body site in high concordance with the re-
sults observed in the Costello et al. [2009], and that this clustering
was highly stable over time while still showing variation within body
sites. Furthermore, microbes in each person could either be classi-
fied as transient, being acquired and lost over short periods of time,
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or persistent, remaining in the community for long periods of time
but not long enough to be considered a core microbiota member. A
later study [Flores et al., 2014]) revealed that this temporal variation
differs dependent upon the body site. Forehead and palm sites pos-
sessed higher temporal variation in alpha diversity, and this variation
appeared to be driven by the acquisition of transient taxa. Given the
exposure of these two sites to constant environmental pressures, it is
perhaps unsurprising to observe a higher level of variation over time
here. Temporal variation within internal sites such as the gut and
tongue however, appeared to be driven by the shifts in relative abun-
dance of species present and it was impossible to use the variability
of one site to predict the variability of another.
The microbiome has been shown to fluctuate with the seasons [Dav-
enport et al., 2014]. The Hutterites are an isolated population of com-
munal emigrants from Europe, making them an ideal population for
study due to less heterogeneity in environmental factors and lower
genetic diversity. They consume three meals a day in a communal
setting, using fresh produce they grow themselves and recipes that
have changed little in the 150 years since settling in America. It was
in this population of people that Davenport et al (2014) found distinct
shifts in microbiota composition from Summer to Winter and this is
likely due to the availability of produce at certain times of the year.
As reported in the paper, in the Summer, food containing high lev-
els of complex carbohydrates were consumed, potentially explaining
the increase in Bacteroidetes. Members of the Bacteroidetes possess
a large number of carbohydrate processing genes [Flint et al., 2012]
increasing the probability that this family of microbes is important
for the degradation of complex carbohydrates.
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1.3 core microbiome and host genetics
The subject of a core microbiome has been the centre of some debate
since conception of the idea. The core microbiome theory postulates
that some microbes are found in everyone, regardless of relatedness
or environmental pressure because of the essential role they perform
for the host [Turnbaugh et al., 2007]. In murine mouse models, a core
gut microbiome of approximately 64 taxonomic species was defined
[Benson et al., 2010] and these accounted for over 90% of the overall
sequence reads. An additional human study found 35% of reads from
the gut could be mapped to other samples, suggesting the presence
of a core microbiome [Qin et al., 2010]. Yet as the skin shows less than
13% similarity between unrelated individuals, this raises the question
of a difference in core communities across sites. The Human Micro-
biome Project (HMP) sought to define a core microbiome across indi-
viduals and sites [Huse et al., 2012]. In order to define a core micro-
biome, researchers set a threshold requiring operational taxonomic
units (OTUs), that is closely related sequences that cluster together
representing a taxonomic unit, to be present in more than 95% of sam-
ples for a given site to be considered a core OTU. At this threshold,
the oral cavity displayed the largest core group, possessing between 7
and 22 core OTUs dependent upon the site sampled, and there were
4 OTUs shared across all oral sites. The vagina displayed the lowest
number of core OTUs (n=3). Only one OTU was present across all
skin sites (Propionibacterium) and no OTU was present across all sites
and individuals. In concordance with the Benson et al study [Benson
et al., 2010], the most abundant OTUs also tended to be the most
prevalent.
Caporaso et al however, discovered little evidence for a core micro-
biome over time, at multiple thresholds for defining core microbiome
25
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membership [Caporaso et al., 2011]. The cut-off that determines what
should be considered a core OTU is subjective and indeed, whether
we should be defining a core microbiome by OTU membership is sub-
ject to debate. While consensus about a taxonomic core microbiome
is lacking, it does appear that there is a ’functional’ core. Using ap-
proximately 150 obese and lean twins and their mothers, Turnbaugh
et al. [2009a] discovered that while microbial profiles changed across
people and time and displayed high levels of β-diversity, their gene
profile, and thus predicted functional profile, remained highly stable.
This was later confirmed in the larger HMP dataset using metage-
nomics [Huttenhower et al., 2012]. It is perhaps best to consider the
microbiome in terms of its functional relevance. This is demonstrated
in obesity and IBD where use of metagenomic sequencing and KEGG
annotation revealed an enrichment of genes involved in membrane
transport [Greenblum et al., 2012]. This may suggest an alteration in
how obese microbiomes interact with the host. Another earlier study
in mice revealed the obese microbiome has an enhanced capacity to
harvest energy from consumed food [Turnbaugh et al., 2006] while in
adolescent humans, an obese microbiome showed an increased abil-
ity to synthesise butyrate, an essential colonic energy source [Ferrer
et al., 2013].
While the presence of a core microbiome may continue to be de-
bated, the idea that there may be such an essential group of microbes
naturally leads one to question whether or not this ’core’ or indeed
the presence of any other microbes, may be driven by host genet-
ics. Twin studies can provide a simple model for dissecting the host
genetic and environmental influences underlying a phenotype, such
as the presence or relative abundance of a microbe. It is assumed
that if a trait were caused by host genetics, then monozygotic twins
would have more similar trait values, compared to DZ twins because
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MZ twins share nearly identical genomes while DZ twins on average
share only 50% of their genetic variants. However the assumption
here is that environmental effects for the two types of twins, as well
as between twins within a pair, are the same, although this is not
necessarily correct.
A number of studies have demonstrated that microbiomes are more
similar between monozygotic twins versus dizygotic twins [Zoetendal
et al., 2001, Stewart et al., 2005, Turnbaugh et al., 2008]. These find-
ings suggest that there may be a host-genetic component driving the
microbiota. However, our recent large-scale study using almost 1000
twins performed an extensive heritability analysis to determine the
contribution of host-genetics to every single OTU found within the
sample [Goodrich et al., 2014]. I will discuss this in more detail in
Chapter 3 where I outline my own contributions to this paper.
Genetic studies in the human host often require large numbers of
study subjects to find effects associated with common genetic vari-
ants because the majority of common genetic effects tend to have
moderate to modest effect sizes on human traits. The latest obesity
genome-wide association study (GWAS) was a meta-analysis with a
total study size of 339,224 individuals [Locke et al., 2015]. This larger
study was able to detect new loci with a lower minor allele frequency
(MAF) than previously found. However the loci discovered to date
still only explain 2.7% of the variance seen in obesity, despite the
obesity’s high heritability. This demonstrates the difficulty of finding
genetic effects in small populations unless the effect size is quite large.
With microbiome studies being mostly limited in sample size, many
using only a couple of hundred individuals, GWAS approaches tend
to be extremely underpowered to detect host genetic variants that
associate with microbes. Candidate gene approaches have had some
success with microbiota studies however, particularly in mouse mod-
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els. A number of genes have been found to be associated with changes
in the microbiota including Apoa1 [Zhang et al., 2010], Nod2 [Frank
et al., 2011, Natividad et al., 2012] and Nlrp6 [Anand et al., 2012]. As
over 90% of the mouse genome is conserved in humans, mice are
good model organisms for studying the relationship between host
genetics and microbiota.
1.4 influence of the environment on the microbiome
The environment is the largest factor affecting the human microbiome.
The number of pressures it can apply is vast and we see the results
of this in the high level of interpersonal variation in microbiotas.
1.4.1 Diet
Diet is perhaps the most significant environmental pressure on the
human gut microbiome and there have been a number of studies out-
lining the implications that diet may have upon gut bacteria. Mouse
models have shown that consumption of a high fat diet leads to
changes in the colonic bacteria [Hildebrandt et al., 2009, Turnbaugh
et al., 2009b] and another, more recent study has revealed that this
alteration may influence mood and depression [Bruce-Keller et al.,
2015]. Dietary fat is not the only aspect of diet that can alter the gut
microbiota. Reductions in the amount of carbohydrate consumed has
a resultant effect on the levels of butyrate produced in the gut [Dun-
can et al., 2007], perhaps indicating a less acidic environment in the
gut that may not be suitable for short chain fatty acid (SCFA) fer-
mentation. Vegetarianism also has a profound effect upon the gut
microbes [David et al., 2014, Zimmer et al., 2012], with lower levels
in Bacteroides observed in vegan and vegetarian samples. Dietary fi-
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bre has been studied extensively in microbiome research due to the
benefits to both colonic health and microbial communities. Consump-
tion of dietary fibre results in an increase of butyrate and other SCFA,
and also leads to the increase of bacteria considered to be beneficial
for health, such as Bifidobacterium and Lactobacilli [Shen et al., 2012,
Arora et al., 2012] and the effects of this have been linked to allergy
[Trompette et al., 2014], IBD [Thibault et al., 2010] and even autism
[Macfabe, 2012]. Dietary interventions are the best method to observe
changes in the human microbiota, and further studies are required to
fully tease apart the underlying mechanisms that drive dietary effects
upon the gut microbiome.
1.4.2 Co-habitation
Diet, while perhaps the most influential factor, is not the only environ-
mental pressure that can influence the human microbiota. Living with
other people in the same household has an effect upon your micro-
bial communities, as does in fact, living with a dog [Song et al., 2013].
In this study it was found that couples living together shared more
microbes than individuals living in different households. In addition,
if there was a pet dog living in that household then the microbiome
of the owners would be more similar to their own dog than to dogs
in other households.
1.4.3 Smoking
There is some evidence to suggest that smoking affects the intesti-
nal microbiota. Smoking cessation results in an increase in overall
microbial diversity as well as an increase in the relative abundance
of Firmicutes and Actinobacteria [Biedermann et al., 2013]. Despite
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the interventional nature of the study, the sample size (10 subjects)
was quite small and it remains the only published study to assess the
impact of smoking on the gut microbiome. There is however further
evidence to suggest that alterations to both the respiratory tract [Mor-
ris et al., 2013] and oral microbiotas [Mason et al., 2015] are linked
with cigarette smoking.
1.4.4 Method of Delivery
Method of delivery, that is whether or not a baby is born vaginally
or by caesarian section, is thought to affect the human microbial com-
munities. During a natural, vaginal birth, the foetus is forced through
the birthing canal, receiving essential microbes from both the canal
and from any faeces or other matter surrounding the vagina. During
caesarian section however this does not happen and the baby does
not receive this initial dose of microbes. 16s profiling of mothers and
babies delivered naturally or by caesarian section revealed large dif-
ferences in the microbiomes of babies born by the different methods,
particularly with the levels of Lactobacillus [Dominguez-Bello et al.,
2010]. Furthermore, babies delivered via caesarian were no more sim-
ilar to their mothers than any other person. These pertubations can
take up to 6 months to stabilise into a ’normal’ gut profile [Gronlund
et al., 1999] although another study has suggested differences may
be observed as late as seven years [Salminen et al., 2004]. If these dif-
ferences do persist into late childhood, it is as yet unclear whether
this dysbiosis would have any effects on the host health. Studies have
shown that children who are born by caesarian section are at more
risk of developing health issues such as allergy [Negele et al., 2004,
Eggesbo et al., 2003] and obesity [Huh et al., 2012], but there are a
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number of factors that may contribute to these associations that may
not necessarily be linked with the microbiome.
1.5 disease and dysbiosis
Dysbiosis in the human gut microbiome has so far been linked with
a wide range of conditions and illnesses including obesity, IBD &
IBS, cancer, autism and allergy, to name a few. Given how the host
relies on the microbiome for essential functions, it is not altogether
unreasonable to assume that imbalances in the microbiome can result
in disease.
1.5.1 Cancer
A very large observational study (n=3,112,624) in 2008 reported an
increased relative risk (RR) of a number of cancers with antibiotic use
[Kilkkinen et al., 2008], including the most common cancers; breast,
lung, prostate and colon. The observational nature of the study does
not allow for adjustment for confounding factors, such as smoking
which is a known risk factor for cancer, as this data was not collected.
However later studies have confirmed links between antibiotic use
and colorectal cancer [Wang et al., 2014], breast cancer [Sergentanis
et al., 2010, Tamim et al., 2008] and prostate cancer [Tamim et al.,
2010].
A number of studies have linked individual microbes to cancer.
E.coli has been found to be significantly higher in individuals suffer-
ing from colorectal cancer than controls. When mice received E.coli
orally, those receiving E.coli developed more colonic polyps than con-
trols [Bonnet et al., 2014]. It has been suggested that butyrate and
other SCFA produced by the colonic microbiota help to reduce col-
31
1.5 disease and dysbiosis
orectal cancer risk [O’Keefe et al., 2009], potentially by reducing in-
flammation [Arpaia et al., 2013]. This could perhaps explain the link
between low-fat-high-fibre diets and breast cancer [Gorbach, 1984,
Thomson, 2012], given that high fibre diets help to produce SCFA,
while oestrogen, a known causative risk factor for breast cancer, can
be metabolised from cholesterol. Breast cancer patients have also been
shown to have a lower bacterial diversity in the gut, independent of
oestrogen levels [Goedert et al., 2015].
1.5.2 Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD) is not just one disease, but a group
of inflammatory disorders of the gut, principally Crohn’s disease and
ulcerative colitis. In Crohn’s patients it was found that in the gut
both Bacteroidetes and Proteobacteria were more abundant while
Clostridia (of the Firmicutes phylum) were reduced [Gophna et al.,
2006, Frank et al., 2007]. While the findings are not any indication of
causation, the reduced abundance of Clostridia may have potential im-
plications on the production of SCFA including butyrate, thus leading
to inflammation.
Perhaps most intriguingly with Crohn’s disease in particular is the
effect mutations in the gene NOD2 may have upon the gut micro-
biome. NOD2 is a known Crohn’s disease susceptibility gene [Ogura
et al., 2001], and acts a sensor for the bacterial cell wall peptidogly-
can, muramyl dipeptide (MDP) [Girardin et al., 2003]. NOD2 is pri-
marily expressed in the Paneth cells in the intestinal ileum [Stappen-
beck et al., 2002] and thus likely to be important for host defence.
Presence of NOD2 mutations have been associated with changes in
the human gut microbiota, particularly a decrease in Faecalibacterium
and Escherichia [Frank et al., 2011]. Nod2-deficient mice show a re-
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duced ability to prevent colonisation of pathogenic bacterial species
[Petnicki-Ocwieja et al., 2009] and also possess higher loads of both
Firmicutes and Bacteroidetes in the ileum [Rehman et al., 2011].
Probiotic treatment for Crohn’s disease has had variable results,
with some studies showing no difference between the case and con-
trol groups and others showing an effective difference [Saez-Lara
et al., 2015]. This could perhaps be due to host genetic influence of
NOD2 or it may be down to the different strains used in each study.
In ulcerative colitis however, probiotics seem to have a good effect
overall in reducing the symptoms experienced by the host [Saez-Lara
et al., 2015], providing a potential treatment option for sufferers.
1.5.3 Diabetes
Diabetes can be defined as two conditions: type 1 diabetes (T1D) and
type 2 diabetes (T2D). T1D is characterised as the lack of insulin
caused by the autoimmune destruction of pancreatic beta cells and
patients require regular insulin injections to keep their glucose levels
within the normal range. The cause of T1D remains unknown and it
contributes to between 5-10% of all diabetes cases [Daneman, 2006].
T2D is characterised as insulin resistance leading to hyperglycaemia.
High glucose and fatty acid levels lead to the phosphorylation of
the IRS-1 receptor, and thus its impairment. This receptor no longer
binds to insulin and glucose accumulates in the blood. A mixture of
lifestyle factors and host genetics play a role in T2D but it can be man-
aged through dietary adjustment and reduction of any cardiovascular
risk factors the patient may have, for example, obesity.
Only 50% of monozygotic twins will show concordance in present-
ing T1D and in dizygotic twins the concordance rate dips to 10%
[Achenbach et al., 2005]. This suggests that extraneous environmen-
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tal factors must be responsible in part for triggering the disease. Re-
search that followed infants predisposed to T1D found a marked
change in microbial alpha diversity of infant guts that went on to
develop T1D, more specifically, the alpha diversity changed in the
window between seroconversion and T1D diagnosis [Kostic et al.,
2015]. Diabetes-induced rats that were fed dahi, an Indian fermented
dairy product containing Lactobacillus acidophilus and Lactobacillus ca-
sei, showed delayed onset of diabetic symptoms [Yadav et al., 2007].
Furthermore, germ-free NOD mice will develop diabetes however,
NOD mice raised in specific pathogen free conditions will not present
with diabetes, suggesting that key components of the microbiome
may act as a trigger for the progression of T1D [Wen et al., 2008].
1.5.4 Obesity
Obesity is one of the most well-studied diseases in terms of micro-
biome dysbiosis. Mouse models were used to discover the initial link
between obesity and the microbiota. Taking germ-free mice and in-
oculating them with the microbiota of conventionally raised mice
led to a 60% increase in body fat of the germ-free mice [Backhed
et al., 2004]. Furthermore, genetically obese mice revealed an increase
in Firmicutes members compared with lean littermates [Ley et al.,
2005]. This increase in Firmicutes was observed in a number of stud-
ies including in humans [Ley et al., 2006] however not all studies
found this trend [Duncan et al., 2008], and one study even reported
the opposite [Schwiertz et al., 2010]. A meta-analysis of obesity stud-
ies concluded that there were no consistent microbial signatures of
obesity across studies [Walters et al., 2014]. Consumption of a fat
or carbohydrate-restricted diet that resulted in weight loss also al-
tered the ratio of Firmicutes to Bacteroidetes [Ley et al., 2006]. This
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so-called Bacteroidetes:Firmicutes ratio imbalance between obese and
lean individuals was found to favour energy harvest in obese sub-
jects [Turnbaugh et al., 2006] suggesting that the dysbiosis observed
in obese individuals helped them to extract more energy from food.
Diet-induced obesity (DIO) was also transmissable by inoculating
germ-free mice with the gut microbiomes of DIO mice [Turnbaugh
et al., 2008] suggesting a causative role for the microbiome in the
progression of obesity.
Research has begun to move towards pinpointing particular mi-
crobes that may influence obesity. When Bacteroides thetaiotaomicron
cocolonises with Methanobacteria brevii, adiposity in the host increases,
potentially due to the ability of this pairing to ferment dietary fruc-
tans [Samuel and Gordon, 2006]. In our collaborative study, it was ob-
served that M. brevii co-occurs with Christensenella minuta and when
mice were inoculated with twin microbiomes containing C. minuta,
those receiving C. minuta gained less weight than those who did not
receive it [Goodrich et al., 2014]. More detail on these analyses can
be found in Chapter 3 and Chapter 4. Strains of Lactobacillus and
Bifidobacterium may have a beneficial effect on adiposity reduction
and weight gain [Mekkes et al., 2014, Wang et al., 2015] providing a
promising probiotic weight-loss treatment option to explore.
Obese individuals often have reduced gut microbial alpha diver-
sity [Goodrich et al., 2014, Turnbaugh and Gordon, 2009] showing
that not only are the types of bacteria present in the gut different dur-
ing obesity, but that there are fewer species in evidence. This may be
an indication of the dietary and behavioural differences between lean
and obese individuals, given that isolated hunter-gatherer communi-
ties such as the Amerindians and Hadza tribes have the most diverse
microbial communities of any group of humans studied [Clemente
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et al., 2015, Schnorr et al., 2014] while also possessing active lifestyles
and a diet that is diverse and varies with seasonal availability.
1.6 aims
The aim of this research is to explore genetic and environmental influ-
ences on the gut microbiome in twins, to characterize the human gut
microbiome in obesity, and to relate these findings to metabolomic
profiles. To this end, I first applied twin modelling approaches to as-
sess gut microbiome heritability and explore microbial associations
with specific enviromental factors in Chapter 3. I then pursued large-
scale analyses of the gut microbial profiles in twins with respect to
obesity, adiposity, and related phenotypes in Chapter 4 and Chap-
ter 5. Visceral fat is traditionally difficult to measure and as such, hu-
man microbiome analyses with visceral fat have yet to be performed.
I addressed visceral fat and the microbiome in this thesis. In addi-
tion I explored the hypothesis that host genetics may influence the
observed microbial associations in obesity. Lastly, I tested for asso-
ciation between gut microbial profiles and human blood and faecal
metabolomics datasets, and explored the findings in the context of
kidney function and obesity in Chapter 6.
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Part II
R E S E A R C H
2
D ATA A N D M E T H O D S
2.1 data
There are a number of subsets used within this body of research
for each of the different analyses. This section will describe each
dataset and the methods used to collect this data. Table 1 provides
an overview of each dataset used in each thesis section and subsec-





MZ DZ Singletons Male Female
Full 16S Dataset 1081 342 490 145 104 20 1061
Subsets
Chapter 3 Section 3.2.1 Heritability of the Gut Microbiota 1081 342 490 145 104 20 1061
Section 3.2.2.1 Diet 838 278 422 138 0 0 838
Section 3.2.2.2 Method of Delivery 536 124 328 84 0 0 536
Section 3.2.2.3 Smoking 851 268 374 209 0 17 834
Chapter 4 Section 4.2.1 Christensenella vs Adiposity 960 344 474 142 0 19 941
Section 4.2.2 Christensenella vs Inflammation 913 349 441 123 0 3 910
Section 4.2.3.1 Adiposity Candidate Gene Analysis 886 320 440 126 0 13 873
Section 4.2.3.2 Immune Candidate Gene Analysis 886 320 440 126 0 13 873
Chapter 5 Section 5.2.1 Heritability of Adiposity 726 310 416 0 0 14 712
Section 5.2.2 Diversity vs Adiposity 960 344 474 142 0 19 941
Section 5.2.3 MiWAS Obesity 960 344 474 142 0 19 941
Section 5.2.4 Candidate Gene Analysis 886 320 440 126 0 13 873
Chapter 6 Section 6.2.1 Metabolite-wide, microbiome wide AS 831 272 428 131 0 10 821
Section 6.2.4 Kidney Function with Microbiome 854 288 414 152 0 15 839
Section 6.2.5.1 Faecal Metabolomics with Obesity 49 42 0 7 0 0 49
Section 6.2.5.2 Faecal Metabolomics with 16S 27 22 0 5 0 0 1
Table 1: Description of all datasets used within this thesis, arranged by chap-
ter.
2.1.1 Diet Data
Diet data in the TwinsUK cohort was previously collected, described
and validated [Teucher et al., 2007]. Participants were asked to com-
plete a 131-item food frequency questionnaire (FFQ), from which nu-
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trients were derived and food items placed into groups based on sim-
ilarity in nutrient content. Each food group had a frequency of intake
calculated (Σ servings/week) that was then adjusted for total energy
intake, and the resultant residuals where subsequently analysed us-
ing Principle Coordinates Analysis (PCoA). The first 5 PCs were kept
for further analysis due to their representation of actual dietary pat-
terns and explain 22% of the total variance (Table 2). The FFQs were
conducted at two time points, and an average of the PCs was taken
for further analysis.
Diet PC Dietary Pattern Description
Score 1 Fruit and Vegetable Frequent intakes of fruit, allium and crucifer-
ous vegetables; low intakes of fried potatoes.
Score 2 High Alcohol Frequent intakes of beer, wine and allium veg-
etables; low intakes of high fiber breakfast ce-
reals and fruit.
Score 3 Traditional English Frequent intakes of fried fish and potatoes,
meats, savoury pies and cruciferous vegeta-
bles.
Score 4 Dieting Frequent intakes of low-fat dairy products;
low-sugar soda, low intake of butter and sweet
baked products.
Score 5 Low Meat Frequent intakes of baked beans, pizza and soy
foods; low intakes of meat, other fish, seafood
and poulty.
Table 2: Dietary patterns in the TwinsUK cohort.
2.1.2 Method of Birth Data
Method of birth is collected from every subject via the first question-
naire they complete upon registering with the TwinsUK cohort. Rate
of caesarian section in this cohort is approximately 4% which is much
lower than the current national average of just over 50%
(http://www.nhs.uk/conditions/pregnancy-and-baby/pages/giving-
birth-to-twins.aspx), however much more representative of the time




als that were unsure of their delivery method were removed from the
dataset.
2.1.3 Smoking Data
Smoking data was collected via a number of questionnaires between
1992 and 2010. Subjects may indicate whether they are a current
smoker, ex-smoker or have never smoked. A final status column was
then created to indicate an overall status for each subject. If a subject
consistently aligned to smoker, ex-smoker or never smoker, they were
given a "clean" code of A, B or C. Subjects that answered inconsis-
tently, but where the majority of responses aligned to one particular
status, were given a provisional code of A4, B4 or C4. For my analyses
I recoded these individuals to 0, 1 and 2 (Table 3).







Responded only ever as a never/non-smoker





Responded only ever as a current smoker or
NA in all questions asked.
No B 1
Yes B4 1
Ex-Smoker Responded as a smoker, followed by responses




Responded as both smoker and ex-smoker in
no clear pattern. NA included.
No D 2
Yes D4 2
Table 3: Smoking coding in the TwinsUK cohort and analyses with 16S data.
2.1.4 Adiposity Data
Adiposity data is collected during a subject’s annual clinical visit.
Visceral fat, % Trunk Fat, Android and Gynoid fat, lean and total
mass as well as subcutaneous fat were estimated using a Dual En-
ergy X-ray Absorptiometry (DEXA) machine, provided by Hologic.
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Due to the different absorption properties of the tissues within the
body, body composition can be estimated by measuring the absorp-
tion of x-rays at two different energies. This provides a non-invasive,
accurate and direct measurement of adiposity [Hill et al., 2007]. Sub-
jects were asked to lie flat, still and straight while a whole-body scan
took place. Visceral fat mass was calculated from one cross-section of
the whole body at L4-L5, the typical location of a CT slice. Height and
weight measurements are collected during the annual visit also, and
BMI was calculated as standard [Eknoyan, 2008]. Android:Gynoid ra-
tio was calculated as android fat divided by gynoid fat.
2.1.5 Blood Cell Counts and Insulin
Blood cell counts, including white blood cell count (WBC), neutrophils,
monocytes, eosinophils, and lymphocytes were measured in blood
samples taken during a subject’s annual clinic visit by the departmen-
tal laboratory using fluorescence activated cell sorting (FACS). Total
white blood cell count was measured as thousands of cells per ml
and subsequent cell sub-type counts were calculated by multiplying
the proportion of the WBC count comprised by each cell type by the
total WBC measure. This data has previously been described in Nalls
et al (2011) PLoS Genetics [Nalls et al., 2011].
Fasting insulin (mIU/L) was measured by immunoassay (Abbott
Laboratories Ltd.,Maidenhead, U.K.) as described in Jamshidi et al.
[2006].
2.1.6 Kidney Function Data
Estimated glomerular filtration rate (eGFR, mL/min/1.73 m2) mea-
sures the clearance of creatine from the blood and was estimated from
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standard blood creatinine using the CKD-EPI equation [Levey et al.,
2009]. Chronic Kidney Disease (CKD) outcome was defined as an
eGFR <60 ml/min/1.73 m2 according to the current Kidney Disease
Outcome Quality Initiative (K/DOQI) guidelines. Both phenotypes
have been previously described in Goek et al. [2012].
2.1.7 Faecal 16S Profiles and Diversity
Subjects were asked to collect a faecal sample at home and bring it
to their annual clinic visit. Samples were collected in a 15mL conical
tube and were refrigerated for approximately 1-2 days prior to the
clinical visit. Recent literature has shown that storage of faecal sam-
ples at 4 ◦C for 3 days prior to freezing at −80 ◦C shows no significant
alterations to the microbial profiles [Choo et al., 2015]. Once received,
samples were frozen and stored at −80 ◦C before being shipped to
Cornell University on dry ice. The following methods in this sub-
section were performed by Julia Goodrich in the Ley Lab at Cornell
University.
DNA was extracted from the 100mg of faecal sample using the
MoBio Power Soil® DNA isolation kit (MoBio Laboratories Ltd, Carls-
bad, CA). PCR was performed using the primers 515F and 806R for
the V4 hypervariable region of the 16S rRNA gene as previously de-
scribed [Caporaso et al., 2011]. PCR was carried out in duplicate us-
ing 2.5 2.5 U Easy-A high-fidelity enzyme, 1 x buffer (Stratagene, La
Jolla, CA), 10-100 ng DNA template, and 0.05 mM of each primer. The
PCR cycles were as follows: initial denaturation at 94 ◦C for 3 minutes
followed by 25 cycles of denaturation at 94 ◦C for 45 seconds, anneal-
ing at 50 ◦C for 60 seconds, extension at 72 ◦C for 90 seconds, and
a final extension at 72 ◦C for 10 minutes. The PCR duplicates were
combined and purified using the Mag-Bind® magnetic bead purifica-
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tion system (EZPure, Omega Bio-Tek, Norcross, GA) then quantified
using the QuantiT PicoGreen dsDNA assay kit (Invitrogen, Carlsbad,
CA). Aliquots were combined to yield a final concentration of approx-
imately 15ng/µl.
Paired-end sequencing was performed on the Illumina MiSeq plat-
form at Cornell Biotechnology Resource Center Genomics Facility.
fast-q join (ea-utils package) was used to merge matched mate pair
reads and reads exceeding 275bp in length were discarded. Sequences
containing unreadable barcodes, ambiguous bases or reads with a
Phred quality score6 25were also discarded. This resulted in 81,634,331
quality-filtered seuqences. QIIME 1.7.0 (Quantitative Insights Into Mi-
crobial Ecology) was used to analyse the remaining sequences. Closed-
reference OTU picking was used to pick OTUs at 97% sequence iden-
tity, against the May 2013 Greengenes database and the taxonomic
assignment given to the reference sequence was given to each OTU
which resulted in 9839 OTUs. Diversity analyses used the Greengenes
phylogenetic tree and β diversity was calculated using an OTU table
that had been rarified to 10,000 sequences per sample. Taxonomic
summaries of the OTUs were generated at six levels from genus to
phylum from the non-rarified OTU table. OTUs that were not present
in over 50% of the samples were further excluded. The final OTU table
was composed of 768 OTUs and 141 taxonomic summaries. This table
was then adjusted for the following covariates using a linear model:
identity of technician (of two), sequencing run (16 instrument runs),





Genotypes were derived from an unselected population of 5654 sub-
jects prior to this research. The genotyping and imputation steps for
the TwinsUK cohort have been described in detail previously [An-
drew et al., 2006, Zhai et al., 2011, Mangino et al., 2009]. Briefly,
genoyping of the TwinsUK cohort was performed using a combina-
tion of Illumina arrays (HumanHap300, HumanHap610Q, 1M-Duo
and 1.2MDuo). A number of quality control steps were previously ap-
plied to these genotype data by other researchers in the department,
including genotype call posterior probability threshold greater than
0.95, and exclusion of SNPs with Hardy-Weinberg (P<1x10-6) and
with minor allele frequencies (MAF) <1%. Imputation to HapMap
variants was performed by Dr So-Youn Shin in Dr Nicole Soranzo’s
group at the Wellcome Trust Sanger Institute. Briefly, the sparser
HumanHap300 dataset was imputed to the HumanHap610Q using
phased TwinsUK HumanHap610Q haplotypes as a reference. Next,
the combined panel was imputed using reference haplotypes from
the HapMap2 project (rel 22, combined CEU+YRI+ASN panels). I ob-
tained this cleaned data then applied further QC, a MAF criteria of
0.05 to ensure rare variants were excluded, thus reducing potential
false positives. Of the 960 individuals with microbial 16S data, 886
were genotyped.
2.1.9 Metabolomics Data
Serum and plasma metabolite profiles in the TwinsUK cohort were
available for 6055 individuals, of whom 831 had available gut mi-
crobiome data and were considered for this work. The metabolite
data were generated by Metabolon Inc and underwent quality con-
44
2.1 data
trol (QC) checks and normalisation procedures by Idil Erte, a PhD
student within the department. Metabolites were isolated from serum
and plasma, and then analysed using ultra-performance liquid chro-
matography tandem mass spectrometry (UPLC-MS/MS) and gas chro-
matography mass spectrometry (GC-MS). With the former technique,
the sample was loaded into a column with a mobile phase, in this
case filled with water, 95% methanol containing 0.1% formic acid or
6.5 mM ammonium bicarbonate, and a stationary phase. This elu-
ent was then subjected to electro-spray ionisation (ESI), sorted by the
mass of its ions by electromagnetic fields and detected. The station-
ary phase for GC-MS was a 5% phenyldimethyl silicone column. The
temperature was increased from 60 ◦C to 340 ◦C over a 17 minute
period before entering the mass spectrometer. Here the sample un-
derwent electron ionisation, then subjected to the mass spectrometer
procedures of acceleration, deflection and detection.
These mass spectrometry values were then compared to a refer-
ence library that used molecular weight, retention time and in-source
fragment values in order to identify the metabolites as known chem-
ical compounds. The metabolite levels were quantile-normalised and
any data points that were greater than 4 standard deviations away
from the mean were removed. Missing data were imputed using the
R package ’mice’ [van Buuren and Groothuis-Oudshoorn, 2011] and
the quantile-normalized values were further adjusted using linear re-
gression for age, serum/plasma, batch, day and BMI.
Faecal metabolites were determined using UPLC-MS/MS with pos-
itive ion mode electrospray, UPLC-MS/MS with negative ion mode
electrospray, GC-MS and LC polar platform at Metabolon Inc. Metabolon
normalised the values in terms of raw area counts. I then performed
further QC on these measurements. I removed any metabolites present
in less than 25% of samples as well as any metabolites that was mea-
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sured as zero or a constant throughout the entire dataset. Metabolites
were inverse normalised then imputed using the R package ’mice’
[van Buuren and Groothuis-Oudshoorn, 2011].
2.2 statistical methods
2.2.1 Linear Mixed Effects Regression
A significant amount of work contained within this thesis focused
on phenotypic associations with 16S profiles in the human gut. All
phenotypic analyses were conducted using the statistical program, R
[R Core Team, 2014] and the package LME4 [Bates et al., 2014]. The
main gut microbiome-phenotype analyses were performed using lin-
ear mixed effects regression (LMER), taking into account twin struc-
ture. Mixed-effects models are particularly effective at describing the
relationship between a response variable, predictors and covariates,
which can be fixed effects or random effects. If a set of possible lev-
els is fixed within a variable, and no further observations will yield
more levels, for example, no matter the number of extra observations,
gender will only have 2 levels: male and female, and as such this co-
variate would be a fixed effect. However if the observed levels were
only a sample of all the possible levels, this would be a random effect.
To test for association between OTUs and phenotypes, I compared
the fit of two LMER models: a null model which excluded the phe-
notype/measure of interest, and a full model, which included pheno-
type/measure of interest in the predictors. All OTUs have undergone
prior adjustment for the following technical covariates, number of se-
quences, technician, sequencing run and shipment batch as well as
age. These models are shown in their simplest form below:
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null : phenotype = sex+ (1|famID) + (1|zygosity)
full : phenotype = OTUs+ sex+ (1|famID) + (1|zygosity)
Using the R package, LME4, I performed the LMER using the mod-
els shown above. In both the null and full models, family ID and
zygosity were taken as random factors, while in the full model each
OTU was added as a fixed effect. Dependent upon the phenotype
studied, additional covariates may have been added to the model.
Each phenotype was normalised to the Gaussian distribution prior to
the analyses, to ensure that each phenotype was normally distributed.
The results from this regression were then analysed using an ANOVA
(analysis of variance) to determine the significance of the difference
between the two models. To account for multiple testing over hun-
dreds of OTUs and taxonomy levels where appropriate, I applied
Bonferroni correction, which is overly stringent as OTUs are not in-
dependent of each other. In some analyses I also applied Benjamini-
Hochberg FDR correction using the R package ’fdrtool’ [Klaus and
Strimmer., 2015], a more relaxed multiple testing correction. This
method takes sorted p-values and divides each p-value by its per-
centile rank.
2.2.2 Discordant MZ analyses
In order to investigate potential non-genetic effects in the microbiome-
phenotype results I explored the data using only monozygotic (MZ)
twins. Taking only MZ twin pairs, I compared the difference in phe-
notype values and the difference in OTU values. That is to say, I took
the difference between twin 1 and 2 for both the phenotypes and the
47
2.2 statistical methods
OTUs, ensuring always to take the low value from the high to pre-
serve signed differences, and compared these by Pearson correlation
in R.
2.2.3 Twin-Based Heritability Estimates
Heritability in this dataset is described in detail in Chapter 3.
2.2.4 Candidate Gene Analysis
Genetic association testing of human genetic variants with gut mi-
crobes was performed at candidate human genes using the open
source program GEMMA (Genome-wide Efficient Mixed Model As-
sociation, [Zhou and Stephens, 2012]). Firstly, a kinship matrix is cal-
culated to account for familial structure within the data. In these
analyses, I calculated the standardized matrix, however a previous
study has shown that it makes little difference which method is used
to create the kinship matrix [Eu-Ahsunthornwattana et al., 2014]. To
perform the candidate genetic association test, I used the univariate
linear mixed model which takes a matrix of covariates and considers
each phenotype of interest (in this case, OTU) individually. GEMMA
tests for association between each specified human SNP and the phe-
notype of interest, and evidence for association is estimated using 3
test statistics: the Wald test, the likelihood ratio test, and the score
test. Results were considered for further investigation if they passed






where the number of loci refers to the total number of genes tested,
and the number of phenotypes refers to the total number of OTUs
(and where appropriate taxonomy levels) tested.
49
3
H E R I TA B I L I T Y O F T H E G U T M I C R O B I O M E
3.1 background
Quantitative genetics is concerned with the study of continuous, or
quantitative, phenotypes and their underlying genetics. These traits
are often influenced by multiple genes but can also be affected by
the environment, such as diet, living conditions and even education.
Therefore, the variance of a phenotype can be described below:
VP = VG + VE
VP = Phenotypic variation
VG = Genotypic variation
VE = Environmental variation
VG can be further subdivided into dominance genetic vari-
ance (VD) and additive genetic variance (VA) and as such can be rep-
resented in the following way:
VG = VA + VD
Additive genetic variation can be described as the cumula-
tive effect of alleles at a given loci i.e. if AA is white and aa is red,
Aa will be pink because the effect is additive. In contrast dominance
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genetic variance is described as the interaction between alleles and
thus in the same scenario, if AA is white and aa is red then Aa will
be white (or red, depending on which allele is dominant), but impor-
tantly will not be the average value between the two homozygotes.
Using this framework we can then calculate heritability of a
trait in a given population, or more simply, how much of the variance
of a trait is attributed to genetics. There are two concepts of heritabil-
ity that can be calculated; Broad-sense heritability, or H2, which is the
ratio of total genetic variance to phenotypic variance:
H2 = VG/VP
and narrow-sense heritability, or h2, which is the sum of additive
genetic variance to phenotypic variance:
h2 = VA + VP
These calculations are not without assumptions however. They
ignore the potential interaction between genetics and environment as
well as potential epistatic interaction, ie. gene by gene interactions.
Family-based studies are ideal for determining heritability
of a given trait due to the relatedness between individuals. There are
three potential family-based studies that can be employed for this
task; Family studies, adoption studies and twin studies. Family stud-
ies are important to establish disease risk for relatives for a disease
that another family member may have. Adoption studies are useful
for teasing apart environmental differences vs genetic by looking at
traits associated with either the biological parents or adoptive parents.
Twin studies are perhaps the most popular choice of family study,
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particularly for heritability. Using the assumptions on the relatedness
between identical (monozygotic) and non-identical (dizygotic) twins,
heritability can be calculated for a given trait. It is on twin studies I
will focus next.
3.1.1 Twin Studies and Heritability
Twin studies provide a simple model for understanding underlying
genetic causes due to the ability to compare monozygotic and dizy-
gotic twins. Twins are the perfect controls for each other; they are the
same age and they possess very similar early-life environmental ex-
posures. This is in addition to their genetic relatedness. Monozygotic
twins are almost 100% identical while dizygotic twins share approx-
imately half their genetic variation. The main assumption of twin
studies is that if a trait were caused by host genetics then monozy-
gotic twins would have more similar trait values compared to DZ
twins because MZ twins share nearly identical genomes while DZ
twins on average share only 50% of their genetic variants, although
this is not necessarily correct.
The ACE model is one approach to calculating twin-based
estimates of heritability [Neale and Cardon, 1992]. In this approach
the classical twin study typically decomposes the phenotype variance
into three components that are attributed to genetics (A), common
environment (C) and unique environment (E) effects. A number of
methods are available to calculate heritability including intra-class
correlations (ICCs) and structural equation modelling (SEM).





where, rMZ represents the correlation in trait values in MZ twins.
Dizygotic twins however, share half their genetic variation and, we
assume, 100% of their common environment therefore:
rDZ = 0.5 ∗A+C
where rDZ is the correlation in trait values in DZ twins. Using this
assumption, A, C and E can be estimated no-matter which method of
calculation is used.
3.1.2 ICC Method
The intraclass correlation (ICC) is a statistical method used to de-
scribe how similar two groups are to each other. This method can be
used to calculate heritability by calculating the ICC between twins,
resulting in rMZ and rDZ. The A component can be estimated by tak-
ing twice the difference between ICCMZ and ICCDZ as monozygotic
twins are twice as similar as dizygotic twins:
A = 2(ICCMZ− ICCDZ)
As we know the ICC is the sum of A and C, we can estimate C by




Finally, to calculate E (unique environment) we consider that A + C +
E is equal to 1, and so we can subtract ICC from 1:
E = 1− ICC
3.1.3 Structural Equation Modelling and OpenMX
Structural equation modelling (SEM) is an alternative approach to es-
timate twin-based heritability, based on path analysis and regression.
OpenMX is a package in R that conducts SEM to estimate heritability
of a given trait. OpenMX provides two methods of modelling that
can be employed; path analysis and matrix specification. Path analy-
sis uses a path diagram in order to calculate the latent variables, in
the case of heritability, A, C and E. Figure 1 shows the path diagram
for twin ACE heritability modelling in OpenMX.
The second method of SEM modelling employed by OpenMX,
and used to calculated heritability in this thesis, is matrix specifica-
tion. Matrices are specified for the path coeefficients a, c and e and
then to calculate variance matrices for A, C and E are calculated by
squaring the path coefficients. MZ and DZ covariance matrices are
calculated according to the assumptions shown in Figure 1. Selection
of a particular method comes down to the preference of the user.
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Figure 1: Path diagram for the calculation of heritability in monozygotic
and dizygotic twins.(Image taken from OpenMX user manual:
http://openmx.psyc.virginia.edu/docs/OpenMx/latest/OpenMxUserGuide.pdf)
3.1.4 Evidence Of Genetic Effect On The Microbiome
Many studies have attempted to understand whether there is an un-
derlying host genetic component influencing the microbiome, but a
clear explanation has not yet been found. A number of approaches
have been used to address the question of heritability such as twin
studies, mouse models and QTL detection.
Two 16S genetic studies into the human gastrointestinal mi-
crobiota have been performed using twins [Zoetendal et al., 2001,
Stewart et al., 2005]. In both cases the results were suggestive of a host
genetic basis for the gut microbiota however neither of these studies
mention which aspects of the microbiota are heritable, only that the
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similarity in faecal bacteria between monozygotic twins was signif-
icantly higher than dizygotic twins. Alternatively, a different twin
study using 16S rRNA and metagenomics found no basis for heri-
tability [Turnbaugh et al., 2009a]. However, components of diet and
specific lifestyle choices have previously been shown to be heritable
[Teucher et al., 2007, Chaput et al., 2014] and these may have a great
impact on the microbial species present within the gut.
Mouse models have been useful for a wide range of studies
including gene knock-out models where certain genes are knocked
out and the effect this has on a given phenotype is observed. Studies
have demonstrated that the microbiota of mice in the same litter is
more similar than mice from a different litter, however this is may be
a maternal effect, whereby mice are inoculated by the mother’s mi-
crobiota while being born vaginally. There are approaches to try and
reduce this effect in order to study genetic influences such as cross-
fostering and uterine transplants of embryos in genotypically differ-
ent mothers. The latter approach was used by Friswell et al. [2010]
but rather than discovering a genetic influence, they found a second
maternal effect.
Using large numbers of intercross model animals it is pos-
sible to explore both the impact of host genetic background and en-
vironmental factors. One of the first studies to use this approach in
order to characterise genetic influences on the microbiome was that
by Benson et al. [2010]. Among other things, they found the presence
of a core microbiome composed of 64 taxonomic groups that were
present in most, if not all of the mice sampled. It could be suggested
that the presence of such a conserved group in all mice would indi-
cate a genetic relationship, however as yet no definitive genetic link
has been found. These findings confirm the results found in Qin et
al (2010) where 35% of reads from any one sample could be mapped
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to other samples thereby hinting at the existence of a common core
microbiome [Qin et al., 2010].
There is evidence for the effect of individual genes on the
microbiome in both humans and mice. Mice lacking the RELMB gene
have significantly altered abundances of Bacteroidetes, Firmicutes and
Proteobacteria compared with wild-type mice [Hildebrandt et al., 2009].
The mechanism underlying this finding is unknown but it was noted
that mice lacking this gene did not become obese when fed a high-fat
diet. A number of the genetic variants, that have so far been linked
with the microbiome, cause disease within the host, for example a sin-
gle nucleotide polymorphism (SNP) within the human MEFV locus
which encodes pyrin, a key protein in white blood cells that is thought
to help regulate inflammation, results in familial Mediterranean fever
whilst also being associated with lower microbial diversity [Khacha-
tryan et al., 2008]. Further interactions have been noted for Crohn’s
disease [Frank et al., 2011], Coeliac’s disease [Vaahtovuo et al., 2003]
and obesity [Zhang et al., 2010].
A problem with these studies is small sample size. In order
to detect host genetic effects, that often have a small effect size, a
sample size of thousands of subjects is required, even hundred’s of
thousands as we have seen with genome-wide association studies of
complex traits.
In this chapter I will address heritability of the human gut
microbiome in twins and explore a number of potential environmen-
tal factors, including diet, method of delivery and smoking, that may
affect the host gastrointestinal flora.
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3.2 results and discussion
3.2.1 Heritability Of The Human Gut Microbiome
Our study, a collaboration led by Dr Ley (Cornell University), was the
first large-scale study to characterise heritability for all gut microbe
OTUs in a dataset of 416 twin pairs [Goodrich et al., 2014]. The dataset
was comprised of 342 monozygotic twins, 490 dizygotic twins and
143 singletons, predominantly female. The aim of the work was to
characterise heritable microbes in the human gut and if there were
heritable microbes, determine how they were related to BMI. Using
OpenMX, Ms Goodrich (Cornell University) calculated heritability for
each OTU and collapsed taxonomy.
While my colleagues at Cornell used OpenMX to calculate
narrow-sense heritability, I used the ICC method of estimating heri-
tability to confirm their results. I considered 909 microbial units, 768
OTUs and 141 taxonomic summaries.
Figure 2 shows the correlation between my heritability esti-
mate from ICC, and the heritability estimated from Cornell university
using SEM. The Pearson correlation coefficient for A and E were 0.55
and 0.54 respectively. The C component however only had a correla-
tion coefficient of 0.3. A table of all the microbial units and their ICC
and ACE heritabilities can be found in Appendix A. The peak ICC
heritable microbe was a Ruminococcaceae OTU (2*(rMZ-rDZ) = 0.72).
ICC heritability ranged from 0-0.72.
We also showed that microbiota diversity is more similar
between twins than unrelated individuals using weighted and un-
weighted Unifrac distances, as well as the Bray Curtis metric (Stu-
dent’s T-Test, p < 0.009). Furthermore, monozygotic twins have more
similar microbiotas than dizygotic twins, but only when the un-weighted
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Figure 2: Correlation of heritability components calculated by ICC and SEM.
Unifrac metric was considered (p = 0.032), suggesting that types of
species shared drive similarities between monozygotic twins rather
than abundance similarity, as weighted Unifrac takes OTU abundance
into account when calculating Unifrac distances.
The heritability estimates from SEM in this dataset (calcu-
lated by Ms Goodrich) are shown in Figure 3 below at each node
of the phylogenetic tree. Certain branches of the families Ruminoco-
cacceae and Lachnospiraceae were found to be highly heritable, with
heritability ranging from 0-0.38 (Figure 3). A complete table of both
ACE and ICC heritability estimates can be found in Appendix A (Ta-
ble A1).
These heritabilities were then replicated in 2 independent
datasets Turnbaugh et al. [2009a] & Yatsunenko et al. [2012]). The
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Figure 3: Heritability of OTUs in the TwinsUK cohort. Reproduced from
Goodrich et al, 2014 [ref:goodrich2014]
most heritable microbe was Christensenella, a microbe that was char-
acterised relatively recently and as such little is known about it. Ms
Goodrich created co-occurence networks and found that Christensenel-
laceae formed the centre of a highly heritable hub of microbes, includ-
ing the interesting Archaea member, Methanobacteriaceae. Methanobac-
teriaceae are capable of producing methane naturally and are key
organisms in the fermentation of complex compounds in the gut [Pi-
mentel et al., 2012]. Microbes in this co-occurrence hub were also
enriched in lean individuals, and may play a key role in obesity,
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its prevention or downstream effects on the human organism. When
Christensenella was spiked into mice the association with obesity was
confirmed, as mice that possessed Christensenella showed less weight-
gain than those that had no Christensenella. That a highly heritable
microbe has such an effect on weight-gain suggests the importance
for host genetics in microbiota interactions with health.
3.2.2 Environmental Effects On The Microbiome
In the ACE results from SEM and ICC we observed that for most
OTUs, the unique environment component (E) accounted for the high-
est proportion of variance in the OTU showing the importance of en-
vironmental effects on the microbiome. A number of environmental
effects on the microbiome have been studied, such as method of birth
and diet, with the latter having been studied most extensively.
3.2.2.1 Diet
Arguably, one of the most important factors affecting the human gut
microbiome is diet. The microbes that live in our guts depend on the
food we eat for their own sustenance, while helping to digest our
food in the process. For this reason, small shifts in what we eat can
change microbial community composition significantly. Typically, in
large cohort-based studies such as this, diet information is collected
from study participants using a questionnaire known as a Food Fre-
quency Questionnaire (FFQ). Participants are asked to estimate how
often they eat a particular item of food and indicate an approximate
portion size that they would normally consume. From this, nutrients
can be derived and food groups created based on the similarity in
nutrient content between items.
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In a study of elderly subjects (ages between 64-102) of Irish
nationality it was concluded that a healthy, diverse diet correlated
with a more diverse gut microbiome [Claesson et al., 2012]. Using
FFQ data, they found four dietary groups: DG1 (low fat/high fibre),
DG2 (moderate fat/high fibre), DG3 (moderate fat/low fibre) and
DG4 (high fat/low fibre). DG1 showed the highest microbial and di-
etary diversity and as expected, DG3 and DG4 showed the lowest
diversity. The study was unable conclude whether diversity of the
diet affects microbial diversity, or if the ratio of fat:fibre was key.
Metagenomic analysis of gnotobiotic mice that had been
transplanted with stool samples from adult humans and placed on
either a Western diet or a low fat, plant polysaccharide-rich diet
(LF/PP) revealed a number of species that differed between the two
diets [Turnbaugh and Gordon, 2009]. Western diet humanised mice
had higher levels of Erysipelotrichi species when compared to mice
on the LF/PP diet. In addition, there were significant increases in the
relative abundances of Bacilli and decrease in Bacteroidetes. Adipos-
ity gains were seen in mice that were fed the Western diet, but not
in those fed the LF/PP diet. When new mice were transplanted with
cecal contents from these humanised mice, those that had a Western
diet donor gained significantly more fat than those mice with LF/PP
donors.
Both of these studies have focused on high fat/low fat diets
and implications with obesity but a recent study into use of artificial
sweeteners sheds a new unusual light on the role of the microbiome
in obesity. Artificial sweeteners are often used in diet soft drinks and
sugar-free sweets, purporting to be the healthy alternative to other
high calorific products. In this study, mice that had been fed saccha-
rin showed an increase in glucose intolerance both in the lean state
(p <0.001) and obese state (p < 0.03) [Suez et al., 2014]. When antibi-
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otics were given to mice consuming saccharin, glucose intolerance
disappeared and mice were no different than the controls, indicating
a role for the microbiota in driving the glucose intolerance. Mice con-
suming saccharin displayed a significant dybiosis from controls in-
cluding increases in relative abundance of taxa within the Bacteroides
and Clostridiales. Furthermore, these mice had altered bacterial func-
tional profiles, showing marked increases in glycan degradation re-
sulting in high-energy harvest. The study also extended its findings
regarding glucose intolerance to humans volunteers using diet ques-
tionnaires and blood measures of glucose. As glucose intolerance is
seen in a high number of obesity cases, this study has important im-
plications for the role of sweeteners in cardiometabolic disease and
the growing obesity epidemic and has provided a sound basis for the
role of the microbiome in propagating this glucose intolerance.
As there is a wealth of evidence supporting the change that
diet can make in the gut microbiome, I used FFQ diet data for 838
individuals that had been derived in a previous study on twins (see
Chapter 2 for further information.) [Teucher et al., 2007] to determine
whether diet associates with changes in the gut microbiome in the
TwinsUK cohort. To begin with, I looked at the first 5 principle com-
ponents that roughly equated to 5 dietary patterns: PC 1 was a fruit
and vegetable diet, PC 2 was a high alcohol diet, PC 3 was the tradi-
tional English diet, characterised as a diet high in fried fish, pies and
meat as well as some cruciferous vegetables. PC 4 was a dieting pro-
file, high in low-calorie drinks and low-fat dairy products. The final
score, PC 5 was a low meat diet. As expected, each score was nor-
mally distributed. A linear mixed effects regression was used to test
the association between each diet PC and OTU, adjusting for zygosity
and family structure. In total, 4545 tests were performed. The results
can be found in Table 4.
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OTU Family Genus & Species Diet P Value Std Err Estimate FDR
759816 Ruminococcaceae Unknown High Alcohol 2.86E-07 0.0644 0.3334 0.00114
232828 Ruminococcaceae Unknown High Alcohol 5.00E-07 0.0547 0.2772 0.00114
Collapsed Ruminococcaceae Ruminococcus Fruit and Veg 5.89E-06 0.0047 -0.0216 0.00702
Collapsed RF32 (Order) Low Meat 9.27E-06 0.0230 -0.1026 0.00702
Collapsed RF32 (Unknown) Low Meat 9.27E-06 0.0230 -0.1026 0.00702
Collapsed RF32 (Unknown) Unknown Low Meat 9.27E-06 0.0230 -0.1026 0.00702
Collapsed Odoribacteraceae Butyricimonas High Alcohol 5.08E-05 0.0130 0.0531 0.03114
179744 Clostridiales (Order) Unknown Fruit and Veg 8.25E-05 0.0706 0.2798 0.03850
Collapsed Lachnospiraceae Lachnospira Traditional English 8.63E-05 0.0109 -0.0432 0.03850
190961 Lachnospiraceae Unknown High Alcohol 9.32E-05 0.0448 0.1761 0.03850
194488 Ruminococcaceae Unknown Traditional English 0.000103 0.0575 -0.2255 0.03903
258099 Ruminococcaceae Unknown Fruit and Veg 0.000119 0.0645 -0.2495 0.04146
2318497 Clostridiaceae Unknown Fruit and Veg 0.000152 0.0232 0.0883 0.04761
4434334 Clostridiaceae Unknown Low Meat 0.000167 0.0114 0.0431 0.04761
Table 4: Significant diet associations with the human gut microbiome that
pass an FDR correction threshold of 5%.
A multiple testing threshold was applied to the results using
Bonferroni correction, estimated at P = 1.1x10-5 and 6 associations sur-
pass this. 14 associations pass an FDR threshold of 5% and 485 associ-
ations were nominally significant, passing a p-value threshold of 0.05.
The top association was between OTU 759816 (Ruminococcaceae) and
PC2 (High Alcohol) with a p-value of 2.86E-07. In fact the High Al-
cohol diet PC held a large number of associations with OTUs in not
just the Ruminococcaceae family, but also other families such as the
Odoribacteriaceae, (Butyricimonas, p = 5.08E-05, q = 0.0311), or in the
Pasteurellaceae family, in particular Haemophilus parainfluenzae (p =
0.00075, q = 0.11). In some cases, these associations are positive sug-
gesting that an increase in OTU abundance coincides with increased
alcohol consumption. It is unclear in which direction this relationship
goes without an in-depth look into causal models, but one potential
explanation for these associations is that these microbes aid in the
metabolism of alcohol.
PC 1, a fruit and veg diet, also had a number of nominally
significant associations, most notably with the Ruminococcus collapsed
taxonomy (p = 5.89E-06, q = 0.007) and OTU 179744 (Clostridiales; Un-
known species, p = 8.25E-05, q = 0.038). Fruit and veg is a significant
source of fibre and many studies have shown how fibre affects the
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microbiome, promoting a more diverse microflora as well as widely
regarded beneficial species such as Faecalibacterium prausnitzii.
While it is interesting to look at the diet principle compo-
nents, they do not capture exact diets. For example, the fruit and veg
diet is characterised as a diet that is high in fruit and vegetables, but
people could also be eating a large amount of fatty foods alongside
fruit and veg. A more accurate way to assess the effect of diet on the
microbiome is to look at nutrient intakes, such as the breakdown of
different fats. It was interesting to note that despite the large wealth
of evidence in studies to date showing the effect of dietary fat on
the microbiome, we saw few significant associations between OTUs
and the traditional English PC, which we considered to be that most
alike to a high fat diet. So instead we looked at dietary fat intakes
to determine whether the PC wasn’t an accurate proxy for high fat
intakes or whether fat intakes had little effect on this sample. In this
part of the analysis we considered the following intakes: trans fat,
saturated fat, monounsaturated fat, polyunsaturated fat and total fat,
all of which were adjusted for energy intake. My colleague Ms Tess
Pallister extracted the nutrient variables from available FFQ data and
I performed an association analysis between these fat intakes and gut
16S data. The top association between trans fat and the collapsed tax-
onomy for Ruminococcus was the only association that surpassed FDR
correction for multiple testing (p = 2.70E-07, q = 0.001). There were a
further 383 nominally significant results.
3.2.2.2 Method Of Birth
Until recently it was thought that a baby did not come into contact
with microbes until after birth. The womb was considered to be a ster-
ile environment except in cases of disease, but recent findings have
changed this view. Amniotic fluid, a litre of which is swallowed by
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a foetus each day, is teeming with microbial life, giving the foetus
its first inoculation of bacteria [DiGiulio, 2011, Jiménez et al., 2005].
A new study has shown that even the placenta has a microbiota,
giving further evidence to abolish the idea of a sterile womb [Aa-
gaard et al., 2014]. The largest transmission of microbes to the foetus
however is during birth [Dominguez-Bello et al., 2010]. The vagina is
a microbially-rich site mainly dominated by lactic-acid bacteria that
help to maintain a constant low pH and play a key role in protecting
against urogenital illness [Ravel et al., 2011]. If a child is born vagi-
nally, the foetus passes through the birth canal and is bathed in these
bacteria, but if born by caesarean section, it misses out on this dose
of microbes. A study by Dominguez-Bello et al. [2010] revealed that
children born vaginally have skin microbes similar to their mother’s
vagina and can be assigned to their mother based on these profiles.
Children that had been born by C-section however were no more alike
to their mother than any other person, and their microbiome was
more alike to a skin microbiota, showing enrichment of pathogenic
species such as Staphylococcus. This may have significant implications
for newborn health, for example, the incidence of methicillin-resistant
Staphylococcus aureus infection (MRSA) in C-section babies is much
higher than vaginally-born babies, perhaps because of the higher
presence of Staphylococcus species. Of course, this is not a causal
link and other factors may be affecting this observed effect, such
as the prevalence of premature births in C-section deliveries, but it
does pose an intriguing insight into potential health issues posed by
method of delivery.
Contraction of MRSA infection is not the only illness thought
to be influenced by method of delivery. There is evidence to suggest
that obesity [Huh et al., 2012], asthma [Thavagnanam et al., 2008]
and allergy [Negele et al., 2004, Eggesbo et al., 2003] are all affected
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by whether or not a child was born vaginally. In a follow-up study
however, Dominquez-Bello and colleagues showed that the a normal
birth microbiota can be partially restored to caesarean-born infants by
exposure to maternal vaginal fluids at birth [Dominguez-Bello et al.,
2016]. If a delivery method induced microbial dysbiosis is responsible,
at least partially, for these illnesses, then this study provide promising
results for future treatments and therapies.
The TwinsUK cohort is well phenotyped and information re-
garding method of delivery was available for a subset of 536 individ-
uals (see Chapter 2 for complete sample characteristics.). In the UK,
caesarian section is currently the method of birth for approximately
60% of twin births, however in the 1950’s, around the time a large
proportion of our sample was born, the incidence rate was 3%. In
the sample presented within this thesis, caesarean section accounted
for 3.9% of the sample, being representative of the time. I wished to
explore whether method of delivery effects on the human gut micro-
biome might still be present in later life. Using a similar linear mixed
effects model as outlined in Chapter 2, we placed the OTU as the de-
pendent variable within the model and considered method of birth
as a fixed effect. As expected, the results were not particularly signif-
icant, with only 22 associations passing a nominal p-value threshold
of 0.05 (Table 5).
The top association with OTU 180352 (Clostridiales; unknown)
had a p-value of 0.007 and a negative direction of effect, potentially
suggesting a reduction in abundance of this OTU after a C-section,
but not passing a multiple testing threshold. Considering there are
such low numbers of C-section twins in this sample, there is not
enough power to determine differences in the microbiota, especially
so much later in life.
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OTU Family Genus & Species P Value Std Err Estimate
180352 Lachnospiraceae Unknown 0.0073 0.1608 -0.4381
176865 Ruminococcaceae 0.0078 0.1376 -0.3675
182874 Bacteroidaceae Bacteroides (Unknown) 0.0138 0.2135 0.5307
4395096 Bacteroidaceae Bacteroides ovatus 0.0138 0.1132 0.2810
340474 Bacteroidaceae Bacteroides (Unknown) 0.0190 0.1110 -0.2626
578016 Porphyromonadaceae Parabacteroides distasonis 0.0201 0.3218 -0.7503
216710 Ruminococcaceae Unknown 0.0203 0.3303 0.7685
183970 Lachnospiraceae Blautia (Unknown) 0.0216 0.1669 -0.3861
182255 Bacteroidaceae Bacteroides (Unknown) 0.0268 0.1531 0.3408
175836 Ruminococcaceae Unknown 0.0275 0.0896 -0.1989
186416 Lachnospiraceae Unknown 0.0306 0.6308 1.3670
2875735 Bacteroidaceae Bacteroides (Unknown) 0.0332 0.1135 0.2425
4381553 Bacteroidaceae Bacteroides (Unknown) 0.0340 0.6264 -1.3344
179847 Lachnospiraceae Blautia (Unknown) 0.0360 0.1042 -0.2197
3439403 Bacteroidaceae Bacteroides (Unknown) 0.0374 0.2175 0.4542
180401 Lachnospiraceae Blautia 0.0375 0.1161 -0.2426
191779 Lachnospiraceae Bacteroides (Unknown) 0.0380 0.1133 -0.2356
157453 Ruminococcaceae Unknown 0.0395 0.3403 0.7049
403701 Veillonellaceae Dialister (Unknown) 0.0403 0.4066 -0.8371
193551 Lachnospiraceae 0.0429 0.1339 -0.2722
3588390 Bacteroidaceae Bacteroides (Unknown) 0.0441 0.5989 1.2081
190649 Ruminococcaceae Unknown 0.0468 0.1014 0.2026
Table 5: Nominally significant associations between the human gut micro-
biome and method of delivery.
3.2.2.3 Smoking
Smoking has become one of the leading causes of preventable death
worldwide, killing over 480,000 people each year in the US alone
[General, 2014]. In fact, smoking is a risk-factor for not just lung can-
cer, emphysema and pulmonary disease but also irritable bowel dis-
ease (IBD) and ischaemic heart disease along with a much reduced
lifespan. Yet despite the adverse health conditions associated with
smoking, it remains a popular habit and drives a thriving multi-
billion pound industry. Heritability of smoking behaviour is report-
edly quite high at 44% and 55% of the variance is driven by shared
environment [Vink et al., 2005]. Interestingly, the heritability of nico-
tine dependence is even higher at 75%, having intriguing implications
for people wishing to quit smoking and suggesting that some people
may find it much more difficult to quit than others [Vink et al., 2005].
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With such inhalation of toxins in the smoke, it is logical to
assume that there would be an effect on the microbiome in the lung.
Yet new research has come to light showing that smoking also affects
the gut microbiome, with a potential influence on the weight gain so
often seen after smoking cessation [Biedermann et al., 2013]. Partici-
pants in the smoking cessation group had a 2.2kg mean increase in
body weight, supporting previous findings [Aubin et al., 2012] and
this was not due to differences in calorie or nutrient intake. Further-
more, the relative abundance of Firmicutes and Actinobacteria sig-
nificantly increased after smoking cessation, while the relative abun-
dance of Proteobacteria decreased after the participant had stopped
smoking, similar to that seen in comparisons between lean and obese
subjects. Each study group could be clearly separated using Unifrac
showing clear differences in beta diversity while alpha diversity was
not significantly different between smokers and non-smokers.
In my dataset I had smoking status for a total of 851 people
(534 non-smokers, 262 ex-smokers and 55 smokers). Firstly I looked
at alpha diversity vs smoking status, as measured by PD Whole Tree
Averages. There was no significant difference between smoking status
and alpha diversity although a negative trend could be seen with a
minor reduction in alpha diversity in smokers (Figure 4).
Next I looked at beta diversity between smokers, ex-smokers
and non-smokers. 3 metrics are used to measure beta diversity: weighted
and unweighted unifrac metrics and Bray Curtis. No metric showed
any clustering according to smoking status (Figure 5) suggesting that
smoking does not significantly alter microbial diversity in the gut.
With this in mind, I wanted to see if any individual OTUs
changed significantly in smokers. Using a linear mixed effects model,
I assigned each OTU to be the response variable and adjusted for
family, zygosity and sex. The top association was with OTU 4426298,
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Figure 4: Boxplots of PD Whole Tree Averages for each smoking status
group.
Figure 5: PCoA plots showing diversity in the 3 beta diversity metrics,
coloured according to smoking status. A. Unweighted Unifrac met-
ric. B. Bray-Curtis metric. C. Weighted Unifrac metric.
a Bifidobacterium animalis OTU (p=0.0005, β=-0.38, SE=0.12 Figure 6).
While this result does not pass Bonferonni there is a clear stepwise
reduction in B. animalis from smokers through to non-smokers. After




Figure 6: Boxplot of B. animalis in smokers, ex-smokers and non-smokers.
B. animalis is a well-known probiotic, used to aid gut health
and reduces symptoms of bloating [Philippe et al., 2011, Guyonnet
et al., 2007]. Here we see it negatively associated with smoking sta-
tus showing a marked decrease in smokers. Research in smokers has
shown that smoking puts them at increased risk of gut Crohn’s dis-
ease [Cottone et al., 1994] but the mechanism of this effect is poorly
understood. Reduction of B. animalis may be part of the reason if
this is the case, and provides a potential treatment option for smok-
ers suffering from poor gut health. While overall diversity remains
unchanged in smokers, differences at the OTU level may have some
effects on health.
3.3 conclusion
In this chapter I have explored the effects of host genetics using
heritability analysis and the impact of major environmental factors
thought to affect the human gut microbiome in a large sample of
adult twins. Some microbes in the human gut microbiome are mod-
erately heritable, but a large role can be attributed to environmental
factors. In this cohort there appear to be no strong, long-term effects
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on the gut microbiome from method of delivery, while smoking may
have a small effect on gut community composition. Diet showed a
number of associations with gut microbial composition in our sam-
ple, but the findings leave questions unanswered due to the difficult
nature of measuring dietary intakes accurately, but there are some
effects seen with dietary fat. As Christensenella was found to be the
most heritable microbe, I was interested to see what else I could dis-
cover about this relatively unknown bacteria. Chapter 4 is about my
work characterising this microbe further.
72
4
C H R I S T E N S E N E L L A
4.1 background
Christensenella is an obligate anaerobe, like most bacteria in the hu-
man gut microbiome. Its characterisation was recent [Morotomi et al.,
2012] and as such little is known about this seemingly important mi-
crobe. It produces butyrate and as well as being present in human
samples, the characterised strain shares 96.7% sequence identity with
an uncultured clone found in a captive Dugong dugon, commonly
known as the dugong [Morotomi et al., 2012, Tsukinowa et al., 2008].
Our collaborative work, led by Dr Ley and lead analyst Ms
Goodrich, establishing the heritability of the human microbiome [Goodrich
et al., 2014] (Section 3.2.1) led to the discovery that Christensenella is
the most heritable microbe in our cohort of twins as well as in 2
other datasets (Yatsunenko et al. [2012] and Turnbaugh and Gordon
[2009]), and approximately 39% of its variance can be attributed to
host genetic influence. It co-occurs with the methanogen-producing
Archaea and is more abundant in lean twins. Network analysis re-
vealed that Christensenellaceae forms the centre of a heritable hub of
microbial families, including the Dehalobacteriaceae, Methanobacte-
riaceae, SHA-98 and RF39.
These microbes were also significantly associated with a lean
BMI (indicated as a red or orange node, Figure 7B). In order to con-
firm the methanogen-Christensenellaceae co-occurrence, faecal trans-
plants were performed on germ-free mice, inoculating them with ei-
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Figure 7: Network of Christensenella and connected microbes. A) Network
module of OTUs that co-occur with Christensenella. Nodes are
coloured according to their heritability. Red is heritable while
blue is not heritable. B) Network module of OTUs that co-occur
with Christensenella. Nodes are coloured according to their FDR-
adjusted p-value with BMI. Red is highly significant while blue is
not significant (P>0.05). Reproduced from Goodrich et al. [2014]
ther a microbiome from an obese donor twin with no methanogens
(O-), an obese donor twin with methanogens (O+), a lean donor twin
with no methanogens (L-) or a lean donor twin with methanogens
(L+). Christensenellaceae is present throughout the study in all but
one donor group, and mice that received a transplant from a L+ or O+
donor showed the highest relative abundance of Christensenellaceae
throughout the study confirming the co-occurrence of Christensenel-
laceae with the methanogens (Figure 8A).
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Figure 8: Germ-free faecal transplantation with donor stool from obese and
lean twins that either possess or don’t possess methanogens. Re-
produced from Goodrich et al. [2014]
Furthermore, mice that had received stool from the L+ donor
showed reduced weight gain in comparison to mice that had received
stool from the other donor groups (Figure 8E,F) as well as possess-
ing the highest alpha diversity (Figure 8C). In order to infer causal-
ity of Christensenellaceae, stool from an obese donor that had no
Christensenellaceae was spiked with Christensenella minuta and trans-
planted into mice. Mice that received C. minuta showed attenuated
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weight gain in comparison to mice who did not receive C. minuta
(Figure 9A).
Figure 9: Mice spiked with C. minuta show less weight gain than those who
did not receive C. minuta. Reproduced from Goodrich et al. [2014]
This difference was also seen in the total adiposity in the
mice (measured by whole body dual energy x-ray absorptiometry
(DEXA) scanning, Figure 9B), a difference that was more significant
than % weight change, showing that in particular, Christensenella was
affecting the adipose tissue of mice. This indicates a potential protec-
tive role for Christensenella in the prevention of adiposity gain.
Our previous collaborative study, Goodrich et al. [2014], high-
lighted the importance of Christensenella in obesity, both in twins and
in mice. The previous study was limited to BMI however. Here, I
extend this work by exploring the association of Christensenella with
multiple adiposity phenotypes in twins including central adiposity,
body fat distribution and the difficult to measure, but clinically rele-
vant measure, visceral fat. As a result of these findings, I proceeded
to investigate the association between Christensenella and immune-
related phenotypes. Lastly, I linked the results to the observation that
Christensenella is one of the most heritable gut species, by comparing





4.2.1 Christensenella associates with multiple adiposity measures
Using an LMER model as outlined in Section 2.2.1, I explored the
association between the abdominal adiposity measures visceral fat
mass (VFM) and % trunk fat (pTF) as well as the whole-body met-
ric, body-mass index (BMI) in 960 individuals (Table 6). Abdominal
adiposity, or central adiposity, is the measure of visceral and subcu-
taneous fat in the abdominal region. Increased central adiposity is
also highly correlated with adverse cardiometabolic outcomes [Yusuf
et al., 2004]. Visceral fat is the adipose tissue that surrounds organs
while subcutaenous fat is found beneath the surface of the skin. It is
in fact visceral fat that has the most implications for health. I discuss
adiposity in more detail in Chapter 5. Heritability of these measures
were also explored and the results of that analysis can be found in
Section 5.2.1.
Phenotype Abbreviation Description Sample Size Time between samples
Visceral Fat VFM Deep adipose tissue that forms around organs, composed of adipocytes.
960 0-16 years% Trunk Fat pTF % of central mass that is formed of adipose tissue (both visceral and subcutaenous).
BMI BMI Body mass distribution.
Table 6: Phenotypes used in adiposity Christensenella association study.
At both the family level (Christensenellaceae) and a genus
level (Christensenellaceae.unknown genus), there were a total of 17
nominally significant associations (Table 7). The peak association was
between an unknown genus in the Christensenellaceae family and
VFM (P=3.51x10-6, β=-0.0071, SE=0.0015). Both VFM and pTF (peak
pTF association P=2.21x10-5, β=-0.0542, SE=0.0127) formed stronger
associations with Christensenellaceae than BMI (peak BMI associa-
tion P=0.0008, β=-0.0429, SE=0.0126).
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OTU Family Genus & Species Pheno P Value Std Err Estimate
Collapsed Christensenellaceae Unknown VFM 3.51E-06 0.0015 -0.0071
Collapsed Christensenellaceae VFM 5.03E-06 0.0015 -0.0071
Collapsed Christensenellaceae pTF 2.21E-05 0.0127 -0.0542
176318 Christensenellaceae Unknown VFM 3.19E-05 0.0017 -0.0071
Collapsed Christensenellaceae Unknown pTF 3.24E-05 0.0125 -0.0525
176318 Christensenellaceae Unknown pTF 6.52E-05 0.0140 -0.0563
4402903 Christensenellaceae Unknown VFM 0.0001 0.0019 -0.0074
Collapsed Christensenellaceae BMI 0.0008 0.0126 -0.0429
Collapsed Christensenellaceae Unknown BMI 0.0012 0.0125 -0.0410
4402903 Christensenellaceae Unknown pTF 0.0025 0.0160 -0.0488
4402903 Christensenellaceae Unknown BMI 0.0081 0.0157 -0.0420
176318 Christensenellaceae Unknown BMI 0.0090 0.0139 -0.0369
231952 Christensenellaceae Unknown VFM 0.0109 0.0055 -0.0140
555547 Christensenellaceae Unknown VFM 0.0250 0.0040 -0.0089
555547 Christensenellaceae Unknown pTF 0.0356 0.0336 -0.0708
2256425 Christensenellaceae Unknown VFM 0.0380 0.0052 -0.0108
555547 Christensenellaceae Unknown BMI 0.0523 0.0329 -0.0640
Table 7: Adiposity associations with Christensenella
These associations are negative, indicating an increase of
Christensenella in low adiposity individuals, though this does not
indicate a causal relationship. Following adjustment for BMI, all as-
sociations with pTF lose nominal significance and only 4 associations
with VFM remain (Table 8).
OTU Family Genus & Species Pheno P Value Std Err Estimate
176318 Christensenellaceae Unknown VFM 0.00033 0.00962 -0.0347
Collapsed Christensenellaceae Unknown VFM 0.00334 0.00877 -0.0258
Collapsed Christensenellaceae VFM 0.00462 0.00886 -0.0252
231952 Christensenellaceae Unknown VFM 0.0101 0.0317 -0.0818
Table 8: Adiposity associations with Christensenellaceae following adjust-
ment for BMI.
4.2.2 Christensenella and inflammation
Visceral fat tissue is able to secrete the inflammatory cytokine, Il-6
which may contribute to the widespread systemic inflammation that
is associated with obesity. As the strongest Christensenella associations
were with visceral fat, I chose to explore white blood cell (WBC)
78
4.2 results
counts in the TwinsUK cohort as WBCs are typically increased in an
inflammatory state. These were measured in blood that was taken
during the subject’s annual clinical visit using FACS [Nalls et al.,
2011].
Phenotype Abbreviation Description Sample Size Time between samples
White Blood Cell Count WBC A measure of the white blood cells (leukocytes) present in the blood.
913 2-6 years
Neutrophils NA The most abundant leukocyte in blood.
Monocytes NA The largest leukocyte in blood.
Lymphocytes NA Cells important for immunity.
Table 9: White blood cell phenotypes explored.
Using a linear mixed-effects regression on approximately
900 twins, I obtained 16 nominally significant associations (P<0.05)
with white blood cell count, neutrophils, lymphocytes and monocytes
(Table 10).
OTU Family Genus & Species Pheno P Value Std Err Estimate
Collapsed Christensenellaceae Unknown WBC 0.00048 0.0134 -0.0471
Collapsed Christensenellaceae WBC 0.00059 0.0136 -0.0469
Collapsed Christensenellaceae Neutrophils 0.00094 0.0138 -0.0459
Collapsed Christensenellaceae Unknown Neutrophils 0.00096 0.0137 -0.0453
231952 Christensenellaceae Unknown WBC 0.00111 0.0494 -0.1615
Collapsed Christensenellaceae Unknown Monocytes 0.00173 0.0137 -0.0431
2256425 Christensenellaceae Unknown Neutrophils 0.00228 0.0482 -0.1475
Collapsed Christensenellaceae Monocytes 0.00244 0.0139 -0.0422
2256425 Christensenellaceae Unknown WBC 0.00401 0.0473 -0.1365
231952 Christensenellaceae Unknown Lymphocytes 0.00749 0.0477 -0.1278
231952 Christensenellaceae Unknown Neutrophils 0.00831 0.0506 -0.1339
176318 Christensenellaceae Unknown WBC 0.0159 0.0151 -0.0366
231952 Christensenellaceae Unknown Monocytes 0.0221 0.0510 -0.1170
2256425 Christensenellaceae Unknown Lymphocytes 0.0264 0.0458 -0.1018
176318 Christensenellaceae Unknown Neutrophils 0.0311 0.0154 -0.0332
176318 Christensenellaceae Unknown Monocytes 0.0374 0.0154 -0.0322
Table 10: Christensenella associations with white blood cell types.
The peak association was between an unknown genus within
Christensenellaceae and WBC counts (P=0.00048, β=-0.047, SE=0.0134).
Once again, these associations were negative, suggesting an increase
in white blood cell types when Christensenellaceae is less abundant.
This would in fact support the visceral fat findings, showing an in-
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crease in immune cells when Christensenella is reduced. Adjustment
for BMI reduces the number of nominally significant associations
to 12, however WBC remains the top association (P=0.004, β=-0.13,
SE=0.049).
4.2.3 Candidate gene analysis
Christensenella is the most heritable microbe in this dataset and I was
therefore interested to see if I could pinpoint any host gene variants
that associate with Christensenella which could explain the phenotypic
associations seen above. The dataset is underpowered to perform a
full genome-wide association study however, so instead I conducted
two candidate gene analyses. The first was to determine host adipos-
ity gene influences on Christensenella and the second was to determine
immune gene influences.
4.2.3.1 Adiposity gene variant candidate gene analysis
The NHGRI-EBI GWAS Catalog [Welter et al., 2014] is a catalog of
published results from previous GWAS studies. Results can be searched
according to phenotype of interest and downloaded for further use.
The list of candidate obesity GWAS SNP associations was extracted
from the NHGRI-EBI GWAS Catalog. The reported SNPs were taken
as the lead SNP, and candidate gene regions were extended to include
additional SNPs within a 10 kb region either side of the lead SNP.
Overall, I considered associations with 1795 SNPs across 53 unique
genomic regions. No MAF criteria were applied during the initial
SNP selection. The analysis was performed using GEMMA [Zhou
and Stephens, 2012] using a kinship matrix to account for family re-
latedness within the sample as described in Chapter 2.
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OTU Family Genus & Species Gene SNP MAF P Value Beta
2256425 Christensenellaceae Unknown BDNF rs7934165 0.475 2.60E-05 -1.33E-01
2256425 Christensenellaceae Unknown BDNF rs2030324 0.475 2.67E-05 -1.33E-01
2256425 Christensenellaceae Unknown BDNF rs10767665 0.475 2.67E-05 -1.33E-01
2256425 Christensenellaceae Unknown BDNF rs2049046 0.461 7.20E-05 -1.24E-01
Table 11: Adiposity candidate gene associations with Christensenella.
There was only one gene association with Christensenella that
had suggestive evidence for association (threshold P= 1x10-4, Table 11).
This was with variants within the BDNF gene (Peak P=2.6x10-5, MAF=0.475).
BDNF encodes the brain-derived neurotrophic factor which is found
at synapses and helps to regulate synaptic plasticity. Due to the ex-
pression of BDNF in locations of the brain that control body weight
and eating, it is believed that BDNF plays an important role in these
activities [Lapchak and Hefti, 1992]. How this might affect Chris-
tensenella is unclear but one hypothesis may be that genetic variants
within BDNF affect what the host eats, thus impacting the levels of
Christensenella.
4.2.3.2 Immune gene variant candidate gene analysis
I performed a candidate gene analysis using 1039 SNPs found in
278 regions of the human genome that had previously been linked
with immune function in the TwinsUK cohort [Roederer et al., 2015].
No host genetic associations with Christensenella surpassed a multiple
testing threshold of P=1.9x10-7. There were 159 nominally significant
associations. The top association was with a variant within the GPC6
gene (rs4773780, P=1.09x10-05, MAF=0.139). GPC6 encodes the pro-
tein glypican-6 which has been implicated in cell growth and division
[Oikari et al., 2016]. Interestingly, silencing of this gene in bile duct
cell lines caused an increase of proinflammatory markers in these
cells [Karlsen et al., 2010] suggesting a role for the gene in minimis-
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ing inflammation. Again, how this might influence Christensenella is
unclear.
OTU Family Genus & Species Gene SNP MAF P Value Beta
231952 Christensenellaceae Unknown GPC6 rs4773780 0.139 1.09E-05 -1.86E-01
Collapsed Christensenellaceae Christensenella ATF6 rs2341479 0.135 6.46E-04 -1.10E-01
176318 Christensenellaceae Unknown FAS rs3740286 0.373 1.10E-03 -3.80E-01
2256425 Christensenellaceae Unknown C10orf96 rs7099441 0.106 1.41E-03 -1.66E-01
Collapsed Christensenellaceae MYL3 rs3792558 0.089 1.42E-03 -6.65E-01
Collapsed Christensenellaceae Unknown MYL3 rs3792558 0.089 1.64E-03 -6.64E-01
Collapsed Christensenellaceae ENTPD1 rs12761960 0.096 2.48E-03 -6.92E-01
Collapsed Christensenellaceae ENTPD1 rs12770313 0.096 2.48E-03 -6.92E-01
Collapsed Christensenellaceae ENTPD1 rs11595122 0.096 2.48E-03 -6.92E-01
Collapsed Christensenellaceae Christensenella ATF6 rs2298019 0.1 2.59E-03 -1.18E-01
Collapsed Christensenellaceae ENTPD1 rs3181115 0.096 2.74E-03 -6.84E-01
Collapsed Christensenellaceae ALDH18A1 rs11592789 0.093 2.78E-03 -6.80E-01
Collapsed Christensenellaceae Unknown ENTPD1 rs12761960 0.096 2.95E-03 -6.83E-01
Collapsed Christensenellaceae Unknown ENTPD1 rs12770313 0.096 2.95E-03 -6.83E-01
Collapsed Christensenellaceae Unknown ENTPD1 rs11595122 0.096 2.95E-03 -6.83E-01
Table 12: Top 15 nominally significant immune gene variant associations
with Christensenella.
The 6th ranked gene association between host immune ge-
netic variants and Christensenella was observed with variants within
the Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1) gene
that encodes the Treg Cluster of Differentiation 39 (CD39, Peak P=2.48x10-3,
MAF=0.096, Figure 10). Tregs, or regulatory T cells, are essential im-
mune suppressors that are critical to distinguishing between host and
non-host cells. CD39 is an important marker of inflammation. It has
the ability to revert a cell back to its anti-inflamed state via degra-
dation of ATP, ADP and AMP to adenosine [Borsellino et al., 2007].
White blood cells such as neutrophils and monocytes express CD39
acting as transports to get the TREG to key sites of inflammation
and furthermore, mice deficient in CD39 are unable to suppress T-
cell proliferation [Beldi et al., 2008]. The negative association here
would suggest a reduction of Christensenella in individuals with these
variants. If we assume that these variants impact the functionality of
CD39 resulting in increased inflammation, then these results would
also concur with the findings presented in Table 10 and support the
link between Christensenella and inflammation.
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Figure 10: Locus-zoom plot of ENTPD1 associations with Christensenella
4.3 conclusion
My aim in this chapter was to determine whether Christensenella was
associated with adiposity or body mass while also developing a hy-
pothesis about how Christensenella affects adiposity. The abundance
of Christensenella associates with visceral fat, the component of adi-
pose tissue with important metabolic implications, independently of
BMI. Candidate gene analysis exploring obesity genes found a nomi-
nally significant association between Christensenella and BDNF, a gene
responsible for signalling and synaptic plasticity in the brain, partic-
ularly in regions that control food and drink consumption [Bramham
and Messaoudi, 2005]. An immediate theory as to how this gene in-
fluences Christensenella is not apparent, but one hypothesis is that
variations in BDNF may influence what the host eats or how much
[Rios, 2013], thus impacting levels of Christensenella.
As visceral fat has important implications with inflamma-
tion and immune response, I pursued association analyses between
Christensenella and immune phenotypes available in the TwinsUK co-
hort at the time. Christensenella was significantly associated with a
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number of leukocyte sub-types as well as overall white blood cell
count. White blood cells are good markers of inflammation due to
their involvement in both the innate and adaptive immune response,
and transport of Tregs. Furthermore, another candidate gene analy-
sis of immune traits showed Christensenella to be associated with host
genetic variants in GPC1 and ENTPD1, both of which have implica-
tions with inflammation. While it is unclear how GPC1 may interact
with Christensenella, ENTPD1 encodes an anti-inflammatory Treg that
is typically present on neutrophils and monocytes. It is potentially via
leukocytes that CD39 interacts with Christensenella and thus results in
the associations seen not only in the immune candidate gene analysis,
but also the white blood cell association analysis.
This suggests a potential interaction between ENTPD1 Chris-
tensenella and inflammation that warrants further investigation.
The approaches used in this section yielded interesting re-
sults at the candidate level. In Chapter 5 I apply these approaches on




M I C R O B I O M E - W I D E A S S O C I AT I O N S T U D Y
( M I WA S ) O F O B E S I T Y
5.1 background
Of particular interest to researchers is the interaction of the micro-
biota with disease. Many diseases have now been linked to changes
in the gut microbiota and these include ulcerative colitis [Rooks et al.,
2014], obesity [Turnbaugh and Gordon, 2009, Walters et al., 2014], di-
abetes [Kostic et al., 2015] and irritable bowel syndrome [Major and
Spiller, 2014]. A number of study designs have been used to under-
stand the role of the microbiome in these diseases such as mouse
models, twin designs, case-controls and statistical modelling and in
this chapter I will focus on the methods that I have used, twin design
and statistical modelling.
Due to the large number of phenotypes characterised in the
TwinsUK cohort, I performed a number of association scans compar-
ing each of the phenotypes with the entire 16s gut microbiota. This I
have termed a Microbiome-Wide Association Study (MiWAS).
5.1.1 Obesity
Obesity has become a significant problem in recent years, originally
within Western populations but now extending worldwide. In 2008 it
was estimated that approximately between 10-14% of the world’s pop-




this, obesity is largely preventable with the diet and lack of exercise
being the largest risk factors for the development of the disease [Bar-
ness et al., 2007, Kelly et al., 2008]. There has been a large drive to
understand the role of the microbiome in obesity and there are many
differing views on whether differences observed are cause or effect.
Studies on early life exposure to antibiotics have found some
evidence suggesting disruption of the microbiota may result in obe-
sity later in life [L et al., 2014, Trasande et al., 2013]. Mouse models
have also provided some evidence to suggest a causative role for the
microbiome in obesity. Germ-free mice innoculated with the gut mi-
crobiome from conventionally-raised mice show a 60% increase in
adiposity [Backhed et al., 2004] while faecal analysis of obese mice
shows differences in community profiles from lean mice [Ley et al.,
2005]. But of course, there are studies that show no differences in
the gut microbiome between lean and obese subjects [Duncan et al.,
2008]. Studies do seem to agree on the same phyla of bacteria that
change in obesity, observing increases in Firmicutes and decreases
in Bacteroidetes in lean/obese individuals, in what has come to be
known as the Firmicutes:Bacteroides ratio.
A recent meta-analysis by the Knight Lab of available mi-
crobiome studies of obesity that have focused on BMI showed no
consistent trend across microbiome studies, in either microbial pro-
files or alpha diversity [Walters et al., 2014]. The authors propose that
this is likely due to the differences in sample collection and method-
ological differences between studies, such as the use of qPCR vs am-
plicon sequencing. They highlight the importance of developing a
"gold-standard" pipeline for handling of microbiome samples, espe-




Measurement of obesity in microbiome studies has been mostly
limited to BMI in humans. As BMI measures overall adiposity with-
out distinction between fat mass and lean mass it is not the most
accurate measure of obesity [Romero-Corral et al., 2008]. Mouse stud-
ies however tend to use epididymal fat weight, a visceral fat proxy
in mice, and DEXA-derived measurements of total fat mass, both of
which are a far more accurate assessment of adiposity. DEXA (dual-
energy x-ray absorptiometry) uses x-rays to assess body composition.
This procedure works on the basis that x-rays travel through differ-
ent tissues at differing rates. Measuring the transit time of these rays
can provide a whole-body view of the location of fat and in what
quantity. Differences in this characterisation of obesity could in part
explain the differing results found by the multitude of obesity stud-
ies. Another point worth noting is the lack of studies using visceral fat
as a marker of obesity. Visceral fat, or adipose tissue, is the fat tissue
that is highly associated with cardio-metabolic disorders [Sironi et al.,
2012]. It is the deep layer of fat tissue that sits around organs and is
the hardest to be rid of once it has developed. Traditionally however,
visceral fat has been difficult to measure in humans, requiring time-
consuming and expensive CT and MRI scans. Recent developments
in DEXA technology means that visceral fat can now be estimated
in the same location as a typical CT slice cross-section in the lumbar
region L4-L5. DEXA scans are much quicker than CT scans and also
estimate overall body fat as well as android, gynoid and trunk fat.
A number of studies have confirmed that DEXA estimations of vis-
ceral fat are highly correlated with CT scan measurements [Snijder




In this Chapter my aim was to investigate the association
between the gut microbiome and obesity using multiple measures of
adiposity in a large sample twins.
5.2 results
In order to investigate the effect of the gut microbiome on obesity in
my dataset, I used DEXA-derived measurements on subjects who had
provided a faecal sample for 16s profiling. Summary characteristics
of the obesity phenotypes can be found in Table 13. The sample was
composed of a total of 960 predominantly female twins as described
in Chapter 2.
Phenotype Average (Range) Sample Size Abbreviation
Visceral Fat 567.21 (1.28 - 1919) 866 VFM
% Trunk Fat 31 ( 3.2 - 54.7)
960
pTF
BMI 29 (15.7 - 50.7) BMI
Android Fat 2152.4 (295.67 - 6590.99)
866
AFM
Android Lean 2989.48 (1671.46 - 5863.63) ALM
Android Total Mass 40.13 (58.6 - 11.84) ATM
Gynoid Fat 4596.55 (1033 - 10556.22) GFM
Gynoid Lean 6167.25 (3600.15 - 10335.66) GLM
Gynoid Total Mass 42. 14 (59.81 - 15.57) GTM
Android:Gynoid Ratio 0.46 (0.16 - 1.08) A:G
Subcutaneous Fat 1611.63 (416.39 - 3621.28) SFM
Table 13: DEXA variables summary
5.2.1 Heritability of Adiposity
First, I estimated heritability of all adiposity measures used, includ-
ing the new visceral measures using OpenMX. Previous heritability
estimates of other adiposity measures, including BMI, had been quite
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high, attributing approximately 70% of the variance in obesity to ge-
netic effect [Chaput et al., 2014, Fox et al., 2007]. In this dataset, I
estimated that BMI has a heritability of 76% and % Trunk Fat has a
heritability of 57%, so it is unsurprising that visceral fat has a heri-
tability of 73% ( Figure 11). This value is greater than estimates in
previous studies of visceral fat heritability that show heritability to
lie between 36-55% [Fox et al., 2007, Chaput et al., 2014, Rice et al.,
1997] .
Figure 11: Polar histogram of adiposity heritability in the TwinsUK cohort.
Green indicates additive genetics, orange indicates common envi-
ronment and blue indicates unique environment. A. Heritability
estimates of visceral fat (VFAT), % Trunk Fat (pTF) and BMI in
the TwinsUK cohort. B. Estimates of visceral fat in the Framing-
ham [Fox et al., 2007], Heritage [Rice et al., 1997] and Quebec
[Chaput et al., 2014] cohorts.
5.2.2 Microbial Diversity
The next analyses were concerned with determining microbial diver-
sity changes with changes in adiposity, to determine if microbial di-
versity is reduced in those subjects with more adipose tissue. Alpha
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diversity, as measured by Faith’s diversity or PD whole tree averages,
was calculated using QIIME by Ms Goodrich. PD whole tree aver-
ages calculates diversity based upon branch lengths in the phyloge-
netic trees. OTUs that are closely related to other OTUs add a small
amount to the diversity while OTUs that are entirely unique add a
large amount to the diversity. This differs to other methods of alpha
diversity, such as Shannon diversity, as it does not account for species
abundance.
Alpha diversity showed a significant negative association
with each of the fat phenotypes. However no significant association
was obtained with either of the lean phenotypes, ALM and GLM
(Figure 12). Visceral fat mass showed the most significant association
(P=5.11x10-6). This confirms the findings in previous studies and the
validity of the current data.













Figure 12: Boxplots showing reduced alpha diversity between high and low
fat subjects. BMI high and low cut-offs were determined using
the clinical standard healthy BMI ranges (>30 = High, <25 = Low).
For all other measures High and Low were determined as being
>1SD from the mean.
Two recent metagenomics studies have both found lower mi-
crobial gene counts in obese individuals indicating a reduction in mi-
crobial diversity [Le Chatelier et al., 2013, Cotillard et al., 2013], sup-
porting the findings above. In Cotillard et al. [2013], a dietary inter-
vention in obese individuals was able to increase the microbial gene
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count in obese individuals providing a potential treatment option for
microbiota restoration in obesity.
Beta diversity showed no clustering according to status of
obesity (Figure 13).
Figure 13: Scatterplots coloured according to obesity status as measured
by BMI. A. Bray-Curtis metric. B. Unweighted Unifrac metric. C.
Weighted Unifrac metric.
5.2.3 Microbial Associations With Adiposity
I next sought to determine which individual microbes differed signif-
icantly in abundance in obesity. Using a linear mixed effects model,
defining the phenotype as the response variable and the OTU as a
predictor, adjusting for zygosity, sex, batch and family structure (re-
fer to Chapter 2 for more detail), I performed 9999 tests, comparing
11 phenotypes against 909 microbial units (768 OTUs and 141 taxon-
omy levels). There were 66 associations that surpassed a Bonferonni




Figure 14: Phylogenetic tree of OTUs associated with visceral fat in the Twin-
sUK cohort, coloured according to significance of change. Yellow
indicates nominal significance and red the most significant.
If we consider a conservative Bonferroni threshold of P=5x10-6,
66 associations pass multiple testing (Table 14 and these were associ-
ations between 34 microbial units (20 OTUs and 14 taxonomy levels)
and the 11 adiposity phenotypes. A complete table of the 66 associ-
ations can be found in Appendix A (Table A2). 38% of these associ-
ations are with visceral fat showing the strength of this variable in
finding microbial associations with obesity.
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OTU Parent Taxonomy (Level) Taxonomy (Level) Pheno P Value SE Beta
207487 Lachnospiraceae (Family) Lachnospira (Unknown Species) VFM 1.82E-09 0.0053 -0.0324
199344 Lachnospiraceae (Family) Unknown (Genus & Species) GTM 3.46E-08 0.0414 0.2352
199344 Lachnospiraceae (Family) Unknown (Genus & Species) GLM 4.46E-08 0.0173 0.0971
4349261 Lachnospiraceae (Family) Unknown (Genus & Species) pTF 9.09E-08 0.0342 -0.1844
207487 Lachnospiraceae (Family) Lachnospira (Unknown Species) AFM 2.08E-07 0.0173 -0.0907
Collapsed Tenericutes (Phylum) pTF 2.24E-07 0.0088 -0.0463
289734 Lachnospiraceae (Family) Unknown (Genus & Species) VFM 2.30E-07 0.0014 0.0071
176269 Lachnospiraceae (Family) Lachnospira (Unknown Species) VFM 2.34E-07 0.0014 -0.0075
199344 Lachnospiraceae (Family) Unknown (Genus & Species) BMI 2.42E-07 0.0560 0.2957
193769 Lachnospiraceae (Family) Ruminococcus gnavus ATM 2.45E-07 0.0167 0.0879
193769 Lachnospiraceae (Family) Ruminococcus gnavus GLM 2.85E-07 0.0095 0.0497
193769 Lachnospiraceae (Family) Ruminococcus gnavus GTM 2.88E-07 0.0226 0.1197
Collapsed Tenericutes (Phylum) Mollicutes (Class) pTF 5.17E-07 0.0098 -0.0501
322835 Lachnospiraceae (Family) Lachnospira (Unknown Species) VFM 6.00E-07 0.0054 -0.0272
199344 Lachnospiraceae (Family) Unknown (Genus & Species) ATM 6.19E-07 0.0308 0.1577
Collapsed Tenericutes (Phylum) VFM 6.76E-07 0.0011 -0.0053
Collapsed Mollicutes (Class) RF39 pTF 7.77E-07 0.0105 -0.0527
Collapsed RF39 (Order) Unknown (Family) pTF 7.77E-07 0.0105 -0.0527
Collapsed RF39 (Order) Unknown (Family & Genus) pTF 7.77E-07 0.0105 -0.0527
Collapsed RF3 (Class) VFM 8.13E-07 0.0035 -0.0177
Table 14: Top 20 MiWAS results with adiposity measures.
The main families with taxa that had high significance were
Lachnospiraceae and Ruminococcaceae. The top association was be-
tween a Lachnospira OTU and visceral fat mass (ANOVA, p=1.82x10-9,
β= -0.03). There were a number of Lachnospira OTUs in the results
that surpassed Bonferroni correction as well as a number of Teneri-
cute collapsed taxonomies. The families Ruminococcaceae and Lach-
nospiraceae are members of the Firmicutes and have previously been
associated with obesity [Daniel et al., 2014, Zhang et al., 2009]. A sig-
nificant number of OTUs that contributed to the top significant associ-
ations were moderately heritable including the family, Christensenel-
laceae, known previously to have associations with BMI [Goodrich
et al., 2014] as well as significant associations with visceral fat mass
(Chapter 4, Table A1)(p=3.51x10-6).
To date, this is the first visceral fat-microbiome study in
humans and the results have implications for the role of the micro-
biota in obesity. Visceral fat has important ramifications on cardio-
vascular disease and studies have shown it to be implicated in in-
sulin resistance by secreting retinol binding protein 4 (RBP4) [Klöt-
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ing et al., 2007]. Furthermore, visceral fat promotes the inflammatory
phenotype often seen in obesity by secreting the proinflammatory
adipokine, IL-6 [Fontana et al., 2007] which can further lead to in-
sulin resistance and type 2 diabetes. Due to the highly heritable sta-
tus of visceral fat and aspects of the human microbiota, in the next
section I will explore potential host adiposity gene effects on the gut
microbiome association in obesity.
5.2.4 Human Obesity-Linked Genes and the Gut Microbiome in Obesity
Obesity is highly heritable, as shown in Section 5.2.1, and some as-
pects of the microbiome have previously been shown to be heritable
(see Chapter 3). With this in mind, I performed a candidate gene
analysis (CGA) taking genetic variants that had previously been as-
sociated with obesity and testing their association with each OTU
and collapsed taxonomy that had significantly associated with obe-
sity within the TwinsUK 16S dataset.
At the time of thesis submission, there are 97 loci associ-
ated with obesity from genome-wide association studies [Locke et al.,
2015]. At the time of analysis however, there were only 32 "gold-
standard" loci that had been found to be associated with obesity [Spe-
liotes et al., 2010]. There were an additional 21 loci reportedly asso-
ciated with BMI in the NHGRI-EBI GWAS Catalog at the time. The
analyses presented in this chapter are therefore based on this total of
53 obesity-loci. Shortly before thesis submission, the analyses in this
section were repeated and the results with the latest list of 97 obesity
loci and expanded microbiome dataset are shown in the appendix
(Appendix A, Table A3 and Appendix B, Section B.1).
Of all loci associated with obesity in humans to date, two hu-
man obesity genes are of particular interest, FTO and MC4R. FTO was
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the first obesity locus discovered in 2007 [Frayling et al., 2007] and
is widely regarded as one of the biggest contributors to the obesity
epidemic. It is now believed that FTO affects obesity by controlling
energy intake as opposed to expenditure [Speakman et al., 2008] and
in 2013 this was further supported when it was found that genetic
variants in FTO affect levels of the hormone ghrelin which controls
satiation and food intake [Karra et al., 2013]. But a recent study has
proposed that FTO actually only has a very small, peripheral effect on
obesity and that it is in fact IRX3, a neighbouring gene that is the cul-
prit [Smemo et al., 2014]. The authors suggest that FTO interacts with
the promoters of the IRX3 gene resulting in the obese phenotype.
Melanocortin 4 receptor (MC4R) encodes a protein respon-
sible for binding the hormone, α-melanocyte stimulating hormone.
It has been found to possess very strong effects on obesity. Mc4r-
deficient mice were found to become extremely obese [Huszar et al.,
1997] and the prevalence of MC4R mutations in individuals with a
BMI >30 is approximately 2.5% [Larsen et al., 2005]. In addition, a
number of genome-wide association studies have determined associa-
tions between BMI and genetic variants within or nearMC4R [Scherag
et al., 2010, Loos et al., 2008, Chambers et al., 2008].
In this section I tested for genetic association between hu-
man genetic variants at 53 20kb regions that had been reported to be
associated with BMI in the NHGRI-EBI GWAS Catalog, selecting the
lead obesity-associated GWAS SNP as the centre of each candidate
gene region. Altogether, there were 1795 human SNPs in these 53
regions and a test of association was performed for each of these vari-
ants and all 34 obesity-associated OTUs and taxonomy levels identi-
fied in Section 5.2.3 above.
Three loci that had previously been associated with obesity
showed nominally significant associations with at least one of the
95
5.2 results
34 adiposity-associated microbes identified in Section 5.2.3 (listed in
Table 14 and Table A2). Only the top 3 associations passed a multiple-
testing threshold of P=2.7x10-5 (0.05/(34*53)). The peak association
was between a Lachnospiraceae OTU (OTU 174911) and a variant
within the RPTOR gene (rs8081087, P=1.44x10-7, Figure 15).
Figure 15: Locus-zoom plot of the association between rs8081087 and Lach-
nospiraceae
RPTOR is responsible for controlling the insulin-signalling
pathway through the mTOR pathway in response to nutrient availabil-
ity. When there is an abundance of nutrients, RPTOR binds and acti-
vates mTOR which in turn promotes the kinase activity S6K1, lead-
ing to phosphorylation of IRS-1 and subsequent inhibition of insulin
signalling. Two other gene variants surpassed nominal significance
but not the multiple-testing threshold. These were genetic variants in
PROX1 and TFAP2B.
I then explored the association between rs8081087 with vis-
ceral fat, pTF, BMI and insulin, and also explored adiposity associ-
ations with the significant Lachnospiraceae OTU 179411. While the
SNP rs8081087 was not significantly associated with adiposity phe-
notypes, other variants within RPTOR showed nominally significant
associations with VFM (peak P=8.37x10-4) as well as insulin (peak
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P=9.93x10-4). Furthermore, the Lachnospiraceae OTU, 174911, was
nominally associated with the serum metabolite lathosterol (P=0.000185),
a precursor to cholesterol whose levels have been shown to differ dur-
ing insulin resistance [Pihlajamaki et al., 2004]. Further metabolite as-
sociation results will be discussed in detail in Chapter 6. In addition,
gene expression profiles across multiple tissues in the pilot GTEX
data showed that RPTOR is expressed at greater levels in sigmoid
colon, oesophagus (gastroesophageal junction and muscularis), and
skeletal muscle (http://www.gtexportal.org/).
5.2.5 Exploring Causality
In order to infer causality, I decided to apply Mendelian Randomisa-
tion (MR) to the data, specifically exploring the RPTOR SNP - Lach-
nospiraceae OTU 174911 - Visceral fat pair-wise association results.
To this end I performed analyses in collaboration with Dr Emily
Davenport and Dr Andrew Clark at Cornell University, and the fi-
nal MR results presented in Figure 16 were calculated by Dr Dav-
enport. Mendelian randomisation is a technique to test for causal
relationships using SNP data as an anchor to test whether an inter-
mediate phenotype causes the phenotype of interest [Lawlor et al.,
2008]. There are 3 major assumptions of mendelian randomisation
(Figure 16). The first is that the genotype of interest is associated with
the intermediate phenotype. The second assumption is that the geno-
type of interest has no relationship to the confounding factors that
may affect the relationship between the intermediate phenotype and
phenotype of interest. The final assumption is that the genotype is
only linked to the phenotype of interest via its association with the
intermediate phenotype (Figure 16).
97
5.2 results
Figure 16: Diagram to show the relationship between variables assumed for
mendelian randomisation.
We hypothesised that the SNP rs8081087 may influence the
Lachnospiraceae OTU of interest, OTU 174911, which may in turn af-
fect obesity. MR was done using a two-stage least squares regression,
with either pTF, insulin, VFM, BMI or lathosterol as the outcome vari-
able. The beta coefficients for each phenotype were plotted in a forest
plot (Figure 17) and with the exception of insulin, the phenotypes had
very small effect sizes. If OTU 174911 was mediating the effect of the
RPTOR SNP on visceral fat I would expect to see a significant shift
in the regression coefficient away from zero. Ultimately, the analyses
were not significant and causality could not be inferred for any of the
phenotypes.
The lack of significance however, may simply be down to a
lack of power. Power to detect associations in genetic studies is often
a concern as any given genetic variant often explains only a small
proportion of the phenotypic variance. An online tool, mRnd, created
by the Visscher lab, calculates the sample size one would require to
assess causality using a 2-stage least squares randomisation at a given
power threshold [Brion et al., 2013]. Using this tool, and assuming the
association between rs8081087 and OTU 174911 explained 1% of the
variance, I was able to calculate the sample size required to reach 80%
power to detect causality (Figure 18).
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Instrumental Variable Analyses for 
 rs8081087, OTU174911, and traits
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Figure 17: For each obesity trait, the forest plot shows the betas and confi-
dence intervals from Mendelian Randomisation.
Figure 18: Power curves for determining sample size for Mendelian Ran-
domisation on obesity traits and OTUs.
The results show that using mendelian randomisation, we
would require hundreds of thousands of subjects to detect causality
and it is therefore unsurprising that we do not see an association
with our sample of 960 individuals. We can assume that this is in fact
a generous estimate as our 1% assumption is based upon the FTO
SNP which explains approximately 1% of the variance observed in




In this chapter I have outlined microbiome associations with the novel
phenotype, visceral fat and 9 other adiposity phenotypes. I observed
that the strongest associations between the gut microbiome in obe-
sity were obtained for visceral fat, which is the adiposity phenotype
that is most relevant for cardiometabolic disease risk. I have also con-
firmed the heritability estimates for multiple adiposity phenotypes
within this cohort, showing visceral fat to possess a high heritabil-
ity of 73%. I have also confirmed the association between microbial
diversity and the gut microbiome in this dataset. Using host geno-
type, I have found a promising gene candidate that may influence
the human microbiome and while not successful, attempted to use
mendelian randomisation to infer a causal relationship between this
gene and obesity, with the microbiome at a mediator.
The human gut microbiome plays a large role in obesity, but
it is unclear so far whether this role is causal or reactive. While mouse
models may hint at a causative role, this has yet to be proven in hu-
mans. Host genetics appear to play a role in the presence of certain
microbes, but the genes behind this influence are yet to be discov-
ered. Until large study numbers can be acquired, a candidate gene
approach may be the best method to seek host genes that may be
interacting with host microbes.
After these analyses presented in this chapter had been com-
pleted I obtained additional 16S data just prior to thesis submission.
I repeated the analyses presented in this chapter in the larger twin
dataset and I summarize the updated results briefly in the Appendix B.
100
6
M E TA B O L O M I C S A N D T H E M I C R O B I O M E
6.1 background
Metabolomic profiling is a useful technique to give a snapshot of
metabolic functions in a tissue. While techniques such as proteomics
and gene expression may reveal which gene products are being pro-
duced in any given cell, metabolomic profiling provides an overview
of the functional processes within that cell. This versatile profiling
technique can be performed on a number of sample types including
saliva, faeces, urine and blood. Typically, the metabolites are isolated
from the sample and then analysed using one of a number of meth-
ods, including nuclear magnetic resonance (NMR) and mass spec-
trometry (MS), to determine the identity of each metabolite.
Changes in the metabolic profile can be linked with disease.
In the TwinsUK cohort in particular, a number of metabolomic find-
ings have previously been published based on blood metabolite mea-
surements in approximately 6000 twins. In 2013, C-glycosyl trypto-
phan (C-glyTryp) was found to strongly correlate with ageing and
birth weight in a subset of over 6000 twins (P = 7x10-157 and P = 1.8 x
10-8, respectively) [Menni et al., 2013b]. In the same cohort, 3-methyl-
2-oxovalerate was found to be the strongest biomarker of impaired
fasting glucose (P = 8.46x10-9) [Menni et al., 2013a]. A genome-wide
association study has also been performed on the metabolomics data
in this cohort, resulting in a comprehensive database of hundreds of
genetic associations [Shin et al., 2014].
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Metabolites are produced not only by human cells, but also
microbial cells. Penicillin for example, perhaps one of the most use-
ful drugs of the 21st Century, is a secondary metabolite of the fungi
genus Penicillium. In fact, a number of microbial secondary metabo-
lites are antibiotics, necessary to compete for resources and space.
Metabolon Inc have estimated which host metabolites may be pro-
duced via microbial metabolism (Figure 19).
Figure 19: Host metabolites that are modulated by gut microbial
metabolism. Italicised metabolites are affected by both host and
microbial cells. Non-italicised metabolites are modulated by mi-
crobial cells the majority, if not exclusively, of the time. Graphic
adapted from Guo et al (2015)[Guo et al., 2015].
In the absence of metagenomic and transcriptomic data to
give an overview of collective microbial function, metabolomics can
provide an alternative and useful insight into microbiota metabolic
function. The Human Metabolome Database (HMDB, http://www.hmdb.ca/)
is a comprehensive repository of metabolites found in a range of hu-
man tissues, allowing the researcher to refine a search based upon the
origin of the metabolite. In this way, a search can be refined to just
microbial metabolites such as phylloquinone (vitamin K1). However,
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the line between host metabolite and microbial metabolite becomes
blurred when we consider that microbes can produce many of the
same metabolites as the host (Figure 19).
In this Chapter I sought to determine gut microbial associ-
ations with serum, plasma and faecal metabolites in a set of healthy
twins. Then using a candidate approach, I was able to identify mi-
crobes that may potentially influence chronic kidney disease through
production of metabolites implicated in the etiology of the disease.
6.2 results
6.2.1 Microbiome-wide Metabolome-wide Association Study
The sample size used in this section is 831 individuals that had both
serum/plasma metabolite samples and 16s gut microbiota samples.
In total, 909 microbial units and 508 metabolites (of which 311 metabo-
lite possess a known identity) were considered. Please refer to Chap-
ter 2 for a complete description of the data analysed within this chap-
ter. To determine potential microbially-driven metabolites it was nec-
essary to produce a reference association table, outlining associations
between OTUs and human serum and plasma metabolites. Using a
linear mixed-effects model (as outlined in Chapter 2), in this dataset
of 831 individuals, metabolites were considered as the dependent
variable and the OTU or collapsed taxonomy as the predictor. Co-
variates included BMI, batch, twin structure and zygosity.
Altogether, 111 associations passed Bonferroni correction (P
= 1.07x10-7, Table A4) and 361 metabolite-microbiota associations sur-
passed FDR 1% threshold, composed of 135 unique OTUs and tax-
onomies and 23 unique metabolites. Palmitate was the most abun-
dantly associated metabolite, followed by cholesterol and phenylala-
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nine. Saccharin, 4-acetamidobutanoate, histidine and isoleucine each
had 2 associations, while hypoxanthine had 1 association (Table 15).
The heritable family Christensenellaceae (collapsed family) featured
in the top hits, first with palmitate (P=3.44x10-26) and second with
phenylalanine (P=3.6x10-17). The positive beta of both these interac-
tions suggests an increase of Christensenellaceae when palmitate in-
creases. However this does not necessarily indicate a causal interac-
tion.










Table 15: Bonferonni-significant metabolites and the number of Bonferonni-
significant associations they had with adiposity.
6.2.2 Metabolite-Microbe Associations In Obesity
Of the 111 metabolite associations that passed Bonferroni correction,
16 were with OTUs and collapsed taxonomies that had previously
been associated with adiposity phenotypes that surpassed Bonfer-
onni correction (Chapter 5, Table 16). These associations were com-
posed of 11 unique OTUs/taxonomies and 5 metabolites.
These metabolite-microbe associations were with palmitate,
phenylalanine, histidine, isoleucine and 4-acetomidobutanoate. Palmi-
tate, phenylalanine, histidine and isoleucine all have previously been
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OTU Parent Taxonomy (Level) Taxonomy (Level) Metabolite P Value Estimate SE
Collapsed Christensenellaceae (Family) Unknown Genus palmitate 2.14E-25 0.128803141 0.011953116
Collapsed Christensenellaceae (Family) Unknown Genus phenylalanine 9.42E-17 0.114106241 0.013426764
Collapsed Dehalobacteriaceae (Family) palmitate 1.16E-14 0.211281463 0.026854464
Collapsed Dehalobacteriaceae (Family) Dehalobacterium (Genus) palmitate 3.86E-14 0.21327813 0.027666538
289734 Lachnospiraceae (Family) Unknown Genus and Species palmitate 5.01E-14 -0.087332116 0.011361762
3195723 Ruminococaccaceae (Family) Oscillospira (Unknown Species) palmitate 9.31E-14 0.292033643 0.038521203
292735 Lachnospiraceae (Family) Blautia (Unknown Species) palmitate 2.07E-13 -0.18368881 0.024498402
3014082 Lachnospiraceae (Family) Blautia (Unknown Species) palmitate 1.29E-10 -0.162315269 0.024888197
4465907 Lachnospiraceae (Family) Blautia (Unknown Species) palmitate 4.70E-09 -0.284319785 0.047592053
289734 Lachnospiraceae (Family) Unknown Genus and Species phenylalanine 5.57E-09 -0.074781969 0.012627503
Collapsed Christensenellaceae (Family) Unknown Genus histidine 9.26E-09 0.076426197 0.013171684
292735 Lachnospiraceae (Family) Blautia (Unknown Species) phenylalanine 1.18E-08 -0.157675999 0.027208389
Collapsed Christensenellaceae (Family) Unknown Genus isoleucine 8.82E-08 0.071854811 0.013312587
194488 Ruminococaccaceae (Family) Unknown Genus and Species palmitate 9.22E-08 0.276643443 0.051318572
Collapsed Clostridiales (Order) Unknown Family 4-acetamidobutanoate 1.05E-07 0.045231816 0.00840111
Collapsed Clostridiales (Order) Unknown Family and Genus 4-acetamidobutanoate 1.05E-07 0.045231816 0.00840111
Table 16: Overlap between microbes associated with metabolites (Bonfer-
onni) and obesity (Bonferonni).
linked to metabolic disorders. 4-acetamidobutanoate was one of a
group of metabolites able to distinguish between under-nourished
mice and fully-nourished mice in urine [Preidis et al., 2014]. Given
the metabolic significance of these metabolites in obesity, it is inter-
esting to see obesity-associated microbes showing associations here
also. Of course, these metabolic changes may be a result of dietary
changes in the host. Palmitate is the most abundant of all the fatty
acids, and this may be highly associated with the microbiota simply
due to this. The metabolite data is fasting data however, potentially
minimising any effect from immediate dietary intakes.
6.2.3 Metabolite-Set Enrichment Analysis
Over representation analysis (ORA) is a useful method to determine
pathway enrichment in a given set of significant metabolites. This
analysis was performed using the online tool MSEA (http://www.msea.ca/)
[Xia and Wishart, 2010] which uses a hypergeometric test to deter-
mine whether the set of metabolites is represented more than by
chance. In order to determine if there were any pathways enriched
in these obese-microbe metabolites, I took the metabolites that com-
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prised the nominally significant associations from the obese microbe
crossover results in Section 6.2.2 (Table 17).
Query Match HMDB




4-acetamidobutanoic acid 4-Acetamidobutanoic acid HMDB03681
phenylacetylglutamine Alpha-N-Phenylacetyl-L-glutamine HMDB06344
indolelactate Indolelactic acid HMDB00671
4-methyl-2-oxopentanoate Ketoleucine HMDB00695
Table 17: Metabolites used for MSEA.
Figure 20: Metabolite set enrichment analysis results.
Protein biosynthesis was the only pathway to remain signifi-
cant following FDR correction (FDR-adjusted P=4.33x10-3, Figure 20).
In total, ten pathways were found to be nominally enriched in this
dataset (P <0.05, Figure 20). In addition to the protein biosynthesis
pathway, these were phenylacetate metabolism, valine, leucine and
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isoleucine degradation, histidine metabolism , phenylalanine and ty-
rosine metabolism, glycerolipid metabolism, ammonia recycling, in-
sulin signalling, fatty acid elongation in mitochondria and fatty acid
metabolism. The metabolites enriched in the only significant path-
way, protein biosynthesis, were phenylalanine, isoleucine and histi-
dine and these results suggest that changes in the human gut micro-
biota are linked to obesity and may influence protein metabolism.
6.2.4 Microbial Metabolites and Kidney Function
Chronic kidney disease (CKD) is characterised as the loss of renal
function over a prolonged period of time, often months or years, how-
ever to be distinguished from acute renal failure, the loss of function
must have been experienced for longer than 3 months. Symptoms
include fatigue, increased blood pressure, accumulation of urea and
potassium and anaemia, and the test for CKD measures blood crea-
tinine. Glomerular filtration rate (eGFR) is the rate at which waste
products are filtered from the blood. High levels of creatinine in-
dicates a reduction in eGFR and consequently a reduction in kid-
ney function. Three metabolites, indoxyl sulfate, p-cresol sulfate and
phenylacetylglutamine, were found to be inversely correlated with
eGFR in the TwinsUK cohort [Barrios et al., 2015]. Indoxyl sulfate
and p-cresol sulfate are both uremic toxins and all three metabolites
are microbially-derived, providing some evidence to suggest that the
human microbiota may influence CKD. I was therefore interested to
determine the associations between these three metabolites and the
human microbiota in twins, as well as characterising the associations
between chronic kidney disease and the gut microbiota.
To begin with, I considered the microbiota-metabolite re-
sults for indoxyl sulfate, p-cresol sulfate and phenylacetylglutamine
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in the overall microbiome-metabolite study results outlined in Sec-
tion 6.2.1. 52 16S OTUs were significantly associated with pheny-
lacetylglutamine and 3 with indoxyl sulfate at an FDR threshold of
5% (Figure 21). The top association was between the heritable microbe
family Christensenellaceae and phenylacetylglutamine (P=3.54x10-07).
Christensenellaceae was not significantly associated with either p-cresol
sulfate or indoxyl sulfate however, at any level of significance.
Figure 21: . Interactions between eGFR, indoxyl sulfate, phenylacetyleglu-
tamine, p-cresol sulfate and the human microbiome. Red indi-
cates an inverse association while green indicates a positive as-
sociation. Column heights represent the beta coefficient.Adapted
from Barrios and Beaumont et al, PLoS ONE 2015 [Barrios et al.,
2015]
The majority of the OTUs and collapsed taxonomies that
were significantly associated with these three metabolites, belonged
to the Ruminococcaceae and Lachnospiraceae families, unsurprising given
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that these two families are the most abundant in the human gut mi-
crobiota.
A subset of 854 healthy subjects had data on CKD outcome
(a binary trait denoting disease status), eGFR and 16S microbial pro-
files. Of these 854, 55 (6.4%) individuals had impaired eGFR (<60
eGFR mL/min/1.73m2). To test the association between the human
gut microbiota, a linear mixed effects model was used (as described
in (Chapter 2), accounting for twin structure, zygosity and sex. No
CKD outcome associations surpassed FDR 5%. 46 associations were
nominally significant between 16S data and CKD outcome (Table 18).
The top association was negative with an unknown Lachnospiraceae
OTU (Greengenes 352529, P=0.0052).
OTU Family Genus P Value Std Err Estimate
352529 Lachnospiraceae Unknown 0.00517 0.02881 -0.08080
4447950 Bacteroidaceae Unknown 0.00794 0.01136 -0.03033
Collapsed Lachnospiraceae Lachnobacterium 0.00872 0.01554 0.04096
199677 Unknown (Clostridiales) Unknown 0.00910 0.03467 -0.09085
3943186 Lachnospiraceae Lachnobacterium 0.00974 0.01555 0.04040
151870 Erysipelotrichaceae Coprobacillus 0.01055 0.02357 -0.06043
4469007 Unknown (Clostridiales) Unknown 0.01179 0.00843 0.02132
181167 Lachnospiraceae Dorea 0.01283 0.02176 0.05435
189937 Ruminococcaceae Faecalibacterium prausnitzii 0.01291 0.03402 0.08477
2724175 Lachnospiraceae Unknown 0.01295 0.01539 -0.03838
Collapsed Clostridiaceae 0.01341 0.00813 0.02019
Collapsed Clostridiaceae Clostridium 0.01431 0.00536 0.01319
4202174 Clostridiaceae Unknown 0.01478 0.01065 0.02623
Collapsed Clostridiaceae SMB53 0.01596 0.01068 0.02593
Collapsed Odoribacteriaceae 0.01658 0.00440 0.01063
305318 Lachnospiraceae Unknown 0.01741 0.01883 0.04517
193477 Lachnospiraceae Unknown 0.01943 0.03084 0.07239
2740950 Lachnospiraceae Coprococcus 0.01963 0.01819 0.04281
184465 Lachnospiraceae Unknown 0.02134 0.03534 -0.08187
Collapsed Clostridiaceae Unknown 0.02164 0.00842 0.01944
4443846 Lachnospiraceae Unknown 0.02370 0.02012 -0.04562
2123717 Lachnospiraceae Unknown 0.02527 0.03413 0.07657
3275562 Lachnospiraceae Unknown 0.02647 0.00782 0.01739
4435400 Lachnospiraceae Unknown 0.02706 0.02095 -0.04649
182054 Lachnospiraceae Coprococcus 0.02924 0.02179 -0.04774
Table 18: Top 25 significant 16S associations with CKD outcome.
When analyses were repeated using estimated glomerular
flow rate (eGFR) as the phenotype, 23 associations had nominal sig-
nificant between 16S profiles and eGFR (Table 19). The unknown Ru-
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minococcaceae OTU, 198221, was the top hit (P=0.01). No associations
surpass FDR 5%.
OTU Family Genus P Value Std Err Estimate
198221 Ruminococcaceae Unknown 0.01062 0.04417 -0.11377
4447950 Bacteroidaceae Bacteroides 0.01610 0.02038 0.04926
186022 Lachnospiraceae Blautia 0.01804 0.05092 0.12062
266274 Ruminococcaceae Unknown 0.02016 0.03004 -0.06994
Collapsed Lachnospiraceae Coprococcus 0.02168 0.00709 0.01631
2256425 Christensenellaceae Unknown 0.03142 0.04295 -0.09256
Collapsed Peptococcaceae Unknown 0.03312 0.04347 0.09321
Collapsed Clostridiaceae SMB53 0.03316 0.01927 -0.04121
4448492 Lachnospiraceae Unknown 0.03323 0.02229 0.04760
182054 Lachnospiraceae Coprococcus 0.03361 0.03922 0.08385
180721 Ruminococcaceae Unknown 0.03381 0.03682 -0.07857
179512 Clostridiaceae SMB53 0.03514 0.06540 -0.13811
288810 Ruminococcaceae Unknown 0.03935 0.02732 -0.05646
191779 Lachnospiraceae Blautia 0.03966 0.05396 -0.11159
187504 Ruminococcaceae Unknown 0.04039 0.01583 -0.03249
185814 Ruminococcaceae Unknown 0.04187 0.02457 -0.05017
Collapsed Burkholderiales (class) 0.04218 0.00937 0.01922
782953 Enterobacteriaceae Unknown 0.04240 0.01444 -0.02963
4454531 Enterobacteriaceae Unknown 0.04481 0.03552 -0.07178
4427290 Ruminococcaceae Unknown 0.04573 0.02131 0.04268
Collapsed Betaproteobacteria (class) 0.04579 0.00959 0.01935
Collapsed Enterbacteriaceae 0.04839 0.01378 -0.02760
Table 19: Nominally significant associations between 16S profiles and eGFR.
While the direct associations between the microbiota and
CKD described here are weak, there are some significant associations
between the microbiota and serum metabolites that have been iden-
tified as potential biomarkers for CKD. This provides supportive evi-
dence for the role of the human gut microbiota in CKD progression.
These data were publish in Barrios and Beaumont (2015) PLoS ONE
and the manuscript can be found in Appendix B, Section B.2.
6.2.5 Faecal Metabolomics
All the results described so far in this chapter have concerned blood
serum and plasma metabolites. The following section will describe
preliminary faecal metabolomic analyses. The data is described fully
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in Chapter 2. Faecal metabolomics can be used to measure microbial
metabolic activity in the large intestine, however not all microbial
metabolites are excreted in faeces and so this method will not pro-
duce a comprehensive and accurate picture of gut microbiota metabolism.
P-cresol for example, while produced in the gut via microbial fermen-
tation of tyrosine, phenylalanine and tryptophan, is readily absorbed
by the mucosal cells in the colon and excreted in urine [Roediger and
Babidge, 1997].
Despite their potential usefulness, faecal metabolomics stud-
ies remain few in number. It is unclear why this is the case, how-
ever one study suggests it may be due to a lack of characterisation
of the ’normal’ faecal metabonome [Saric et al., 2008], and so made
efforts to characterise exactly that in mice, rats and humans. They de-
termined that the faecal metabolomic profile is not stable over time
and has unique differences across species that may present issues if
using mice or rats as a model organism for humans [Saric et al., 2008].
I was first interested to explore faecal metabolite associations
with obesity and then to determine human gut microbiome associa-
tions with faecal metabolites. In this pilot dataset of faecal metabo-
lites, there are a total of 60 individuals, all of which are MZ twins. A
subset of 49 individuals had adiposity data.
6.2.5.1 Faecal Metabolomics and Obesity
After normalisation, QC and imputation, I first wanted to determine
faecal metabolite associations with obesity. Using a linear mixed ef-
fects regression, I considered adiposity (either visceral fat, % Trunk
Fat or BMI) as the response variable, metabolite as the predictor and
BMI (except in the case of BMI as the test variable), age and family




When all 3 adiposity phenotypes are considered no associa-
tions surpass Bonferonni. 297 associations surpass a nominal signif-
icance threshold of P<0.05. The top association was between VFM
and N-acetylleucine (P=0.00027), followed closely by an association
between VFM and N-6-trimethyllysine (P=0.00028, Table 20. Full ta-
ble can be found in Appendix A, Table A5).
Metabolite Pheno P Value Std Err Estimate FDR Q Value
N-acetylisoleucine VFM 0.0003 0.0826 0.3379 0.2469
N-6-trimethyllysine VFM 0.0003 0.0830 0.3238 0.2469
X-21742 BMI 0.0003 0.1726 -0.7134 0.2469
pseudouridine VFM 0.0008 0.0905 0.3232 0.2790
S-adenosylmethionine (SAM) VFM 0.0009 0.0943 0.3335 0.2813
N-acetyltyrosine VFM 0.0010 0.0896 0.3130 0.2841
N-acetyltyrosine % Trunk Fat 0.0011 0.0941 0.3270 0.2861
X-12095 % Trunk Fat 0.0012 0.0947 0.3293 0.2873
X-13696 % Trunk Fat 0.0012 0.0990 -0.3438 0.2875
X-12700 VFM 0.0012 0.0814 0.2777 0.2882
X-11612 VFM 0.0013 0.0870 0.2961 0.2891
2-pentanamido-3-phenylpropanoic acid VFM 0.0016 0.0968 0.3259 0.2994
2-aminoheptanoate VFM 0.0019 0.0824 0.2697 0.3065
X-17438 VFM 0.0019 0.0867 -0.2842 0.3078
2-hydroxyoctanoate % Trunk Fat 0.0026 0.0897 0.3120 0.3198
5-methylthioadenosine (MTA) VFM 0.0027 0.0876 0.2755 0.3209
uracil VFM 0.0029 0.0842 0.2635 0.3235
5-methylthioadenosine (MTA) % Trunk Fat 0.0030 0.0917 0.2879 0.3241
lysylleucine VFM 0.0030 0.0890 0.2884 0.3248
5-methyluridine (ribothymidine) VFM 0.0032 0.0970 0.3038 0.3262
Table 20: Top 20 associations between adiposity and faecal metabolites.
When I performed MSEA on nominally significant metabo-
lites associated with visceral fat, the protein biosynthesis pathway
was significantly enriched (P = 5.83× 10-11) and remains so after FDR
correction (Q = 4.67× 10-9). The small sample size and observational
nature of this study prevents any further determination as to how
this pathway may be affected.
6.2.5.2 Faecal Metabolomics and the Human Gut Microbiota
I was next interested in 16S associations with faecal metabolites. Us-
ing a linear model as performed in Section 6.2.1, I tested the associa-
tion between OTUs and faecal metabolites. 22 associations surpassed
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Bonferonni threshold of p=5.4x10-8. This equated to 21 unique mi-
crobial units and 19 unique metabolites. The top association was be-
tween isopalmitic acid and an unknown Lachnospiraceae OTU (Green-
genes OTU 311820, P = 1.08 × 10-9, Table 21) and additionally, a
large number of the top hits were composed of Lachnospiraceae and
Ruminococcaceae associations but only 5 of the Bonferonni-significant
OTUs had associations with Bonferonni-significant OTUs in adiposity
(Section 5.2.3)
OTU Parent Taxonomy Taxonomy Metabolite P Value Beta SE
311820 Lachnospiraceae Unknown isopalmitic acid 1.08E-09 -2.0269 0.1814
302160 Ruminococcaceae Unknown X-22062 1.45E-09 -1.0344 0.0935
197364 Clostridiales (Order) Unknown 13-methylmyristic acid 2.52E-09 -0.4932 0.0121
178478 Bacteroidaceae Bacteroides unknown aspartylleucine 3.27E-09 -0.9131 0.0385
193915 Ruminococcaceae Unknown inositol-1-phosphate (I1P) 5.21E-09 2.2439 0.1416
187180 Ruminococcaceae Unknown valylserine 1.06E-08 -0.8753 0.0246
340711 Ruminococcaceae Unknown X-17698 1.72E-08 2.3798 0.1938
182911 Ruminococcaceae Unknown leucyltyrosine 1.75E-08 -0.6464 0.066
2875735 Bacteroidaceae Bacteroides unknown xanthosine 2.42E-08 1.3294 0.0291
332929 Ruminococcaceae Unknown threonine 2.60E-08 1.5405 0.0324
182911 Ruminococcaceae Unknown threonylarginine 2.82E-08 -0.6407 0.0644
537219 Clostridiales (Order) Unknown lysine 2.92E-08 -0.9477 0.0834
179744 Ruminococcaceae Oscillospira (unknown species) X...17303 3.02E-08 2.2104 0.2442
3195723 Ruminococcaceae Oscillospira (unknown species) X...14697 3.21E-08 -1.1660 0.0635
Collapsed Firmicutes (Phylum) Bacilli N.methylpipecolate 3.55E-08 -0.6708 0.0282
535955 Clostridiaceae ( SMB53 (Unknown species) deoxycarnitine 4.33E-08 0.7161 0.0815
198422 Clostridiales (Order) Unknown N.acetylthreonine 4.35E-08 0.9187 0.0484
Collapsed Tenericutes (Phylum beta.hydroxyisovalerate 5.01E-08 -0.3577 0.0210
Collapsed RF3 (Class) ML615J.28 beta.hydroxyisovalerate 5.01E-08 -0.3577 0.0210
Collapsed ML615J.28 (Order) Unknown beta.hydroxyisovalerate 5.01E-08 -0.3577 0.0210
Collapsed ML615J.28 (Order) Unknown beta.hydroxyisovalerate 5.01E-08 -0.3577 0.0210
174439 Ruminococcaceae Faecalibacterium prausnitzii X...20172 5.30E-08 -1.1966 0.0536
Table 21: Bonferonni-significant associations between 16S microbiome and
faecal metabolites.
In summary, the faecal metabolite pilot provided promising
results that could encourage full-scale analysis. While the sample was
fairly small at 60 samples, this is in fact the largest study of its kind.
A large number of associations were observed between the human
microbiota and faecal metabolites, as expected, however no adiposity
associations surpassed multiple testing thresholds. This may be sim-





In this chapter I was primarily interested in the relationship between
the human gut microbiota and metabolic end-products. Microbiota
associations with metabolites can be quite strong, as demonstrated by
some of the high p-values seen in this Chapter, as well as the sheer
number of associations that surpass an FDR threshold of 1%. This
makes finding meaningful, biological stories somewhat difficult to
tease apart and taking a narrower view using candidate metabolites
can produce clearer insights while awaiting larger samples, replica-
tion and better tools to fully understand the bigger picture. I demon-
strate this in Section 6.2.4 with kidney function and metabolites. Fae-
cal metabolites can provide an insight into the metabolic processes
taking place within the gut, and in the case of metabolites that are
associated with visceral fat, protein synthesis may be impacted in in-
stances of altered visceral fat mass.
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D I S C U S S I O N
This body of work is one of the largest population-based microbiome
studies to date in one of the most well-studied cohorts. It has explored
heritability of adiposity and the human gut microbiome, determined
that the human gut microbiome is strongly associated with adiposity
as well as specific environmental exposures, investigated microbiota
changes associated with renal function decline and explored the effect
of Christensenella in the host.
Using the ICC method, I determined heritability of 16S mi-
crobial profiles in a set of over 900 twins. This was later confirmed by
colleagues at Cornell University using structural equation modelling
and the ACE model [Goodrich et al., 2014]. This is the first heritability
study that has been performed on 16S data, however re-analysis of the
publicly available Yatsunenko et al. [2012] and Turnbaugh and Gor-
don [2009] datasets yielded similar results thus providing validation.
Christensenella was the most heritable microbe in the TwinsUK dataset
while also being highly heritable in the Yatsunenko dataset. With the
observation that levels of Christensenella were higher in lean twins
vs obese twins, our collaborators further explored the role of Chris-
tensenella in obesity. When mice inoculated with Christensenella were
fed high fat diets, the mice that received Christensenella displayed at-
tenuated weight gain. This hints at the possibility that Christensenella
may play a preventative role in the progression of obesity however
little is known and published on this potentially important microbe.
Given the apparent importance of Christensenella I explored
its association with additional phenotypes in the TwinsUK cohort in
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Chapter 4. I first explored its association with additional adiposity
phenotypes, and found strong associations with visceral fat and %
trunk fat, as well as moderate associations with BMI, confirming the
role of this microbe in obesity.
As explained in Chapter 4, Christensenella is an obligate anaer-
obe with the ability to produce butyrate and acetate. While butyrate
is considered to be a beneficial metabolite for the host due to its anti-
inflammatory properties [Meijer et al., 2010], increased SCFA, par-
ticularly proprionate, have been linked with obesity in a few small
to medium-sized studies [Payne et al., 2011, Schwiertz et al., 2010]
likely due to increased energy harvest from food or increased car-
bohydrate consumption [Duncan et al., 2008]. The apparent protec-
tive association between the butyrate-producing Christensenella and
obesity is in contrast to this, however Christensenella is not respon-
sible for the production of all the SCFA in the human host. Poten-
tially, the benefits of increased butyrate may overshadow the effects
of other SCFA. Unfortunately, the TwinsUK cohort does not possess
measures of SCFA at present and so I was unable to confirm or deny
the link between SCFA and obesity in a large sample. Christensenella
also co-occurs with members of the methanogen-producing Archaea
[Goodrich et al., 2014], potentially forming a syntrophic relationship.
The methanogens form other syntrophic relationships however, and
these have been linked with increased host adiposity, both in mice
[Samuel and Gordon, 2006] and in humans [Zhang et al., 2009]. In
mice, Methanobrevibacter smithii was able to modulate the activity of
Bacteroides thetaiotaomicron so that it produced more acetate and less
butyrate [Samuel and Gordon, 2006]. Acetate contributes to lipid syn-
thesis and cholesterol production [Wolever et al., 1995] which would
explain the increased adiposity observed in mice possessing both M.
smithii and B. thetaiotaomicron. I hypothesise that it may not be the
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presence of Christensenella that is important for decreased host adi-
posity, but given that M. smithii is widely shared and present in 64%
of this twin sample, but a possible syntrophic relationship between
the methanogens and Christensenella that may stimulate butyrate pro-
duction instead of acetate and therefore contribute to minimising in-
flammation and providing energy for colonic epithelial cells, instead
of lipid metabolism.
Indeed, my findings do seem to support the hypothesis that
Christensenella may be involved with inflammation. Christensenella was
strongly and negatively associated with visceral fat (Section 4.2.1),
a metabolically significant adipose tissue, capable of secreting the
pro-inflammatory cytokine, IL-6. The direction of association indi-
cates that in instances of increased visceral fat, there tends to be a
reduction of Christensenella. Furthermore, Christensenella tends to be
reduced when white blood cell counts such as monocytes and neu-
trophils are raised (Section 4.2.2). Candidate gene analysis of known
human immune regions revealed a number of suggestive associations
between Christensenella and ENTPD1, the gene that encodes the regu-
latory T-cell (Treg) CD39 that is important in suppressing inflamma-
tory responses by degrading ATP to AMP [Antonioli et al., 2013] (Sec-
tion 4.2.3.2). Given the anti-inflammatory effect of ENTPD1 and its
prominent location upon monocytes and neutrophils, both of which
associated with Christensenella, it presents an interesting association
worthy of further follow-up. Despite all these findings being observa-
tional in nature and not indicative of causality, they do support the
hypothesis that Christensenella is inversely linked with inflammation.
As Christensenella may be beneficial for health it is natural
to question how more Christensenella can be fostered in the host mi-
crobiota. Given that Christensenella produces SCFA it is prudent to
assume that Christensenella would therefore thrive on a high fibre
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diet. Indeed, the presence of Christensenella in the aquatic mammal,
dugong, would seemingly support this theory. D. dugon is a marine
hind-gut fermenter, requiring the colonic microbiome to break down
eelgrass, more specifically in the case of this dugong, Zostera marina.
Zostera species of eelgrass are more fibrous than other species, with
one species, Zostera capricornii, which has a mean neutral detergent
fibre (NDF) level of 63% of dry mass [Marsh et al., 2012]. As terres-
trial grasses typically have 50-70% NDF, this places Zostera species at
quite a high level of fibre content.
The primary focus of my thesis was on exploration of gut mi-
crobiome profiles in obesity as described in Chapter 5. While this is
an area of research that has been studied in depth, previous studies
have used BMI as a measure of adiposity. BMI is an index of over-
all body mass and while an adequate measure the majority of the
time, it can result in children or sportsmen being falsely considered
as obese. This has been demonstrated in rugby players where their
BMI’s were ~29 or above and so considered obese, yet their weight
was due to muscle mass. These individuals also had an higher mi-
crobial diversity than both high and low BMI controls, potentially
due to their diet and high amount of exercise [Clarke et al., 2014].
A number of adiposity measures were used in this thesis, including
BMI, visceral fat and android:gynoid ratio. Each of these measures
a different aspect of obesity; BMI measures overall body mass, irre-
spective of fat and lean mass, android:gynoid ratio adjusts truncal
or android adiposity for gynoid adiposity as the latter is held to be
beneficial for health [Snijder et al., 2005] and visceral fat is primar-
ily concerned with the deep adipose tissue that surround organs and
is strongly linked with disease. Due to the metabolic consequences
of increased visceral fat, chiefly insulin resistance and inflammation
[Fontana et al., 2007], measures of visceral fat are more clinically rele-
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vant than BMI despite being harder to obtain. I observed that associa-
tions between visceral fat and the microbiome are stronger than those
with BMI and in addition, the families of microbes that associate with
BMI, Ruminococcaceae and Lachnospiraceae, associate with visceral
fat estimates also. Yet there is no consensus with direction of effect
within these families. Some genera are more abundant in obese indi-
viduals while others are less abundant and this highlights the impor-
tance of looking at finer-grained taxonomic resolution when consid-
ering microbiome alterations in disease. A number of the microbes
that are associated with visceral fat are also associated with altered
serum metabolite profiles, particularly palmitate, phenylalanine, his-
tidine and isoleucine, all of which have previously been linked with
metabolic disorders (Table 22).
Metabolite Cardiometabolic Disease Link
Palmitate Induces insulin resistance[Thrush et al., 2008]
Phenylalanine Highly associated with diabetes[Wang et al., 2011]
Histidine Ameliorates inflammation in obese women and rats[Sun et al., 2014]
Isoleucine Prevents accumulation of triglycerides in mice[Nishimura et al., 2010]
Table 22: Links between significant metabolites and cardiometabolic disease.
Palmitate has been linked with insulin-resistance in obesity
[Gao et al., 2010, Thrush et al., 2008] however given that it is the
most abundant fatty-acid in food, it is entirely possible that these al-
terations are driven by diet. Enrichment analysis revealed that the
protein biosynthesis pathway is altered with the alteration of these
metabolites. Protein biosynthesis is concerned with the creation of
lean mass, primarily muscle mass, and it is thought to be impaired
in obese individuals, leading to higher fat mass [Guillet et al., 2011].
That microbes associated with obesity also associated with metabo-
lites involved with protein synthesis is perhaps indicative of the in-




Environmental effects are important to consider when analysing
microbiome data. I explored the impact of three specific environmen-
tal factors, smoking, diet and method of delivery, on the gut micro-
biome in twins in Chapter 3. Diet is presumed to be the largest factor
affecting the human microbiome and numerous studies have shown
the effects of a wide range of diets on the gut microbiota. In this
dataset, I found few significant associations and there are a number
of reasons why this might be. The first and most obvious potential
reason is the time difference between the dietary data collection and
the faecal sample collection. The FFQ data was collected prior to 2007
while the faecal collections began in 2010. Another potential reason
is that in a large sample size, the effect of a fatty diet may no longer
present, but the wealth of evidence in animal studies suggests this
may not be the reason for differing results. However it is worth re-
membering that results in animal models may not necessarily trans-
late into human subjects. Lack of dietary evidence in this cohort may
be due to sampling. With any questionnaire there is a risk of partic-
ipant bias due to the unwillingness of a subject to admit to certain
habits. This can result in the alteration of answers to make the subject
appear, for example, to be a healthier eater than they actually are. Nor
does the subject have to lie about their dietary habits to create noise
in the data; simply overestimating or underestimating consumption
of certain foods, however consciously or sub-consciously, will affect
dietary data outcomes. The TwinsUK cohort has had some success in
using its dietary data to find meaningful associations however, sug-
gesting that the dataset is reliable. Heritable food patterns were dis-
covered accounting for 5 broad dietary patterns including traditional
english, dieting, fruit and veg, low meat and high alcohol [Teucher
et al., 2007]. In addition, preferences for garlic and coffee were found
to be highly heritable [Teucher et al., 2007]. Another study found
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that wine and traditional english diet both had effects on bone min-
eral density in the same cohort [Fairweather-Tait et al., 2011]. FFQ
questionnaires may simply be an inaccurate way to measure and diet
intervention studies may be more effective. This involves placing par-
ticipants on specific diets and measuring the effect on the microbiome.
In this way, dietary intakes will be controlled and study groups can
be selected for comparison.
Method of delivery has been reported to affect the gut mi-
crobiome until as late as 7 years of age [Salminen et al., 2004]. In this
sample, there were no strong associations between method of deliv-
ery and the gut microbiome. This could be due to the low incidence
of caesarean section in the sample (3.9%)and it is unlikely there was
reasonable power to detect the effect method of delivery might have
on the microbiome, especially given the current age of the subjects.
Furthermore, infants born by caesarean section may be premature
and possess low birth weight which may confound the results.
The effect that tobacco smoking has on the human gut mi-
crobiome is relatively unstudied. In one study smoking was found to
affect the gut microbiome in such a way that it might influence obe-
sity [Biedermann et al., 2013]. Indeed it does seem that microbial di-
versity is unaffected by smoking as shown in Chapter 3, in agreement
with Biederman et al (2013). However, I observed a negative associ-
ation between the beneficial microbe, B. animalis and smoking status
which may be of interest. Smokers are at a higher risk of developing
the inflammatory disorder, Crohn’s disease [Cottone et al., 1994] but
not ulcerative colitis [Lindberg et al., 1988]. B. animalis spp. lactis has
been found to reduce inflammatory markers in a mouse model of col-
itis [Philippe et al., 2011] however B. animalis has also been found to
induce inflammation in IL-10 deficient gnotobiotic mice [Moran et al.,
2009]. B. animalis can refer to one of two subspecies; B. animalis spp.
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lactis or B. animalis spp. animalis. The different effects of these sub-
species may account for the differences observed in these two studies
and so if B. animalis was to be considered as a probiotic treatment for
gastrointestinal trouble in smokers, the subspecies would have to be
selected carefully. A probiotic intervention in humans using these 2
subspecies of B. animalis would be a good way to replicate the differ-
ence in effect of these two bacteria, and may also result in a viable
candidate to treat gastrointestinal upset in smokers.
As presented in Chapter 3, and discussed above, the gut mi-
crobiome has heritable components and has been shown here for the
first time, particularly species and genera within the Firmicutes phy-
lum [Goodrich et al., 2014]. While the sample size of this dataset is
relatively large for a microbiome study, this is considerably small sam-
ple for GWAS of human traits, where modest genetic effects require
much larger samples to ensure good power to detect associations. Fur-
thermore, the microbiome heritability estimates from the ACE model
in Chapter 3 were not strong, suggesting that we expect modest and
moderate host genetic effects on the human gut microbiome. Instead
I used a targeted candidate approach to perform genetic studies. Us-
ing previously published obesity genetic variants from the NHGRI-
EBI GWAS Catalog I performed a candidate gene analysis with the
gut microbiome, presented in Chapter 4 and Chapter 5. RPTOR was
the top association and encodes the protein raptor, which regulates
the activation of IRS-1 and adipogenesis in response to nutrient and
insulin levels through binding of mTOR [Tzatsos and Kandror, 2006].
Chronic activation of the mTOR pathway has been shown to lead
to insulin resistance and obesity [Patti and Kahn, 2004]. The results
show that Lachnospiraceae is less abundant when there is an increase
in insulin and adipose tissue, but the exact mechanism linking RP-
TOR with Lachnospiraceae remains unknown. Causal models did not
122
discussion
help clarify the relationship. It is possible that RPTOR has epigenetic
or expression effects on colonic epithelium (as suggested by gene ex-
pression profiles from the GTEX consortium dataset), which may lead
to differences in the gut microbiota.
Metabolomics provide a snapshot into the metabolic pro-
cessess that take place within the host. A number of metabolites that
can be measured in human blood and faeces are created by the host
microbiota, thus metabolomics can also provide a snapshot of micro-
biota metabolic processes. In Chapter 6 I explored the associations
between the human gut microbiota and serum, plasma and faecal
metabolites. Serum/plasma metabolites that have been linked with
host health were found in this project to be associated with members
of the gut microbiome in twins. In particular, the cardio-metabolically
important palmitate formed a number of associations. Palmitate has
significant implications on host health, yet is also the most abundant
fatty acid found, which may explain the number of associations. A
number of studies have shown palmitate [Thrush et al., 2008, Hoppa
et al., 2009, Feng et al., 2012] is responsible for inhibiting insulin se-
cretion and the adverse effect of trans fatty acids is well documented
[Willett, 2012], making palmitate an important contributory factor to
diabetes and cardiovascular disease. How the gut microbiome links
to palmitate is unclear. One metabolite that was significantly associ-
ated with members of the human gut microbiome was phenylacetyl-
glutamine. Phenylacetylglutamine is in fact a microbial co-metabolite
[Wijeyesekera et al., 2012] and has been linked with end stage renal
failure in type 2 diabetic patients [Niewczas et al., 2014]. To this end,
I was interested to explore the association between the human gut
microbiota and renal function.
In collaboration with my colleague, Dr Clara Barrios, we ex-
plored the association between renal function, as measured by esti-
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mated glomerular filtration rate, serum/plasma metabolites and the
human microbiome. Firstly, 3 metabolites were identified as being sig-
nificantly and negatively associated with renal function: p-cresol sul-
fate, phenylacetyleglutamine and indoxyl sulfate. All three of these
metabolites are microbial co-metabolites which proposed the hypoth-
esis that the human gut microbiome may be implicated in the progres-
sion of chronic kidney disease. Christensenellaceae, Ruminococcaceae
and Lachnospiraceae had significant associations with phenylacetyl-
glutamine and indoxyl sulfate. When associations between the gut mi-
crobiome and eGFR were tested, there were few significant hits and
none were particularly strong. This can be explained by the predomi-
nantly healthy nature of this cohort. Strong associations with the mi-
crobial metabolites identified as potential CKD biomarkers however
suggest a potential link between CKD and the human microbiome
that should be explored further in a disease-specific cohort. These
results have been published in PLoS ONE [Barrios et al., 2015].
Finally I performed a small-scale pilot analysis, comparing
faecal metabolites to adiposity and 16S microbiome profiles. A num-
ber of metabolites were nominally significantly associated with adi-
posity, although these associations did not surpass a multiple testing
threshold. Metabolite set enrichment analysis revealed that a number
of the significant metabolites were involved in the protein biosynthe-
sis pathway. Potentially, protein biosynthesis may be impacted by al-
terations in the colonic microbiome, mediated by metabolites, that af-
fect obesity. Microbial associations with faecal metabolites were much
stronger, resulting in many more associations than with adiposity.
The top association was with isopalmitic acid, a related metabolite to
the peak metabolite, palmitate, in the serm/plasma metabolite anal-
ysis. The sample size for this study is small, and more samples are
required to detect associations with adiposity, however associations
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with the 16S profiles are strong, confirming the strength of this tech-
nique in determining a snapshot of microbial metabolic activity in
the gut. There are few faecal metabolomics studies published and as
such, it is unclear what is considered a "normal" faecal metabolome
[Saric et al., 2008]. While this may be a powerful technique, it requires
further work to establish baseline measurements before comparisons
can be performed.
In summary, I have contributed to the discovery of genetic
influence on microbial abundance and found some key BMI associa-
tions. In addition, I have characterised the microbiome differences in
obesity using a novel adiposity measure- visceral fat, performed ex-
ploratory analyses to characterise Christensenella further, developed
hypotheses about its role in obesity and inflammation and found
evidence to support such a role. I have performed candidate gene
analyses to discover host genes that may impact microbial communi-
ties and used metabolite profiles to determine changes in early renal
decline. I have also explored known environmental factors in this
dataset, while also looking at smoking, a relatively unknown factor
affecting the microbiome. This work has brought the effect of genetics
to the attention of the microbiome research community and stressed
the importance of considering host genetic effect of microbial commu-
nities. It has further confirmed the need to take obesity into account
when performing analyses or participant selection.
To further this work I would move from observational stud-
ies and begin to perform functional analyses. In order to define the
role of Christensenella in obesity I would perform similar mouse ex-
periments to those in Goodrich et al (2014), this time monitoring cy-
tokines in the blood prior to inoculation with Christensenella and then
at various time points following inoculation. Transcriptomic analy-
sis on the Christensenella microbes would also be ideal, in order to
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see which genes are expressed to gain an idea as to what this im-
portant microbe might be doing to influence obesity of inflammation.
In fact, a meta-transcriptomic analysis on the entire human micro-
biome would be an interesting study to perform in order to under-
stand functional alterations in obesity. Dietary interventions would
also be an option to further a number of the studies performed in
this thesis. Firstly, one study could be aimed at determining the ideal
prebiotics that would promote Christensenella growth, while a second
study could focus on probiotic supplementation to improve the gas-
trointestinal health of smokers. Collection of more faecal and DNA
samples in order to perform a full genome-wide association study
would also be a priority, although many thousands would have to be
collected. This would help to find host genes that may affect micro-
bial composition. In order to address questions regarding butyrate, I
would measure SCFAs and determine associations with obesity and





A P P E N D I X
A
A P P E N D I X A : R E S U LT S TA B L E S
This appendix lists expanded results tables for the thesis.
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A P P E N D I X B : P U B L I S H E D PA P E R S A N D PA P E R S I N
D E V E L O P M E N T
b.1 appendix b1 . heritable components of the human gut
microbiome are associated with visceral fat - in
preparation
The manuscript in this section is an update of the analyses presented
in Chapter 5. The dataset was expanded to include a total of 1313
individuals with obesity and 16S data. This manuscript is currently







1Dept of Twin Research & Genetic Epidemiology, King’s College London, U.K. 
2Dept of Microbiology, Cornell University, Ithaca, NY 14853 US 
3Dept of Molecular Biology & Genetics, Cornell University, Ithaca, NY 14853, USA  
4Dept of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309, USA 
5Biofrontiers Institute, University of Colorado, Boulder, CO 80309, USA 
6Howard Hughes Medical Institute, Boulder, CO 80309, USA 
7Current address: Departments of Pediatrics and Computer Science & Engineering, University of California San 


























B.1 appendix b1 . heritable components of the human gut



















B.1 appendix b1 . heritable components of the human gut





leading	 causes	 of	 preventable	 death	 worldwide1.	 Although	 overall	 obesity	 poses	 a	 global	 health	
epidemic,	 it	 is	 the	accumulation	of	excess	abdominal	 fat	 that	 is	a	critical	 risk	 factor	 for	cardiovascular	
and	metabolic	disease.	Changes	in	diet	and	sedentary	lifestyle	can	partly	explain	obesity,	but	family	and	




Recent	 insights	 show	 that	 the	 gut	microbiota	may	play	 a	 crucial	 role	 in	 obesity	 and	 cardio-metabolic	
disease	risk.	Many	studies	have	linked	different	aspects	of	the	gut	microbiome	to	obesity10-15.	However,	





clear	 Firmicutes/Bacteroides	 ratio	 change	 as	 is	 commonly	 posited15.	 Another	 complicating	 factor	 is	
phenotype	measurement.	While	most	 human	 studies	 consider	 BMI	 as	 the	measure	 of	 obesity10,17,18,	
mouse	studies	typically	use	epididymal	fat	weight19	or	Dual-Energy	X-ray	Absorptiometry	(DEXA)-derived	
measures	 of	 total	 body	 fat20,21.	 BMI	 is	 imprecise	 and	 measures	 overall	 adiposity	 without	 distinction	
between	 lean	 and	 fat	 mass22.	 Estimates	 of	 visceral	 fat,	 however,	 have	 stronger	 associations	 with	
obesity-related	cardio-metabolic	diseases,	 such	as	 type	2	diabetes	and	cardiovascular	disease23-25,	but	
have	typically	been	difficult	to	measure	in	humans.		
A	 recent	 study	 by	 Goodrich	 et	 al	 (2014)26	 was	 the	 first	 to	 report	 heritability	 of	 the	 human	 gut	
microbiota,	with	the	abundance	of	the	family	Christensenellaceae	showing	the	most	variance	attributed	
to	host	genetic	effects	(39%).	Christensenellaceae	was	also	enriched	in	abundance	in	the	microbiomes	
of	 low-BMI	 individuals.	 Here,	 we	 build	 upon	 these	 findings	 to	 explore	 the	 association	 between	 the	
human	gut	microbiome	and	abdominal	adiposity,	 as	 the	main	 risk	 factor	 for	 cardio-metabolic	disease	
risk.	 We	 obtained	 DEXA-based	 measures	 of	 abdominal	 adiposity,	 specifically,	 visceral	 fat	 mass	 and	
previously	 reported	 trunk	 fat	measures27	 in	 the	 twin	 sample	 profiled	 by	Goodrich	 et	 al	 (2014)26.	We	
B.1 appendix b1 . heritable components of the human gut
microbiome are associated with visceral fat - in
preparation
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show	 that	 heritable	 components	 of	 the	 human	 gut	 microbiome26	 are	 significantly	 associated	 with	
visceral	 fat,	 confirming	 the	 key	 role	 of	 the	 microbiome	 in	 cardio-metabolic	 disease	 risk.	 We	 further	






(496	 monozygotic	 (MZ),	 592	 dizygotic	 (DZ),	 2	 with	 unknown	 zygosity	 and	 223	 unrelated	 individuals;	
average	age	63	years	(range	32-87);	96.4%	female).	We	obtained	gut	microbiome	profiles	in	the	1,313	





We	 studied	 6	 adiposity	 measures	 in	 total,	 and	 these	 included	 3	 measures	 of	 abdominal	 adiposity	
(visceral	fat	mass	(VFM),	subcutaneous	fat	mass	(SFM),	percentage	trunk	fat	(pTF)),	2	measures	of	body	
fat	 distribution	 (android/gynoid	 ratio	 (AGR)	 and	 waist-hip	 ratio	 (WHR)),	 and	 one	measure	 of	 overall	
obesity,	 BMI.	 Adiposity	 was	 estimated	 using	 DEXA-derived	measures,	 which	 have	 been	 shown	 to	 be	
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estimate	 over	 all	 OTUs	 was	 0.06.	 The	 most	 heritable	 microbe	 was	 Clostridum	 perfringens	 (h2=0.42	
(95%CI	0.23-0.51)).	Christensenella	was	the	most	heritable	microbe	reported	in	Goodrich	et	al	(2014)26,	
and	while	it	was	not	the	most	heritable	ranked	in	this	larger	dataset,	it	remained	highly	heritable	with	a	




Microbial	diversity	 in	obese	 individuals	has	been	 reported	 to	be	 lower	 than	 that	of	 lean	 individuals35.	
Here	we	estimated	alpha	diversity	of	 the	 sample	using	phylogeny-based	metrics,	and	 report	Shannon	
diversity.	 	 We	 compared	 Shannon	 Diversity	 with	 all	 adiposity	 measures	 using	 a	 linear	 mixed	 effects	
model,	adjusting	for	dietary	principle	components	(see	Methods),	age,	sex	and	family	relatedness.	As	in	
previous	 literature,	we	observed	a	 significant	negative	 association	between	Shannon	diversity	 and	all	
adiposity	phenotype.	VFM	showed	the	most	significant	association	(beta	=	,	se	=	,	P=4.13x10-7)	and	pTF	
showed	 the	 least	 significant	 association,	 though	 it	 surpassed	 nominal	 significance	 (P=1.51x10-2).	
Therefore,	alpha	diversity	measures	in	our	sample	are	not	only	negatively	associated	with	obesity,	but	
are	 also	 significantly	 lower	 in	 individuals	 with	 greater	 abdominal	 adiposity	 and	 visceral	 fat.	
	
Gut	microbiome	profiles	associate	with	central	adiposity	across	twins	
We	 investigated	 the	 association	 of	 each	 OTU	 and	 collapsed	 taxonomic	 trait	 with	 all	 adiposity	 traits,	
including	BMI,	across	individuals.		
OTUs	 found	 in	 less	 than	 25%	 of	 individuals	 were	 discarded	 and	 the	 remaining	 counts	 converted	 to	
relative	abundances.	Residuals	from	models	including	technical	covariates	such	as	sequencing	batch	and	
depth	of	sample	sequencing	were	used	in	analyses	to	control	for	technical	and	batch	effects.	
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in	 the	 top	 significant	 results,	 along	with	 a	 number	 of	 other	OTUs	within	 the	 Lachnospiraceae	 family.	
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and	 environmental	 components	 to	 both	 estimates	 of	 the	 gut	 microbiome	 and	 abdominal	 adiposity.	
Twin-based	 heritability	 estimates	 supported	 a	 strong	 genetic	 component	 for	 visceral	 fat	 and	 our	
heritability	 analyses	 of	 the	 gut	 microbiome	 in	 this	 sample	 showed	 wide	 variability	 in	 heritability	
between	taxa	(0–0.42),	with	members	of	Firmicutes	and	Actinobacteria	being	most	heritable.	The	peak	
Bonferroni	 significant	 OTUs	 associated	 with	 abdominal	 adiposity	 in	 our	 sample	 had	 an	 average	 OTU	
heritability	of	0.16,	suggesting	potential	host	genetic	links	to	the	identified	adiposity	associations.		
To	 explore	 the	 hypothesis	 that	 host	 genetics	 may	 influence	 the	 observed	 microbial-adiposity	
associations,	we	performed	candidate	gene	analysis	comparing	host	genetic	variants	at	human	obesity	
candidate	 loci	with	the	adiposity-associated	gut	microbiome	profiles.	We	selected	SNPs	within	human	
loci	 previously	 associated	 with	 obesity	 as	 reported	 by	 Locke	 et	 al	 (2015)7,	 using	 common	 genetic	
variants	 within	 97	 50kb	 regions	 centred	 around	 peak	 BMI-associated	 GWAS	 SNPs.	 At	 a	 Bonferroni-
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shown	 how	 specific	 members	 of	 the	 human	 gut	 microbiota	 clearly	 associate	 with	 obesity-related	
phenotypes,	 most	 notably	 those	 relating	 to	 VFM.	 Due	 to	 the	 importance	 of	 visceral	 fat	 in	 cardio-
metabolic	disease	risk,	direct	measures	of	visceral	 fat	are	more	 informative	than	BMI	 in	assessing	the	
metabolic	consequences	of	obesity	on	obesity-related	disease.	Most	microbiome	obesity	studies	to	date	
have	used	BMI	as	a	biomarker	of	obesity,	with	some	mouse	studies	using	epididymal	fat.	We	therefore	
present	 a	 dual	 approach,	 using	 BMI	 to	 confirm	 associations	 and	 visceral	 fat	 to	 find	 novel	 metabolic	
associations	 in	 a	 sample	 of	 twins.	 The	 power	 of	 this	 approach	 was	 apparent	 in	 the	 number	 of	 top	
associations	 that	were	observed	with	visceral	 fat.	The	Firmicutes	phylum	showed	the	most	significant	
associations,	 yet	 the	 direction	 of	 association	 differed	 for	 different	 genera	 within	 the	 Firmicutes.	
Furthermore,	the	majority	of	our	top	hits	are	independent	of	alpha	diversity,	suggesting	that	the	OTUs	
significant	in	this	analysis	are	not	just	markers	of	diversity,	but	form	real	associations.	In	the	American	
Gut	 cohort,	 our	 replication	 sample,	 we	 observed	 that	 the	 same	 families,	 Lachnospiraceae	 and	
Ruminococacceae	were	associated	with	BMI.	Firmicutes	have	previously	been	associated	with	obesity	in	
some	 but	 not	 all	 studies,	 and	 several	 of	 these	 studies	 show	 an	 increase	 in	 Firmicutes	 in	 obese	
subjects11,43,44.	For	example,	Ruminococcus	gnavus	has	been	shown	to	be	significantly	enriched	 in	 low	
microbial	 gene	 count	 individuals	 that	 were	 prone	 to	 obesity	 in	 one	 study14.	 However,	 the	 phylum	
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occur	 at	 finer-grained	 taxonomic	 resolution,	 and	because	 the	baseline	abundance	of	different	 genera	
differs	among	human	populations,	opposing	selection	processes	at	different	phylogenetic	levels	may	in	
part	 explain	 differing	 results	 in	 studies	 determining	 microbiota	 differences	 in	 obesity45,46,	 including	
recent	 meta-analyses	 across	 multiple	 obesity	 microbiota	 datasets15,47.	 This	 difference	 in	 directional	
effects	in	genera	of	the	same	family	has	previously	been	observed	in	animal	models.	Mice	consuming	a	
Western	diet	have	previously	been	reported	to	have	increased	levels	of	Eubacterium	dolichum48,	while	
another	 study	 has	 shown	 that	mice	 consuming	 a	 high-fat	 diet	 have	 decreased	 levels	 of	Allobaculum	
OTUs49.	 Both	 of	 these	 microbes	 are	 members	 of	 the	 Erysipelotrichaceae	 family,	 and	 show	 opposite	
directions	of	effect.	
Heritability	of	visceral	fat		
Visceral	 fat,	 the	type	of	adipose	tissue	with	the	most	 important	 implications	for	metabolic	health	was	
highly	heritable	 (73%)	and	showed	the	most	significant	associations	with	the	gut	microbiota.	Previous	




DEXA	 and	 anthropometric	measures,	 potentially	 accounting	 for	 the	 lower	 heritability	 estimate	 as	 the	
visceral	fat	estimate	is	not	measured	as	directly	as	in	this	study.	This	is	the	first	time,	to	our	knowledge,	









abdominal	 visceral	 fat,	 which	was	 highly	 heritable	 in	 our	 sample.	 Furthermore,	 we	 have	 identified	 a	
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DNA	extracted	 from	 faecal	 samples	 underwent	 amplification	 of	 the	V4	 region	 of	 the	 16S	 rRNA	 gene,	
followed	by	paired-end	sequencing	on	the	Illumina	MiSeq	platform.	







gender,	 shipment,	 number	 of	 sequences	 per	 sample	 and	 sequencing	 run,	 the	 final	 dataset	 contained	
2135	OTUs.	
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Microbiome	profiles	 from	 the	American	Gut	 cohort	were	used	as	a	 replication	 sample.	 Subjects	were	
consented	under	 the	protocol	approved	by	 the	University	of	Colorado	 IRB.	Samples	were	collected	at	
home	and	mailed	in	to	the	lab.	These	were	extracted	using	the	Power	Soil	kit,	amplified	using	the	EMP	
primers	 and	 sequenced	 using	MiSeq.	 OTUs	 were	 picked	 against	 Greengenes	May	 2013	 release,	 and	
bloom	 filtered	 to	 computationally	 remove	overabundant	 gammaproteobacterial	OTUs	using	UClust	 in	
QIIME53.	 A	 subset	 of	 samples	were	 selected	where	data	was	 publicly	 available	 and	was	 complete	 for	
sequencing	 plate,	 sequencing	 depth	 (taken	 as	 the	 ENA	base	 count),	 smoking	 status,	 gender,	 age	 and	
BMI	 (n=1101).	 We	 explored	 replication	 specifically	 from	 10	 peak-associated	 OTUs	 within	




Obesity	 phenotype	 data	 were	 collected	 during	 each	 participant’s	 annual	 clinic	 visit.	 We	 explored	 6	
obesity-related	phenotypes	 in	this	work	 for	a	subset	of	1313	twins	 (496	MZ,	592	DZ,	2	with	unknown	







metabolic	 phenotypes,	 we	 performed	 two	main	 analyses.	 First,	 we	 compared	microbiome	OTUs	 and	
phenotypes	by	fitting	a	linear	mixed	effects	model	(LMER)	using	the	R	package	LME4.	In	this	model	the	
phenotype	(or	metabolite	where	appropriate)	was	the	response	variable	and	the	OTU	was	a	fixed	effect	
predictor,	 family	 and	 zygosity	 were	 taken	 into	 account	 as	 random	 effects	 and	 sex,	 diet	 principle	
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Heritability	was	assessed	using	 the	ACE	model.	Under	 the	assumption	 that	 the	dominance	effects	are	
negligible,	the	ACE	model	can	estimate	the	additive	genetic	(A),	common	environment	(C)	and	unique	
environment	 (E)	 components	 of	 the	 trait	 variance.	 Twin	 heritability	 estimates	 were	 obtained	 using	
OpenMX56.	
Candidate	 gene	 analysis	 was	 performed	 using	 the	 software	 GEMMA	 (Genome-wide	 Efficient	 Mixed	
Model	 Association)57	 on	 	 1059	 individuals	 with	 genotypes.	 GEMMA	 implements	 a	 univariate	 linear	
mixed	model	to	perform	association	tests,	using	a	kinship	matrix	to	take	into	account	twin	relatedness.	
The	list	of	candidate	obesity	GWAS	SNP	associations	was	taken	from	Locke	et	al[ref].	The	reported	SNPs	
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Abstract
Introduction
Several circulating metabolites derived from bacterial protein fermentation have been found
to be inversely associated with renal function but the timing and disease severity is unclear.
The aim of this study is to explore the relationship between indoxyl-sulfate, p-cresyl-sulfate,
phenylacetylglutamine and gut-microbial profiles in early renal function decline.
Results
Indoxyl-sulfate (Beta(SE) = -2.74(0.24); P = 8.8x10-29), p-cresyl-sulfate (-1.99(0.24), P =
4.6x10-16), and phenylacetylglutamine(-2.73 (0.25), P = 1.2x10-25) were inversely associ-
ated with eGFR in a large population base cohort (TwinsUK, n = 4439) with minimal renal
function decline. In a sub-sample of 855 individuals, we analysed metabolite associations
with 16S gut microbiome profiles (909 profiles, QIIME 1.7.0). Three Operational Taxonomic
Units (OTUs) were significantly associated with indoxyl-sulfate and 52 with phenylacetylglu-
tamine after multiple testing; while one OTU was nominally associated with p-cresyl sulfate.
All 56 microbial members belong to the order Clostridiales and are represented by anaero-
bic Gram-positive families Christensenellaceae, Ruminococcaceae and Lachnospiraceae.
Within these, three microbes were also associated with eGFR.
Conclusions
Our data suggest that indoxyl-sulfate, p-cresyl-sulfate and phenylacetylglutamine are early
markers of renal function decline. Changes in the intestinal flora associated with these
metabolites are detectable in early kidney disease. Future efforts should dissect this rela-
tionship to improve early diagnostics and therapeutics strategies.
PLOS ONE | DOI:10.1371/journal.pone.0134311 August 4, 2015 1 / 9
OPEN ACCESS
Citation: Barrios C, Beaumont M, Pallister T, Villar J,
Goodrich JK, Clark A, et al. (2015) Gut-Microbiota-
Metabolite Axis in Early Renal Function Decline.
PLoS ONE 10(8): e0134311. doi:10.1371/journal.
pone.0134311
Editor: Giuseppe Remuzzi, Mario Negri Institute for
Pharmacological Research and Azienda Ospedaliera
Ospedali Riuniti di Bergamo, ITALY
Received: April 29, 2015
Accepted: July 7, 2015
Published: August 4, 2015
Copyright: © 2015 Barrios et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: TwinsUK was funded by the Wellcome
Trust; European Community’s Seventh Framework
Programme (FP7/2007-2013). The study also
receives support from the National Institute for Health
Research (NIHR) Clinical Research Facility at Guy’s
& St Thomas’ NHS Foundation Trust and NIHR
Biomedical Research Centre based at Guy's and St
Thomas' NHS Foundation Trust, the King's College
London, the Cornell Centre for Comparative
Population Genomics. Tim Spector is the holder of an
177
Introduction
It is increasingly recognized that the microbiome may affect health and disease of the host.
Indeed the endogenous flora has been recently associated with type 2 diabetes, obesity, meta-
bolic syndrome, cancer and liver cirrhosis among others [1–4]
Metabolites derived from bacteria provide a readout of the metabolic state of an individual
and are the product of genetic [5,6] and exogenous (diet, lifestyle, gut microbial activity) factors
under a particular set of conditions [7]. Under physiological conditions, there is a balance
between the intestinal bacteria and the host, due to the innate immunity that maintains equilib-
rium in inflammation pathways and the intestinal barrier integrity. However, in chronic kidney
disease (CKD), the uremic environment affects the intestinal barrier leading to bacterial dys-
biosis [8]. This activates inflammatory pathways and immune processes and leads to systemic
inflammation [9]. However, the degree of renal impairment that leads into modification of the
intestinal milieu or the deficit of gut-metabolites excretion remains unclear.
A deeper understanding of the gut-microbe-metabolite axis is a prerequisite to improve
therapeutic strategies that manipulate the gut microbiota in the onset of kidney dysfunction.
Indoxyl-sulfate and p-cresyl-sulfate are end-products of bacterial protein fermentation of tryp-
tophan and tyrosine respectively in the colon [10]. In vitro and ex vivo data show that indoxyl-
sulfate and p-cresyl-sulfate may trigger or accelerate cardiovascular disease and progression of
kidney failure [11,12]. Clinical observational studies also correlate high levels of both metabo-
lites with overall mortality as well as cardiovascular disease and renal disease progression [13–
15]. Phenylacetylglutamine is a major nitrogenous metabolite that accumulates in uremia. Its
plasma levels increase after cigarette smoke exposure, in ischemic heart failure patients, hyper-
tension, cardiovascular risk [16] and in the progression to end stage renal disease in type2 dia-
betic patients [17–19].
To date studies have concentrated on changes in intestinal flora and gut-metabolite levels in
advanced stages of CKD [8,9,15,20–24], but potential changes in intestinal microbiota and gut
microbial metabolites in early renal function decline have not yet been fully explored. To this
end, we analyzed the links between metabolites indoxyl-sulfate, p-cresyl-sulfate and phenylace-
tylglutamine and gut microbiota to investigate whether changes at the individual operational
taxonomic units (OTUs) level are detectable in early renal function decline.
Results and Discussion
Association of plasma circulating metabolites derived from bacterial protein fermentation was
analyzed in 4439 individuals with different eGFR from the TwinsUK cohort. The demographic
characteristics of the study populations are presented in Table 1. Out of 4439 individuals only
7.4% had eGFR<60 mL/min/1.73m2. Indoxyl-sulfate (Beta(SE) = -2.74(0.24), P = 8.8x10-29),
p-cresyl-sulfate (-1.99(0.24), P = 4.6x10-16), and phenylacetylglutamine (-2.73(0.25),
P = 1.2x10-25) were significantly and negatively associated with eGFR after adjusting for age,
sex, body mass index (BMI), metabolite batch, type 2 diabetes, family relatedness and multiple
testing using Bonferroni correction (Table 2).
As dietary factors are known to affect metabolites to varying levels [25,26], we tested their
effect on the association between the metabolites and eGFR by including them as covariates in
the linear model. Results were unchanged suggesting that dietary factors do not confound the
three metabolite-eGFR association.
The plasma levels of these metabolites reflect the balance between elimination and genera-
tion. Some studies suggest most of the microbial derived metabolites are protein-bound [27],
hence, elimination would depend on eGFR and the tubular transporter system.
Microbiota, Metabolites and Renal Function
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A recent study, showed that eGFR provides an acceptable estimate of renal clearance of
indoxyl and p-cresyl sulfate (R2 = 0.75, p<0.001) in subjects with eGFR< 60mL/min/1.73m2
[28]. These metabolites may be more sensitive to earlier stages of reduced renal function, as the
eGFR-defined onset of CKD occurs only after half of the kidneys’ filtration ability has been
lost. Moreover, its higher levels in blood suggest the environmental changes affecting the intes-
tinal flora could be playing a role in modifying the intestinal barrier before the onset of CKD.
We used 16S gut microbiome data available in a subset of the TwinsUK cohort individuals,
to test for association between eGFR and plasma levels of indoxyl sulfate, p-cresyl sulfate and
phenylacetylglutamine with 909 gut-microbial profiles (768 Operational Taxonomic Units
(OTUs) and 141 collapsed taxonomies; see Methods). The gut microbiome 16s data have previ-
ously been described [29] and the current study analyzed a subset of 855 individuals with
microbiome, fasting blood metabolites and eGFR data available (see demographic characteris-
tics of the study population in Table 1). After adjusting for age, sex, BMI, metabolite batch,
family relatedness and controlling for multiple testing using false discovery rate (FDR<5%),
3 OTUs were significantly associated with indoxyl-sulphate and 52 with phenylacetylgluta-
mine (see Fig 1 and Table 3 for the full list). One OTU showed a borderline significance
association with p-cresyl-sulphate but did not reach the FDR threshold. All the 56 microbial
profiles belong to the order of Clostridiales and are mainly represented by the anaerobic
Gram-positive families: Christensenellaceae, Ruminococcaceae and Lachnospiraceae. We
then tested for association between these 56 microbies and renal function. After adjusting for
covariates, 3 microbes were nominally associated with eGFR, and 2 were among those associ-
ated with phenylacetylglutamine and one with indoxyl-sulphate (see Fig 1 and Table 3 for
Table 1. General Characteristics of the study population. Left column: Characteristics of population with renal and plasmametabolites data analyzed.
Right column: Characteristics of sub-population with faecal microbiota data analyzed.
Metabolites Microbiota
Sample size, n 4439 855
Age, yrs 53.04±14.08 58.39±10.88
MZ:DZ:singletons 1795:1980:664 288:414:152
Female, n (%) 4162 (93.7) 840 (98.2)
BMI, Kg/m2 25.94±4.79 26.14±4.77
Creatinine, mg/mL 0.83±0.25 0.80±0.16
eGFR, mL/min/1.73m2 84.93±16.85 83.06±15.42
CKD (eGFR  60), n (%) 331 (7.4) 62 (7.2)
Type2 Diabetes, n (%) 78 (1.7) 21 (2.4)
CKD = Chronic Kidney Disease. eGFR = estimated glomerular ﬁltration rate (CKD-EPI equation). MZ = monozygotic, DZ = dizygotic. Values for
categorical variables are given as n (percentage); values for continuous variable as mean (± SD).
doi:10.1371/journal.pone.0134311.t001
Table 2. Association and correlation of the metabolites and the eGFR.
Metabolites eGFR h2[95%CI]*
Beta(SE) p
Indoxyl-sulphate -2.74 (0.24) 8.8x10-29 0.24[0.12;0.37]
p-cresyl-sulphate -1.99 (0.24) 4.6x10-16 0.36[0.28;0.40]
Phenylacetylglutamine -2.73 (0.25) 1.2x10-25 0.33[0.21;0.44]
eGFR = estimated glomerular ﬁltration rate. h2 = Heritability.
*heritability estimates come from Shin SY et al Nat Genet 2014 [6].
doi:10.1371/journal.pone.0134311.t002
Microbiota, Metabolites and Renal Function
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the full list). Microbes can also be affected by diet [29] and antibiotic use [30] and we there-
fore rerun the analyses adjusting for these confounders. Results were in line with those from
the overall cohort, suggesting dietary pattern and antibiotic used are not affecting our associ-
ations. However, as data on diet and antibiotics was available for only 11% of the subjects
with microbiota data, we cannot draw a more robust conclusion.
Previous studies showed that Ruminococcaceae, Lachnospiraceae and Christensenellaceae
families are associated with healthier phenotypes. Indeed, Ruminococcaceae and Lachnospira-
ceae families have been found to be inversely associated with inflammatory bowel disease and
are considered butyrate producers [31,32]. Butyrate is a preferred energy source for colonic epi-
thelial cells and is thought to play an important role in maintaining colonic health in humans.
Additionally, Christensenellaceae has been recently described by our group to be inversely cor-
related with BMI in humans and in experimental murine models [29]. In our data, a higher
abundance of members of these three families was associated with lower circulating levels of
indoxyl-sulphate, p-cresyl-sulphate and phenylacetylglutamine and related to better renal
function. In line with our findings, a reduction in the number of culturable anaerobic bacteria
Fig 1. Circus histogram depicts positive and negative associations between the operational
taxonomic units (OTUs) (middle circle), the metabolites (external circle) and the glomerular filtration
rate (eGFR) (internal circle).Green color shows positive association while red color shows negative. The
heights of the histogram columns represent the beta coefficients in the regression model. Upper left
histograms represent the beta coefficients for the association between the three plasmametabolites and the
eGFR. All the microbial traits belong to the order of Clostridiales and are represented by the families:
Christensenellaceae, Ruminococcaceae and Lachnospiraceae.
doi:10.1371/journal.pone.0134311.g001
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Table 3. Operational taxonomic units (OTUs) belonging to the order Clostridiales and represented by Ruminococcaceae, Christensenellaceae
and Lachnospiraceae families. Table shows those significantly associated with Indoxyl sulfate and phenylacetylglutamine, the nominally associated with
p-Cresyl sulfate and its association with the eGFR.
Gut Microbes h2[95%CI]* Metabolites eGFR
Taxonomy Indoxyl-Sulfate
OTU Order Family Genus.species Beta(SE) p qval** Beta(SE) p
194297 Clostridiales Ruminococcaceae Ruminococcus 0.13 [0;0.25] 0.09(0.02) 0.0002 0.020 -0.86(0.44) 0.049
316732 Clostridiales Lachnospiraceae Lachnospira 0.2 [0;0.34] 0.04(0.01) 0.0006 0.036 0.02(0.20) 0.092
4408801 Clostridiales Ruminococcaceae Oscillospira 0.23 [0;0.35] 0.12(0.03) 0.0007 0.038 0.25(0.54) 0.063
Metabolites eGFR
p-Cresyl
Beta(SE) p qval** Beta(SE) p
147969 Clostridiales Ruminococcaceae Ruminococcus 0 [0;0.0] 0.03(0.009) 0.002 0.057 -0.06(0.22) 0.077
Metabolites eGFR
Phenylacetylglutamine
Beta(SE) p qval** Beta(SE) p
Collapsed Clostridiales Lachnospiraceae Unclassiﬁed 0.21 [0;0.35] -0.02(0.06) 0.0011 0.047 0.21(0.09) 0.028
4483337 Clostridiales Lachnospiraceae Unclassiﬁed 0 [0;0.3] -0.08(0.02) 0.0002 0.021 0.67(0.33) 0.043
177520 Clostridiales Lachnospiraceae Roseburia faecis 0 [0;0.0] -0.17(0.04) 0.0002 0.021 1.21(0.63) 0.056
192406 Clostridiales Ruminococcaceae Unclassiﬁed 0.12 [0;0.24] -0.07(0.01) 2.92x10-5 0.009 0.40(0.26) 0.133
Collapsed Clostridiales Lachnospiraceae Unclassiﬁed 0.23 [0;0.35] -0.03(0.01) 0.0007 0.036 0.22(0.15) 0.145
190162 Clostridiales Lachnospiraceae Blautia 0.16 [0;0.29] -0.16(0.04) 0.0005 0.033 0.95(0.68) 0.163
199710 Clostridiales Christensenellaceae Unclassiﬁed 0.14 [0;0.29] 0.18(0.05) 0.0011 0.046 -1.03(0.76) 0.175
195465 Clostridiales Lachnospiraceae Unclassiﬁed 0.02 [0;0.25] -0.16(0.05) 0.0009 0.043 0.94(0.71) 0.184
289734 Clostridiales Lachnospiraceae Unclassiﬁed 0.29 [0;0.41] -0.05(0.01) 0.0002 0.019 0.25(0.19) 0.190
177515 Clostridiales Lachnospiraceae Roseburia 0 [0;0.24] -0.04(0.01) 0.0009 0.041 0.22(0.17) 0.208
295258 Clostridiales Ruminococcaceae Unclassiﬁed 0.15 [0;0.28] 0.09(0.02) 0.0005 0.033 -0.43(0.35) 0.170
175761 Clostridiales Ruminococcaceae Unclassiﬁed 0.15 [0;0.29] 0.26(0.08) 0.0011 0.046 -1.3(1.09) 0.223
181756 Clostridiales Lachnospiraceae Blautia 0 [0;0.0] -0.22(0.06) 0.0003 0.026 1.04(0.87) 0.232
292735 Clostridiales Lachnospiraceae Blautia 0.03 [0;0.36] -0.11(0.02) 0.0002 0.019 0.46(0.40) 0.253
197930 Clostridiales Lachnospiraceae Unclassiﬁed 0.01 [0;0.14] -0.22(0.05) 0.0001 0.015 -0.85(0.79) 0.283
317677 Clostridiales Ruminococcaceae Unclassiﬁed 0.06 [0;0.2] -0.23(0.06) 0.0003 0.022 -0.91(0.93) 0.330
181485 Clostridiales Lachnospiraceae Ruminococcus 0 [0;0.0] -0.23(0.07) 0.0010 0.044 0.91(0.95) 0.341
194488 Clostridiales Ruminococcaceae Unclassiﬁed 0 [0;0.0] 0.22(0.05) 0.0002 0.021 0.69(0.76) 0.365
4446669 Clostridiales Ruminococcaceae Unclassiﬁed 0 [0;0.0] 0.21(0.06) 0.0006 0.035 -0.68(0.82) 0.408
186955 Clostridiales Lachnospiraceae Unclassiﬁed 0.09 [0;0.23] -0.24(0.05) 2.69x10-5 0.009 0.62(0.78) 0.426
308544 Clostridiales Ruminococcaceae Unclassiﬁed 0.21 [0;0.38] -0.10(0.03) 0.0011 0.047 0.33(0.43) 0.370
176604 Clostridiales Lachnospiraceae Unclassiﬁed 0.16 [0;0.29] -0.12(0.03) 0.0002 0.019 0.32(0.43) 0.454
187917 Clostridiales Ruminococcaceae Unclassiﬁed 0.06 [0;0.26] 0.13(0.03) 0.0001 0.018 -0.31(0.46) 0.500
Collapsed Clostridiales Lachnospiraceae Roseburia.uk 0.04 [0;0.63] -0.04(0.01) 9.33x10-6 0.006 0.08(0.13) 0.512
199430 Clostridiales Ruminococcaceae Faecalibacterium prausnitzii 0.12 [0;0.25] -0.17(0.05) 0.0007 0.037 0.43(0.69) 0.530
174288 Clostridiales Ruminococcaceae Unclassiﬁed 0.03 [0;0.16] -0.16(0.04) 0.0005 0.032 -0.41(0.66) 0.531
1740283 Clostridiales Lachnospiraceae Roseburia 0.04 [0;0.17] -0.21(0.05) 0.0001 0.017 0.46(0.77) 0.545
Collapsed Clostridiales Christensenellaceae Unclassiﬁed 0.38 [0.21;0.5] 0.07(0.01) 3.54x10-7 0.001 -0.11(0.19) 0.550
4217963 Clostridiales Lachnospiraceae Unclassiﬁed 0.05 [0;0.18] -0.29(0.06) 1.26x10-5 0.006 0.51(0.9) 0.572
Collapsed Clostridiales Christensenellaceae Unclassiﬁed 0.38 [0.21;0.49] 0.07(0.01) 4.75x10-5 0.001 -0.10(0.19) 0.580
2298935 Clostridiales Lachnospiraceae Unclassiﬁed 0.01 [0;0.25] -0.11(0.03) 0.0002 0.021 0.22(0.42) 0.604
4332082 Clostridiales Lachnospiraceae Roseburia 0.19 [0;0.31] -0.21(0.05) 0.0003 0.026 0.40(0.79) 0.613
199761 Clostridiales Ruminococcaceae Unclassiﬁed 0.11 [0;0.24] -0.08(0.02) 0.0006 0.033 0.16(0.32) 0.615
175509 Clostridiales Lachnospiraceae Blautia 0.01 [0;0.14] -0.36(0.09) 0.0001 0.016 0.57(1.26) 0.647
3134492 Clostridiales Lachnospiraceae Unclassiﬁed 0.02 [0;0.24] -0.06(0.01) 3.64x10-5 0.016 0.09(0.20) 0.651
(Continued)
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has been observed in CKD or on maintenance hemodialysis patients [33]. Our results suggest
that CKD dysbiosis may start in earlier kidney function decline.
Heritability estimates for the three metabolites and the microbes identified are low/moder-
ate heritability ranging from 0 to 0.38 (See Tables 2 and 3) suggesting that environmental fac-
tors have a major role in explaining the metabolite/microbe variation. Our heritability results
are in line with those reported in non-twin population showing that metabolites derived from
bacterial protein fermentation have low heritability [5].
Our study has some limitations. Firstly, the sample consists of predominantly healthy vol-
unteer females with lower rate of diabetes and results may not be generalisable to males and to
a population sample with greater prevalence of diabetes population. Moreover, estimates of
GFR based on creatinine may underestimate renal function especially when GFR is>60 mL/
min1.73m2. Cystain C has been proposed as an alternative marker of renal function that could
aid to reduce the bias. However, Cystatin C is not measured on the TwinsUK cohort. However,
we have tried to minimize the underestimation bias using the CKD-EPI formula.
The cross-sectional nature of our data does not allow us to draw conclusions as to whether
the findings are causative of kidney function decline or merely correlated with it. Finally, our
study does not provide absolute quantification of the metabolites, and future studies are needed
to establish reference ranges for clinical use.
To our knowledge, this is first study combining metabolome and microbiome data in early
renal function decline. Our results have the potential to identify at risk patients before the
onset of advanced CKD. Also, they open new avenues to our understanding of the renal-gut-
microbiota-metabolite axis, which could improve therapeutic strategies. As well as providing
early markers of renal damage, the microbiome can be manipulated allowing early therapeutic
possibilities for prevention.
Table 3. (Continued)
231952 Clostridiales Christensenellaceae Unclassiﬁed 0.07 [0;0.21] 0.24(0.05) 1.58x10-5 0.007 -0.33(0.76) 0.620
334336 Clostridiales Ruminococcaceae Unclassiﬁed 0.08 [0;0.21] -0.19(0.05) 0.0009 0.042 -0.30(0.75) 0.668
313593 Clostridiales Lachnospiraceae Roseburia 0 [0;0.11] -0.11(0.02) 0.0003 0.021 -0.16(0.40) 0.690
3926480 Clostridiales Lachnospiraceae Roseburia 0.06 [0;0.19] -0.06(0.01) 0.0007 0.037 -0.10(0.25) 0.693
187447 Clostridiales Lachnospiraceae Roseburia 0.02 [0;0.15] -0.15(0.04) 0.0005 0.032 -0.22(0.63) 0.723
4094259 Clostridiales Ruminococcaceae Unclassiﬁed 0.18 [0;0.3] -0.25(0.07) 0.0008 0.039 0.34(1.05) 0.739
190100 Clostridiales Lachnospiraceae Blautia 0.15 [0;0.28] -0.16(0.05) 0.0012 0.047 0.18(0.71) 0.797
4468466 Clostridiales Ruminococcaceae Unclassiﬁed 0.34 [0.1;0.45] 0.04(0.01) 0.0001 0.015 0.03(0.15) 0.809
3265161 Clostridiales Lachnospiraceae Unclassiﬁed 0.18 [0;0.31] -0.20(0.05) 4.89x10-5 0.012 -012(0.60) 0.848
4202174 Clostridiales Clostridiaceae Unclassiﬁed 0.15 [0;0.37] 0.07(0.02) 0.0008 0.040 -0.05(0.32) 0.864
Collapsed Clostridiales Ruminococcaceae Oscillospira 0.13 [0;0.26] 0.09(0.02) 0.0006 0.034 0.06(0.37) 0.868
2250985 Clostridiales Lachnospiraceae Roseburia 0.10 [0;0.24] -0.15(0.04) 0.0003 0.025 -0.08(0.55) 0.887
125624 Clostridiales Lachnospiraceae Unclassiﬁed 0.18 [0;0.15] -0.05(0.01) 0.0001 0.015 0.02(0.21) 0.889
4370941 Clostridiales Ruminococcaceae Unclassiﬁed 0.28 [0.11;0.4] 0.19(0.04) 0.0001 0.015 -0.05(0.65) 0.929
3393191 Clostridiales Lachnospiraceae Roseburia 0.05 [0;0.18] -0.14(0.04) 0.0007 0.038 -0.03(0.59) 0.957
730906 Clostridiales Ruminococcaceae Unclassiﬁed 0 [0;0.0] -0.24(0.07) 0.0008 0.038 0.04(0.96) 0.960
300374 Clostridiales Ruminococcaceae Oscillospira 0.27 [0.11;0.3] 0.23(0.06) 0.0002 0.020 0.01(0.85) 0.983
* Heritability estimates comes from Goodrich JK et al. Cell 2014 [29].
**qval; is the signiﬁcant threshold after apply false discovery rate (FDR <5%) adjustment. eGFR = estimated glomerular ﬁltration rate.
doi:10.1371/journal.pone.0134311.t003
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Study subjects were twins enrolled in the Twins UK registry, a national register of adult twins
started in 1992. The registry consists of over 10,000 predominantly female monozygotic and
dizygotic twins, 18–84 years old, comparable to the general population in terms of lifestyle
characteristics. Healthy twins were recruited from all over the UK as volunteers by successive
media campaigns without selecting for particular diseases or traits. The TwinsUK cohort repre-
sents one of the most detailed omics and phenotypic resource in the word [34].
Data relevant to the present study include, BMI (body weight in kilograms divided by the
square of height in square meters), type 2 Diabetes (t2D) (defined if fasting glucose7 mmol/
L or physician’s letter confirming diagnosis). Renal parameters include estimated glomerular
filtration rate (eGFR) calculated from standard creatinine using the CKD-EPI equation [35].
Dietary scores were obtain from food frequency questionnaires (FFQ) summarizing fruit
and vegetable intake, alcohol intake, meat intake, hypo-caloric dieting and a ‘‘traditional
English” diet as previously describe [25,26]. These five dietary scores are principal component
analysis generated scores. As such they are independent variables standardized to have mean of
zero and a SD of one in the whole TwinsUK study population. Each dietary pattern should be
considered as the representative of a particular food pattern intake
Individuals were requested to complete a questionnaire regarding antibiotics used within
the month previous faecal sample collection.
St. Thomas’ Research Ethics Committee approved the study (EC96/439 TwinsUK) and all
participants provided informed written consent.
Measurement of Metabolites
Non-targeted gas chromatography/mass spectrometry-based profiling was performed fasting
plasma samples from participants in the TwinsUK cohort, using the Metabolon platform, as
described previously [36,37]. Briefly, the Metabolon platform integrates the chemical analysis,
including identification and relative quantification, data reduction, and quality assurance com-
ponents of the process. This integrated platform enables the high-throughput collection and
relative quantitative analysis of analytical data and identified a large number and broad spec-
trum molecules with a high degree of confidence. We inverse-normalised the metabolomics
data and excluded metabolic traits with>20% missing values.
Microbiota analysis
Faecal samples were obtained from adult twin volunteers in the TwinsUK cohort. Faecal sam-
ple collection and 16S rRNA sequencing are described in depth previously in this sample
(Goodrich et al) [29]. Briefly, the V4 region of the 16S rRNA gene was amplified and sequenced
on Illumina MiSeq. Quality filtering and analysis of the sequence data with QIIME 1.7.0, was
followed by closed-reference OTU picking to select OTUs at 97% sequence identity against the
Greengenes May 2013 database as previously reported [38]. OTUs were adjusted for age, gen-
der, shipment, number of sequences per sample and sequencing run. Collapsed taxonomic
bins were created by combining OTUs of the same taxonomic designation into one variable. In
total we used 768 OTUs and 141 collapsed taxonomies.
Statistical analysis
Statistical analysis was carried out using Stata version 12 and R version 3.1.2 (package LME4).
Association analyses between eGFR and metabolites or microbiota profiles were performed
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using random intercept linear regressions adjusting by age, sex, BMI, diabetes, experiment
batch and family relatedness. Linear Mixed Effects Regression (LMER) was used to test the
association between the microbiota and metabolites. Family structure and twin zygosity were
accounted for as random effects and the microbe was the predictor variable. Multiple testing
correction for the microbiota analysis was performed via false discovery rate (FDR<5%).
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B.3 appendix b3 . human genetics shape the gut
microbiome .
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Host genetics and the gut microbiome can both influ-
ence metabolic phenotypes. However, whether host
geneticvariationshapes thegutmicrobiomeand inter-
acts with it to affect host phenotype is unclear. Here,
we compared microbiotas across >1,000 fecal sam-
ples obtained from the TwinsUK population, including
416 twin pairs. We identified many microbial taxa
whose abundances were influenced by host genetics.
The most heritable taxon, the family Christensenella-
ceae, formed a co-occurrence network with other
heritable Bacteria and with methanogenic Archaea.
Furthermore, Christensenellaceae and its partners
were enriched in individuals with low body mass
index (BMI). An obese-associated microbiome was
amended with Christensenella minuta, a cultured
member of the Christensenellaceae, and transplanted
to germ-free mice. C. minuta amendment reduced
weight gain and altered the microbiome of recipient
mice. Our findings indicate that host genetics influ-
ence the composition of the human gut microbiome
and can do so in ways that impact host metabolism.
INTRODUCTION
The human gut microbiome has been linked to metabolic dis-
ease and obesity (Karlsson et al., 2013; Le Chatelier et al.,
2013; Ley et al., 2005; Qin et al., 2012; Turnbaugh et al., 2009).
Variation in host genetics can also underlie susceptibility to
metabolic disease (Frayling et al., 2007; Frazer et al., 2009; Her-
bert et al., 2006; Yang et al., 2012). Despite these shared effects,
the relationship between host genetic variation and the diversity
of gut microbiomes is largely unknown.
The gut microbiome is environmentally acquired from birth
(Costello et al., 2012;Walter andLey, 2011), therefore itmay func-
tionasanenvironmental factor that interactswith host genetics to
shape phenotype, as well as a genetically determined attribute
that is shaped by, and interacts with, the host (Bevins and Salz-
man, 2011; Spor et al., 2011; Tims et al., 2011). Because the mi-
crobiome can be modified for therapeutic applications (Borody
and Khoruts, 2012; Hamilton et al., 2013; Khoruts et al., 2010;
van Nood et al., 2013), it constitutes an attractive target for
manipulation. Once the interactions between host genetics and
the microbiome are understood, its manipulation could be opti-
mized for a given host genome to reduce disease risk.
Although gut microbiomes can differ markedly in diversity
across adults (Human Microbiome Project Consortium, 2012;
Qin et al., 2010), family members are often observed to have
more similar microbiotas than unrelated individuals (Lee et al.,
2011; Tims et al., 2013; Turnbaugh et al., 2009; Yatsunenko
et al., 2012). Familial similarities are usually attributed to shared
environmental influences, such as dietary preference, a powerful
shaper of microbiome composition (Cotillard et al., 2013; David
et al., 2014;Wu et al., 2011). Yet related individuals share a larger
degree of genetic identity, raising the possibility that shared ge-
netic composition underlies familial microbiome similarities.
Support for a host genetic effect on the microbiome comes
mostly from studies taking a targeted approach. For instance,
the concordance rate for carriage of themethanogenMethanobre-
vibacter smithii is higher for monozygotic (MZ) than dizygotic (DZ)
twinpairs (Hansenetal., 2011),andstudiescomparingmicrobiotas
between human subjects differing at specific genetic loci have
shown gene-microbiota interactions (Frank et al., 2011; Kha-
chatryan et al., 2008; Rausch et al., 2011; Rehman et al., 2011;
Wacklin et al., 2011). A more general approach to this question
has linked genetic loci with abundances of gut bacteria in mice
(Bensonet al., 2010;McKnite et al., 2012), but in humans, a general
approach (e.g., using twins) has failed to reveal significant geno-
type effects on microbiome diversity (Turnbaugh et al., 2009; Yat-
sunenkoetal., 2012).Thus, heritablecomponentsof thehumangut
microbiome remain to be identified using an unbiased approach.
Here, we assessed the heritability of the gut microbiome with a
well-powered twin study. Comparisons between MZ and DZ twin
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pairs allowedus toassess the impactofgenotypeandearly shared
environment on their gut microbiota. Our study addressed the
followingquestions:Whichspecific taxawithin thegutmicrobiome
are heritable, and to what extent? Which predicted metagenomic
functions are heritable? How do heritable microbes relate to host
BMI? Finally, we use fecal transplants into germ-free mice to
assess the phenotype effects of the most heritable taxon.
RESULTS
Twin Data Set
We obtained 1,081 fecal samples from 977 individuals: 171 MZ
and 245DZ twin pairs, two from twin pairs with unknown zygosity,








   


















































































































Figure 1. Microbiomes Are More Similar for
Monozygotic Than Dizygotic Twins
(A and C–F) Boxplots of b diversity distances be-
tween microbial communities obtained when com-
paring individuals within twinships for monozygotic
(MZ) twin pairs and dizygotic (DZ) twin pairs, and
between unrelated individuals (UN). (A) The whole
microbiome. (C) The bacterial family Ruminococca-
ceae. (D and E) The bacterial family Lachnospir-
aceae. (F) The family Bacteroidaceae. The specific
distancemetric used in eachanalysis is indicated on
the axes. *p < 0.05, **p < 0.01, ***p < 0.001 for Stu-
dent’s t tests with 1,000 Monte Carlo simulations.
(B) The average relative abundances in the
whole data set for the top six most prevalent
bacterial families (unrarefied data, see Experi-
mental Procedures).
See also Figure S1 and Table S1.
lated). In addition, we collected longitudi-
nal samples from 98 of these individuals
(see Supplemental Information available
online). Most subjects were female,
ranging in age from23 to 86 years (average
age: 60.6 ± 0.3 years). The average BMI of
the subjects was 26.25 (± 0.16) with the
following distribution: 433 subjects had
a low tonormalBMI (<25), 322hadanover-
weight BMI (25-30), 183 were obese (>30),
and 39 individuals in which the current
BMI status was unknown. We generated
78,938,079 quality-filtered sequences
that mapped to the Bacteria and Archaea
in the Greengenes database (average se-
quences per sample: 73,023 ± 889).
Microbiome Composition and
Richness
We sorted sequences into 9,646 opera-
tional taxonomic units (OTUs,R97% ID).
Of theseOTUs,768werepresent inat least
50% of the samples. Taxonomic classifi-
cation revealed a fairly typical Western
diversity profile: the dominant bacterial
phyla were Firmicutes (53.9% of total
sequences), Bacteroidetes (35.3%), Proteobacteria (4.5%),
with Verrucomicrobia, Actinobacteria, and Tenericutes each
comprising 2%of the sequences, and a tail of rare bacterial phyla
that together accounted for the remaining 1% of the sequences.
The most widely shared methanogen was M. smithii (64% of
people, using nonrarefied data), followed by vadinCA11, a mem-
ber of the Thermoplasmata with no cultured representatives
(!6%), Methanosphaera stadtmanae (!4%), and Methanomas-
siliicoccus (!4%, a member of the Thermoplasmata). Forty-six
of the 61 samples in which we detected vadinCA11 also
contained M. smithii, indicating that the two most dominant
archaeal taxa are not mutually exclusive. Faith’s PD was posi-
tively correlated with the relative abundance of the family Meth-
anobacteriaceae (rho = 0.42 rarefied, 0.37 for transformed
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counts, p < 1 3 10"11), which corroborates previous reports of
higher richness associating with methanogens.
Broad Diversity Comparisons between MZ and DZ
Twin Pairs
We observed that microbiotas were more similar overall within
individuals (resampled) than between unrelated individuals (p <
0.001 for weighted and unweighted UniFrac and Bray-Curtis us-
ing a Student’s t test with 1,000 Monte Carlo simulations) (Table
S1A) and were also more similar within twin pairs compared to
unrelated individuals (p < 0.009 for weighted and unweighted
UniFrac and Bray-Curtis) (Figures 1 and S1; Table S1). MZ twin
pairs had more similar microbiotas than DZ twins for the un-
weighted UniFrac metric (p = 0.032), but not the weighted Uni-
Frac and Bray-Curtis metrics (Figures 1A and S1). As greater
similarities for MZ versus DZ twin pairs are seen in unweighted
UniFrac but not abundance-based metrics, MZ similarities are
driven by shared community membership rather than structure.
We next constrained the distance metric analyses to the three
most dominant bacterial families: the Lachnospiraceae and Ru-
minococcaceae (Firmicutes) and Bacteroidaceae (Figure 1B).
We observed greater similarities for MZ compared to DZ twins
using the unweighted UniFrac metric within the Ruminococca-
ceae family (Figure 1C). Within the Lachnospiraceae family,
significantly greater similarity for MZ compared to DZ twins
emerged using the weighted UniFrac and Bray-Curtis metrics
(Figures 1D and 1E). In contrast, when restricted to the Bacteroi-
daceae family, we found that MZ and DZ twins had similar pair-
wise diversity using all three metrics (Figures 1F, S1B, and S1E).
MZ Twins Have More Highly Correlated Microbiotas
We next asked if the abundances of specific taxa were generally
more highly correlated within MZ twin pairs compared to DZ twin











Figure 2. OTU Relative Abundances Are
More Highly Correlated within MZ Than DZ
Twin Pairs
Left: a phylogeny of taxa in the TwinsUK study
(Greengenes tree pruned to include only OTUs
shared by 50% of the TwinsUK participants).
Right: corresponding twin-pair intraclass corre-
lation coefficients (ICCs). ICCswere calculated for
each OTU and the difference in correlation co-
efficients for MZ twin pairs versus DZ twin pairs.
Bars pointing to the right indicate that the differ-
ence is positive (i.e., MZ ICCs >DZ ICCs) and bars
pointing to the left indicate negative differences
(DZ ICCs > MZ ICCs). The scale bar associated
with the phylogeny shows substitutions/site.
See also Figure S2.
pairs. For each twin pair we generated in-
traclass correlation coefficients (ICCs) for
the relative abundances of OTUs. Mean
ICCs were significantly greater for MZ
compared to DZ twin pairs (Wilcoxon
signed rank test on ICCs at the OTU
level, p = 6 3 10"04; Figure 2). Because
many OTUs are closely phylogenetically
related, their abundances may not be independent, which may
inflate levels of significance. To account for this effect, we main-
tained the structure of the phylogenetic tree but permuted the
MZ and DZ labels in 10,000 tests to generate randomized
ICCs. As an independent validation, we also applied these ana-
lyses to two previously published data sets generated originating
in a population of twins from Missouri, USA: ‘‘Turnbaugh’’ (Turn-
baugh et al., 2009), which described 54 twin pairs ranging from
21 to 32 years of age, and ‘‘Yatsunenko’’ (Yatsunenko et al.,
2012), which included 63 twin pairs with an age range of 13–30
years of age. Mean ICCs of OTU abundances were significantly
greater for MZ compared to DZ twin pairs in both of these data
sets (significance by permutation: p < 0.001 and 0.047 respec-
tively; Figure S2), corroborating our observations.
Heritability Estimates for OTUs and Predicted Functions
We estimated heritability using the twin-based ACE model,
which partitions the total variance into three component sources:
genetic effects (A), common environment (C), and unique envi-
ronment (E) (Eaves et al., 1978). The largest proportion of vari-
ance in abundances of OTUs could be attributed to the twins’
unique environments (i.e., E > A; Table S2). However, for the
majority of OTUs (63%), the proportion of variance attributed
to genetic effects was greater than the proportion of variance
attributed to common environment (A > C; Table S2).
From the ACEmodel, we calculated 95% confidence intervals
for the heritability estimates and determined the significance of
the heritability values using a permutation method to generate
nominal p values (Table S2). We found a high correlation be-
tween the tail probability for inclusion of zero in the confidence
interval of heritability and the p values obtained from the permu-
tation tests (rho = 0.872, p < 10"15), indicating substantial
consistency across these tests. Although heritability studies
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traditionally report confidence intervals and nominal p values
only, we also generated FDR-corrected p values (Table S2).
We also applied the ACE model to the abundances of se-
quences mapping to each node in the phylogeny. Across the
three studies, the nodes of the phylogeny with the strongest her-
itabilities lie within the Ruminococcaceae and Lachnospiraceae
families, and the Bacteroidetes are mostly environmentally
determined (Figures 3 and S3). Subsets of the Archaea are
also heritable in the TwinsUK and the Yatsunenko studies (the
Turnbaugh study did not include data for Archaea).
We characterized the longitudinal stability of each OTU by
calculating the ICCs of the OTU abundance across repeat sam-
ples, which consisted of two samples collected from the same
individual at different times. By permuting these repeat sample
ICCs, we found that heritable OTUs (A > 0.2) were more stable
(ICC > 0.6) than expected by chance (Figure S3E; p < 0.001, p
value was determined as the fraction of permutations that had
greater than or equal to the observed number of OTUs that are
both heritable and stable).
We used PICRUSt (Langille et al., 2013) to produce predicted
metagenomes from the 16S rRNA gene sequence data and
applied the ACE model to estimate the heritability of predicted
abundances of conserved orthologous groups (COGs). This
analysis revealed six functions with heritabilities A > 0.2 and
nominal p values < 0.05 (p values are generated by permutation
testing; Extended Experimental Procedures; Table S2). Correct-
ing for multiple comparisons, one category, ‘‘secondary metab-
olites biosynthesis, transport and catabolism’’ (Q), passed a
stringent FDR (A = 0.32, 95% confidence interval [CI] = 0.16–
0.44). We also tested a diversity for heritability and found that it
was not heritable.
The Family Christensenellaceae Is the Most Highly
Heritable Taxon
The most heritable taxon overall was the family Christensenella-
ceae (A = 0.39, 95% CI = 0.21–0.49, p = 0.001; Figure 4A; Table
S2; this taxon passes a stringent FDR) of the order Clostridiales.





















Figure 3. Heritability of Microbiota in the
TwinsUK Data Set
(A) OTU Heritability (A from ACE model) estimates
mapped onto a microbial phylogeny and displayed
using a rainbow gradient from blue (A = 0) to red (A
R 0.4). This phylogenetic tree was obtained from
the Greengenes database and pruned to include
only nodes for which at least 50% of the TwinsUK
participants were represented.
(B) The significance for the heritability values
shown in (A) was determined using a permutation
test (n = 1,000) and are shown on the same phy-
logeny as in (A). P values range from 0 (red) to >0.1
(blue).
See also Figure S3 and Table S2.
data set (A = 0.62, 95% CI = 0.38–0.77;
Figure 4B; Table S2). We repeated this
analysis for the taxa abundances with
the effect of BMI regressed out, and
results were highly correlated (Pearson correlation = 0.95, p <
1 3 10"15).
Christensenellaceae Is the Hub in a Co-Occurrence
Network with Other Heritable Taxa
We observe a module of co-occurring heritable families, and the
hub (node connected to most other nodes) of this module is the
family Christensenellaceae (Figures 5A and S4A). The heritable
module includes the families Methanobacteriaceae (Archaea)
and Dehalobacteriaceae (Firmicutes) and the orders SHA-98
(Firmicutes), RF39 (Tenericutes), and ML615J-28 (Tenericutes).
The Christensenellaceae network is anticorrelated with the Bac-
teroidaceae and Bifidobacteriaceae families. We validated these
results by applying this method to the family-level taxonomic
abundances in the Yatsunenko data set (as this one ismost tech-
nically similar to the TwinsUK data set), where we also found the
same Christensenellaceae-centered module of heritable families
anticorrelated to the Bacteroidaceae/Bifidobacteriaceae mod-
ule (Figure S4B).
Christensenellaceae Associates with a Low BMI
The family Christensenellaceae was significantly enriched in
subjects with a lean BMI (<25) compared to those with an obese
BMI (>30; Benjamini-Hochberg corrected p value < 0.05 from t
test on transformed counts; Table S2). Other members of the
Christensenellaceae consortium were also enriched in lean-
BMI subjects: the Dehalobacteriaceae, SHA-98, RF39, and the
Methanobacteriaceae (Figure 5B). Overall, a majority (n = 35) of
the OTUs with highest heritability scores (A > 0.2, nominal p <
0.05) were enriched in the lean subjects. A subset of OTUs clas-
sified as Oscillospira were enriched in lean subjects, and
M. smithii, although not significantly heritable, was positively
associated with a lean BMI.
Christensenellaceae Is Associated with Health in
Published Data Sets
Because the names Christensenella and Christensenellaceae
were only recently assigned to the bacterial phylogeny, we
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assessed the abundances of sequences assigned to these taxa
in previously published studies. This analysis revealed thatmem-
bers of the Christensenellaceae were enriched in fecal samples
of healthy versus pediatric and young adult IBD patients (p <
0.05) (Papa et al., 2012). Christensenellaceae were at greater
abundance in lean BMI compared to obese-BMI twins in the
Turnbaugh data set, but the difference was not quite significant
(‘‘time-point 2’’ samples, p = 0.07). In a case study of the devel-
opment of an infant’s gutmicrobiome (Koenig et al., 2011), Chris-
tensenellaceae was present at 8.6% in the mother’s stool at the
time of birth and at 20% in the infant’s meconium. We also noted
that Christensenellaceae is enriched in omnivorous compared to
herbivorous and carnivorous mammals (Muegge et al., 2011).
However, we did not find a relationship between Christensenel-
laceae and diet information in human studies (Wu et al., 2011;
Martı´nez et al., 2010; Koren et al., 2012).
Christensenellaceae Is Associated with Reduced
Weight Gain in Germ-free Mice Inoculated with Lean
and Obese Human Fecal Samples
Methanogens co-occurredwith Christensenellaceae in this study
and have been linked to low BMI in previous studies. Because of
this previous association with a low-BMI, we wanted to ensure
that methanogens were present in the Christensenellaceae con-
A
B
Figure 4. MZ Twin Pairs Have Higher Corre-
lations of Christensenellaceae Than DZ
Twin Pairs in TwinsUK and Yatsunenko
Data Sets
Scatter plots comparing the abundances of
Christensenellaceae in the gut microbiota of MZ
and DZ co-twins. Christensenellaceae abun-
dances were transformed and adjusted to control
for technical and other covariates (Residuals are
plotted, see Extended Experimental Procedures)
and the data are separated by zygosity (MZ or DZ
twins).
(A) TwinsUK data set.
(B) Yatsunenko data set.
sortium in an initial experiment exploring
its effect on weight phenotypes. There-
fore,we selected21donors for fecal trans-
fer to germ-freemice based on BMI status
(low or high) and presence or absence
of the methanogen-Christensenellaceae
consortium. Donors fell into one of four
categories: leanwith detectablemethano-
gens (L+), leanwithoutmethanogens (L"),
obese with methanogens (O+), or obese
without methanogens (O"). The abun-
dance of Christensenellaceae positively
correlated with the abundance of metha-
nogens in donor stool (rho = 0.72, p =
0.0002), indicating thatmethanogenabun-
dance was a good proxy for the methano-
gen-Christensenellaceae consortium.
A 16S rRNA analysis of the fecal micro-
biomes before and after transfer to germ-
freemice showed that althoughmembers of the Christensenella-
ceae were present throughout the experiment in recipient mice
(Figure 6A), M. smithii was undetectable in the mouse fecal or
cecal samples (the first sampling was at 20 hr postinoculation).
At 20 hr postinoculation, the microbiota had shifted dramatically
in diversity from the inoculation, but by day 5 had shifted back
partially and remained fairly stable through day 21 (Figures 6B,
6C, S5A, and S5B). Abundances of Christensenella were corre-
lated with PC3 (abundances rarefied at 55,000 sequences per
sample versus unweighted UniFrac; Spearman rho = 0.59, p <
2.2 3 10"16), and PC3 captured the differences between the
four donor groups (Figure 6D). We observed a trend forChristen-
senella abundances as highest in the L+ group and lowest in the
O" group (Figure 6A), which mirrored the weight differences be-
tween those groups: the percent change in body weights of the
recipient mice was significantly lower in the L+ group compared
to theO"group (day 12, p< 0.05, t test; Figures 6Eand6F). Cecal
levels of propionate and butyrate were significantly elevated in
mice receiving methanogen-positive compared to methano-
gen-negative microbiomes controlling for the effect of donor
BMI (two-way ANOVA, p < 0.05 for both SCFAs; Figures S5C–
S5E). Stool energy contentwas significantly higher for themetha-
nogen-positive microbiomes at day 12, when the percent
changes in weight were greatest (two-way ANOVA, p = 0.004,
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no effect of BMI or interaction; Figure S5F). In a replicated exper-
iment, using 21 new donors, the same weight differences were
observed (a significantly lower mean weight gain for the L+
compared to the O"mouse recipients at day 10 postinoculation;
one-way t test, p = 0.047; Figure S5G).
Christensenella minuta Added to Donor Stool Reduces
Adiposity Gains in Recipient Mice
Based on the observation that Christensenella levels in the
previous experiment were similar to the weight gain patterns,


























































































Figure 5. Christensenellaceae Is the Hub of a Consortium of Co-occurring Heritable Microbes that Are Associated with a Lean BMI
The same network built from SparCC correlation coefficients between sequence abundances collapsed at the family level. The nodes represent families and the
edges represent the correlation coefficients between families. Edges are colored blue for a positive correlation and gray for a negative correlation, and the weight
of the edge reflects the strength of the correlation. Nodes are positioned using an edge-weighted force directed layout.
(A) Nodes are colored by the heritability of the family.
(B) Nodes are colored by the significance of the association families and a normal versus obese BMI. Family names are either indicated on the panel, or nodes are
given a letter code. Phylum Actinobacteria: (a) Actinomycetaceae, (b) Coriobacteriaceae; Phylum Bacteroidetes: (c) Barnesiellaceae, (d) Odoribacteraceae, (e)
Paraprevotellaceae, (f) Porphyromonadaceae, (g) Prevotellaceae, (h) Rikenellaceae; Phylum Firmicutes: (i) Carnobacteriaceae, (j) Clostridiaceae, (k) Erysipelo-
trichaceae, (l) Eubacteriaceae, (m) Lachnospiraceae, (n) Lactobacillaceae, (o) Mogibacteriaceae, (p) Peptococcaceae, (q) Peptostreptococcaceae, (r) Rumi-
nococcaceae, (s) Streptococcaceae, (t) Tissierellaceae, (u) Turicibacteraceae, (v) Unclassified Clostridiales, (w) Veillonellaceae; Phylum Proteobacteria: (x)
Alcaligenaceae, (y) Enterobacteriaceae, (z) Oxalobacteraceae, (aa) Pasteurellaceae, (ab) Unclassified RF32; Phylum Verrucomicrobia: (ac) Verrucomicrobiaceae.
See also Figure S4.
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detectable Christensenella was amended with C. minuta and
weight gain of recipient mice was monitored. One obese human
donor was selected from the 21 donors from the first transplant
experiment based on its lack of detectable OTUs assigned to the
genusChristensenella. At day 21 postgavage, mice receiving the
C. minuta treatment weighed significantly less than those that
received unamended stool (nested ANOVA, p < 0.05; Figure 7A).
Adiposity was significantly lower for mice receiving theC.minuta
treatment (nested ANOVA, p = 9.4 3 10"5, Figure 7B). Energy
content for stool collected at day 21 was not different between
treatments (data not shown).
Analysis of the microbial community by 16S rRNA gene
sequencing showed an impact on the overall community diver-
sity that persisted over time (Figures 7C and 7D). After an initial
acclimation (20 hr), the communities within recipient mice began
to separate by treatment regardless of the effects of time and co-
caging (Figures 7C, 7D, and S6). At 5 days postinoculation, the
relative abundance of C. minuta was similar to that observed in
the previous transplant experiment and persisted throughout
the duration of the study. We identified two genera that discrim-
inated the two treatments at day 21: Oscillospira and a genus
within the Rikenellaceae were enriched in the C. minuta treat-
ment (misclassification error rate of 0.06). Oscillospira abun-
dances were significantly correlated with PC2 in the unweighted
UniFrac analysis of the communities (rho = "0.71, p = 0.0009;
Figure 7E), which is the PC that separates the C. minuta-
amended and unamended microbiotas.
DISCUSSION
Our results represent strong evidence that the abundances of
specific members of the gut microbiota are influenced in part
by the genetic makeup of the host. Earlier studies using finger-




B Figure 6. Fecal Transplants fromObese and
Lean UK Twins to Germ-Free Mice Reveal
Levels of Christensenellaceae Posttransfer
Mirror Delayed Weight Gain
(A) Median relative abundances for OTUs classi-
fied as the genus Christensenella in the four donor
treatment groups over time in the recipient mouse
microbiotas.
(B) Principal coordinates analysis of unweighted
UniFrac distances for (1) the inoculum prior to
transplantation, (2) fecal samples at four time
points, and (3) cecal samples at day 21 post-
transplant; see panel legend for color key. The
amount of variance described by the first two PCs
is shown on the axes.
(C) Mean values ± SEM for richness (Faith’s PD) for
the microbiomes of the transplant mice plotted
against time (days postinoculation, with day 0 =
inoculation day).
(D) The mean values ± SEM for PC3 derived for the
same analysis as shown in (B) are plotted against
time (day 0 = inoculation day) for the four treatment
groups. The amount of variance explained by PC3
is in parentheses.
(E) Percent weight change since inoculation for
germ-free mouse recipients of 21 donor stools that
were obtained from lean or obese donors with or
without detectable M. smithii, which was used as
a marker for the Christensenellaceae consortium.
Means for each treatment group are plotted ±
SEM.
(F) Boxplots for percent weight changes for the
four groups at day 12 posttransplant, when
maximal weight differences were observed. Let-
ters next to boxes indicate significant differences if
letters are different (p < 0.05). For all panels: dark
blue, L+, lean donor with methanogens; light blue,
L", lean donor lacking methanogens; dark orange,
O+, obese donor with methanogens; light orange,
O", obese donor without methanogens. We
repeated this experiment with a set of 21 newmice
and unique human donors and recovered the same
effect.
See also Figure S5.
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et al., 2005;Zoetendal et al., 2001), butwithout sequencedata it is
not possible to know if the taxa shown here to be heritable were
also driving those patterns. The Turnbaugh et al. (2009) and Yat-
sunenko et al. (2012) studies, which are quite similar in experi-
mental approach, reported a lack of host genetic effect on the
gut microbiome, most likely because both studies were under-
powered. Nevertheless, reanalysis of the data from both studies
validated our observation that the abundances of taxa are more
highly correlatedwithinMZ thanDZ twin pairs. Thus, host genetic
interactions with specific taxa are likely widespread across hu-
man populations, with profound implications for human biology.
The most highly heritable taxon in our data set was the family
Christensenellaceae, which was also the hub of a co-occurrence
network that includes other taxa with high heritability. A notable
component of this network was the archaeal family Methanobac-
teriaceae. Similarly, Hansen et al. (2011) had previously identified
members of theChristensenellaceae (reported as relatives ofCat-
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Figure 7. Addition of Christensenella min-
uta to Donor Stool Leads to Reduced
Weight and Adiposity Gains in Recipient
Mice
(A) Boxplot of percent weight change for germ-free
mouse recipients of a single donor stool only
(lacking detectable Christensenella in unrarefied
16S rRNA data) or the donor stool amended with
live C. minuta.
(B) Boxplots showing percent body fat for mice in
each group at day 21 (n = 12 mice per treatment).
(C and D) Principal coordinates analysis of un-
weighted UniFrac distances for (1) the inoculum
prior to transplantation, (2) fecal samples at five
time points posttransplant; see legend for color
key. The amount of variance described by the first
two PCs is shown on the axes. The same data
projection is shown in (C) and (D); sample symbols
are colored by time point (C) and by treatment (D).
(E) Relationship between PCs from the PCoA
analysis and levels of Oscillospira at day 21 (rho =
"0.71, p = p < 0.001). Symbols are colored by
treatment.
See also Figure S6.
patterns could derive from different sce-
narios: for instance, multiple taxa may be
heritable and co-occur while each taxon
is affected by host genetics indepen-
dently, or alternatively one (or a few) taxa
may be heritable and other taxa correlate
with host genetics due to their co-occur-
rencewith thesekeyheritable taxa.Further
experimental research will be required
to elucidate if the co-occurring heritable
taxa interact in syntrophic partnerships
or simply respond similarly to host-influ-
enced environmental cues in the gut.
Our results suggest that environmental
factors mostly shape the Bacteroidetes
community, because most were not heri-
table. These results are consistent with those of a recent study
of Finnish MZ twins, in which levels of Bacteroides spp. were
more similar between twins when their diets were similar (Simo˜es
et al., 2013). Members of the Bacteroidetes have been shown to
respond to diet interventions (Wu et al., 2011; David et al., 2014)
Importantly, the family Christensenellaceae is heritable in the
Yatsunenko data set and its network is also present. This valida-
tion did not involve a directed search using the taxa identified in
this study but was made by applying the ACE model indepen-
dently. In the TwinsUK as well as the Missouri twins data sets,
the majority of OTUs with the highest heritability estimates fell
within the Ruminococcaceae and Lachnospiraceae families.
The Missouri and TwinsUK studies differed somewhat in the
levels and structure of heritability, which may relate to study
size (Kuczynski et al., 2010), participant age (Claesson et al.,
2011), population (Yatsunenko et al., 2012), and/or diet (Wu
et al., 2011), all of which have been shown to affect microbiome
structure.
796 Cell 159, 789–799, November 6, 2014 ª2014 Elsevier Inc.
B.3 appendix b3 . human genetics shape the gut
microbiome .
193
The high heritability of the Christensenellaceae raises ques-
tions about the nature of interactions between the host and
members of this family, but to date there is little published
work with which to infer their roles. Christensenella minuta is
Gram-negative, nonspore forming, nonmotile, and produces
SCFAs (Morotomi et al., 2012). A review of publicly available
data suggests it is present from birth and associates with a
healthy state but not with diet. Thus, although diet is a heritable
trait in the same population (Menni et al., 2013; Teucher et al.,
2007), it does not appear to be driving the heritability of the Chris-
tensenellaceae. Obesity is also strongly heritable in the TwinsUK
population, raising the question of whether the heritabilities we
saw for gut microbes were driven by BMI. To test this, we reran
the heritability calculations using residuals after regressing out
the effect of BMI and found that results of the two analyses
were highly correlated. This suggests that the effect of host ge-
netics on Christensenellaceae abundance is independent of an
effect of BMI.
Our transplantation experiments showed a moderating effect
of methanogen-presence in the human donor on weight gain of
recipient mice, although strikingly, M. smithii did not persist in
mice. In contrast, Christensenellaceae levels in mice mirrored
their weight gain. Transfer to germ-free mice of microbiomes
from obese and lean donors generally results in greater adiposity
gains for obese compared to lean donors (Ridaura et al., 2013;
Turnbaugh et al., 2008; Vijay-Kumar et al., 2010). These studies
have not reported themethanogen or Christensenellaceae status
of the donors, so whether these microbes affect the host pheno-
type is unknown. M. smithii has been associated with a lean
phenotype inmultiple studies (Million et al., 2012, 2013;Schwiertz
et al., 2010; Armougom et al., 2009; Le Chatelier et al., 2013),
raising the possibility that methanogens are key components
of the consortium for regulating host phenotype. The results of
our methanogen-Christensenellaceae transfer revealed that
althoughmethanogensmaybe amarker for a lowBMI in humans,
they are not required to promote a lean phenotype in the germ-
freemouse experimental model. This result suggests thatmetha-
nogens may be functionally replaced by another consortium
member in the mouse, while the Christensenellaceae are not.
The results of the C. minuta spike-in experiments supported
the hypothesis that members of the Christensenellaceae pro-
mote a lean host phenotype. Addition of C. minuta also remod-
eled the diversity of the community. Intriguingly, Oscillospira,
which includes heritable OTUs in the TwinsUK data set and is
associated with a lean BMI, was enriched in the C. minuta-
amendedmicrobiomes. HowC.minuta reshapes the community
remains to be explored. The relatively low levels ofC. minuta and
its profound effects on the community and the host may indicate
that it is a keystone taxon. Together these findings indicate that
the Christensenellaceae are highly heritable bacteria that can
directly contribute to the host phenotype with which they
associate.
Conclusions
Host genetic variation drives phenotype variation, and this study
solidifies the notion that our microbial phenotype is also influ-
enced by our genetic state. We have shown that the host genetic
effect varies across taxa and includes members of different
phyla. The host alleles underlying the heritability of gut microbes,
once identified, should allow us to understand the nature of our
association with these health-associated bacteria and eventually
to exploit them to promote health.
EXPERIMENTAL PROCEDURES
Human Subjects and Sample Collection
Fecal samples were obtained from adult twin pair participants of the TwinsUK
registry (Moayyeri et al., 2013). Most participants were women (only 20 men
were included). Twins collected fecal samples at home, and the samples
were refrigerated for up to 2 days prior to their annual clinical visit at King’s Col-
lege London, at which pointed they were stored at "80#C until processing.
Diversity and Phylogenetic Analyses
We amplified 16S rRNA genes (V4) from bulk DNA by PCR prior to sequencing
on the Illumina MiSeq 23 250 bp platform at Cornell Biotechnology Resource
Center Genomics Facility. We performed quality filtering and analysis of the
16S rRNA gene sequence data with QIIME 1.7.0 (Caporaso et al., 2010).
Predicted Metagenomes
PICRUSt v1.0.0 was used to predict abundances of COGs from theOTU abun-
dances rarefied at 10,000 sequences per sample.
Heritability Estimations
Heritability estimates were calculated on the OTU abundances, taxon bins, no-
des throughout the bacterial phylogenetic tree, a-diversity, and PICRUSt-pre-
dicted COGs using the structural equation modeling software OpenMx (Boker
et al., 2011).
Microbiota Transfer Experiments
Stool samples from the Twins UK cohort were selected as described in the
main text and inoculated into 6-week-old germ-free Swiss Webster mice via
oral gavage, with one recipient mouse per fecal donor. Mice were single-
housed. For the Christensenella minuta addition, three experiments were con-
ducted: In the first experiment, one treatment group received only donor stool
inoculum, whereas the other received donor stool amended with 1 3 108
C. minuta cells; for the second experiment, a heat-killed C. minuta control
was added; in the third experiment, the heat-killed control was compared to
live C. minuta only (no vehicle-only control). Mice were housed four per
cage, with three cages per treatment. In all experiments, mice were provided
with autoclaved food and water ad libitum andmaintained on a 12 hr light/dark
cycle. Body weight and chow consumption were monitored and fecal pellets
were collected weekly. At sacrifice, adiposity was analyzed using DEXA.
Body, mesenteric adipose tissue, and gonadal fat pad tissue weights were
collected at this time. Gross energy content of mouse stool samples was
measured by bomb calorimetry using an IKA C2000 calorimeter (Dairy One).
Wet cecal contents were weighed and resuspended in 2% (v/v) formic acid
by vortexing and measured using a gas chromatograph (HP series 6890)
with flame ionization detection.
Statistical Analysis
Values are expressed as the mean ± SEM unless otherwise indicated. Full
methods are described in the Supplemental Information.
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